The role of social supports on the financial toxicity of Cancer. by Smith, Lisa C
University of Louisville
ThinkIR: The University of Louisville's Institutional Repository
Electronic Theses and Dissertations
5-2019
The role of social supports on the financial toxicity
of Cancer.
Lisa C. Smith
University of Louisville
Follow this and additional works at: https://ir.library.louisville.edu/etd
Part of the Social and Behavioral Sciences Commons
This Doctoral Dissertation is brought to you for free and open access by ThinkIR: The University of Louisville's Institutional Repository. It has been
accepted for inclusion in Electronic Theses and Dissertations by an authorized administrator of ThinkIR: The University of Louisville's Institutional
Repository. This title appears here courtesy of the author, who has retained all other copyrights. For more information, please contact
thinkir@louisville.edu.
Recommended Citation
Smith, Lisa C., "The role of social supports on the financial toxicity of Cancer." (2019). Electronic Theses and Dissertations. Paper 3186.
https://doi.org/10.18297/etd/3186
  
 
 
 
 
THE ROLE OF SOCIAL SUPPORTS ON THE FINANCIAL TOXICITY OF CANCER 
 
 
By 
 
 
Lisa C. Smith 
B.A., University of Nevada, Reno, 1994 
B.S., University of Nevada, Reno, 1997 
M.S.S.W., University of Louisville, 2013 
 
 
 
A Dissertation  
Submitted to the Faculty of the  
Raymond A. Kent School of Social Work of the University of Louisville 
In Partial Fulfillment of the Requirements  
For the Degree of 
 
 
Doctor of Philosophy 
in Social Work 
 
 
Raymond A. Kent School of Social Work 
University of Louisville 
Louisville, Kentucky 
 
And 
 
College of Social Work 
University of Kentucky 
Lexington, Kentucky 
 
 
 
May 2019 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Copyright 2019 by Lisa C. Smith 
 
All rights reserved 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
  
 
 ii 
 
 
 
 
 
 
THE ROLE OF SOCIAL SUPPORTS ON THE FINANCIAL TOXICITY OF CANCER 
 
By 
 
Lisa C. Smith 
B.A., University of Nevada, Reno, 1994 
B.S., University of Nevada, Reno, 1997 
M.S.S.W., University of Louisville, 2013 
 
 
A Dissertation Approved on 
 
April 10, 2019 
 
 
by the following Dissertation Committee:  
 
 
____________________________________ 
Karen Kayser, Ph.D., MSW, Chair 
 
 
____________________________________ 
Barbara Head, Ph.D., CHPN, ACSW, FPCN 
 
 
____________________________________ 
Lesley Harris, Ph.D., MSW 
 
 
____________________________________ 
Jamie L. Studts, Ph.D. 
 
 
____________________________________ 
Thomas R. Lawson, Ph.D., MSW 
 
 
 
 
 
  
 
 iii 
 
 
 
 
 
DEDICATION 
 
“For from him and through him and to him all things. To him be the glory forever! 
Amen.” Romans 11:36 
 
Scott & Madisen, 
All things are possible when you have others who believe in you. Thank you for all the 
support and encouragement along the way.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 iv 
 
 
 
 
 
ACKNOWLEDGMENTS 
 Thank you to all those who made this possible. I am extremely grateful for the 
guidance and mentorship from Dr. Karen Kayser. Your encouragement to THINK BIG 
and to question ‘why not’ pushed me to achieve more than I imagined. I am a better 
person and a better researcher because you believed in me and gave me the opportunity to 
succeed. I value your advice, opinion, and friendship. 
 I sincerely thank my dissertation committee members for supporting and 
encouraging me along this path. Dr. Barbara Head, thank you for your continual support, 
comfort, and the many opportunities to grow professionally. Dr. Lesley Harris, you 
deliver the toughest of feedback with a bit of sugar. Thank you for guiding me when I 
was lost in those rabbit holes. Dr. Tom Lawson, I will forever remember that whatever I 
do, I should do with conviction. Thank you for being one of my biggest supporters. Dr. 
Jamie Studts, when I was on the verge of tears you made me laugh. Thank you for your 
humor and teaching me to be serious but not take it so seriously. I will forever aspire to 
be like you all.  
Thank you to my PhD cohort and friends. Greatest of thanks goes to Verena 
Schmidt for your willingness to listen to my project and provide affirmation and inquiry. 
To both Verena Schmidt and Georgia Anderson, thank you for being my accountability 
partners and holding me accountable; “You got this!” Dr. Sam Cotton, my dearest of 
friends, you inspire me.  
  
 
 v 
 
 I will forever be indebted to the many funders that helped support my doctoral 
education and research. I truly appreciate the funding from the University of Louisville’s 
Strategic Plan 2020 tuition award. I am thankful for the opportunities provided through 
the Kent School of Social Work. The Graduate Assistantship was instrumental in 
directing my path into oncology social work. Furthermore, the many teaching 
opportunities strengthened me as an instructor and colleague. My sincere gratitude goes 
to the American Cancer Society for funding two years of my doctoral research through 
the Doctoral Training Grant in Oncology Social Work. A world full of opportunities and 
possibilities became available.  
 A heartfelt ‘thank you’ to my family and friends for your love and support. To my 
mom Lori, whom I strive to be like in every way, thank you for never letting me give up.  
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 vi 
 
 
 
ABSTRACT 
THE ROLE OF SOCIAL SUPPORTS ON THE FINANCIAL TOXICITY OF CANCER 
Lisa C. Smith 
April 10, 2019 
Background It is evident that health care costs in the United States are astronomical and 
are expected to continue to rise. Cancer is one of the most expensive diseases to treat. As 
medical care costs continue to increase, so do insurance premiums, co-payments, and out-
of-pocket health-related expenses. Consequently, the cancer experience can have a 
negative impact on an individual’s financial stability. Although literature exists on the 
impact of cancer-related financial burden and its effects on quality of life, we do not have 
a full understanding of the nature of the financial burden on individuals and their 
families. Likewise, research on social supports has concentrated on social, emotional, 
functional, and physical well-being but not on the financial well-being of individuals with 
cancer.  
The purpose of this study, driven by the theoretical frameworks of the Transactional 
Model of Stress and Coping Theory (Lazarus & Folkman, 1984), Stress-buffering 
Hypothesis (Cohen & Wills, 1985), and the Financial Toxicity Framework (Carrera & 
Zafar, 2018) is to understand the role of social support in the relationship between 
financial toxicity and quality of life of individuals living with cancer.  
Methods This research project used a multiple methods approach composed of two 
studies. Study 1 was a secondary analysis of data from a study exploring the lived 
  
 
 vii 
 
experiences of 26 cancer survivors who self-reported financial hardship due to the costs 
of their cancer experience. Interview transcripts were analyzed using a theory-based 
direct approach to Qualitative Content Analysis. Study 2 recruited 126 participants who 
had a diagnosis of blood (Leukemia, Lymphoma or Myeloma) or breast cancer within the 
past 5 years. Using the Introduction to Mediation, Moderation, and Conditional Process 
Analysis (PROCESS) macro for SPSS, moderator and mediator analyses were conducted 
to determine the specific path by which social support intervenes in and on the 
relationship between financial toxicity and quality of life.  
Summary of Finding Findings confirm the existence, use and need for social support 
that addresses financial toxicity. Three categories were identified from the qualitative 
analyses of Study 1: Helpful Supports, Unhelpful Supports, and Gaps in Support. 
Although there was representation of several key aspects of social supports (emotional, 
informational, instrumental, and social constraint), barriers to accessing support and 
missing support emerged from the data analysis process. Further evidence from Study 2 
provides empirical support for the importance of social support on the relations between 
financial toxicity of cancer and quality of life. Received social support moderated and 
perceived social support mediated the relationship between financial toxicity and quality 
of life.  
Conclusions Social support plays a critical role in helping to protect patients from 
cancer-related financial toxicity. More needs to be done to address the financial needs of 
patients. Oncology social workers can play an essential role in assisting patients in 
averting financial toxicity.  
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CHAPTER I: INTRODUCTION 
“You treat a disease, you win, you lose. You treat a person, I guarantee you, 
you’ll win, no matter what the outcome.” 
 – Patch Adams 
  
While the systematic diagnosis and treatment of diseases such as cancer are 
obviously crucial in saving lives, they can impact a patient’s life beyond their health and 
physical well-being. People do not simply separate their health and health care into silos; 
instead, their health is deeply intertwined with their overall well-being and quality of life. 
Physical, social, emotional, and economic aspects of life can all suffer health-related 
consequences. Subsequently, patient care needs to go beyond the medical treatment of the 
disease which requires a complex understanding of attitudes and beliefs, psychosocial 
needs, the financial impact, and preferences for communication and information. It 
compels the medical field to meet the patient where the patient is currently functioning 
emotionally, socially, economically, and physically. It necessitates treating the whole 
patient and not just a fraction thereof.  
From a traditional standpoint, the goal of our medical system has been to identify, 
triage, and cure medical aliments.  However, delivering a better experience leading to 
positive overall outcomes requires a multi-faceted design of patient care. Whole patient 
care, (i.e., patient-centered care) seeks to provide care that is responsive to each 
individual’s needs and preferences. Transitioning from the traditional model to a patient-
centered one, putting psychosocial needs on par with medical needs, has been an ongoing 
  2 
effort of the Institute of Medicine (IOM). Standards proposed for patient-centered care 
and distress screening brought attention to the importance of treating the whole patient, 
emphasizing the importance of addressing psychosocial needs and concerns in the 
treatment process. Of particular interest for this work, the IOM standards highlight 
identifying those patients at risk for financial hardship (Institute of Medicine, 2013), thus, 
recognizing the impact that financial distress can have on patients.  
As the costs of medical care continue to rise, particular attention has been given to 
the financial burden and distress resulting from cancer care costs - so much so that it has 
been termed financial toxicity. The term financial toxicity encompasses both the objective 
burden and subjective distress brought on by the costs of cancer care. Objectively, 
patients face astronomical medical costs and unexpected out-of-pocket expenses. 
Subjectively, they experience overwhelming feelings of distress (Zafar et al., 2013). This 
septic situation can result in negative outcomes for patients and their families. (See the 
literature review in Chapter 2 and the framework proposed by Carrera and Zafar (2018) 
in Chapter 3 for a more detailed examination of financial toxicity.)  
In this first Chapter, I provide the significance and purpose of conducting this 
research. This includes a brief overview of the study design as well as the specific aims, 
research questions and implications for healthcare professionals, patients and the field of 
social work. 
Significance  
In the United States, a staggering estimate of 1,735,350 new cases of cancer will 
be diagnosed this year (NCI, 2018). The exact number of those patients who will 
experience financial toxicity (objective burden and subjective distress) as a result of their 
  3 
cancer experience is difficult to surmise. However, a systematic review exploring the 
extent of financial burden concluded that a “substantial amount of cancer survivors” are 
affected by the objective financial burden of cancer care (Gorden, Merollini, Lowe, & 
Chan, 2017). More specifically, two nationwide surveys reported a third (Kent et al., 
2013) to half (Pisu et al., 2015) of their participants experienced financial burden. This 
number is staggering and suggests that a substantial number of people may indeed face 
financial hardship as a result of their cancer experience.  
While there is growing empirical evidence of the financial toxicity (objective 
burden and subjective distress) faced by many cancer patients, gaps in our understanding 
of the issue still remain. Studies have attempted to better understand and describe this 
issue, yet a thorough literature search found two studies that have attempted to intervene 
on the impact of financial toxicity through an influencing variable. In one study 
researchers attempted to address financial toxicity through the use of patient navigation 
(Shankaran et al., 2018). The second study implemented the Care Payment program 
which provided patients with 0% APR lines of credit (Lessard & Solomon, 2017). This is 
indicative of a gap in knowledge regarding influences of variables that may alleviate 
financial toxicity. Further knowledge is needed to develop interventions and standardized 
practice procedures for identifying and assisting those at risk of cancer-related financial 
toxicity. It is therefore the goal of this study to provide insight into the lived experiences 
of cancer patients by understanding their use of social support and the impact of social 
support on the patients’ experience with financial toxicity. 
Purpose. The purpose of this project is to explore the role of social support in the 
context of cancer-related financial toxicity (objective burden and subjective distress). 
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This research project attempts to address the lack of information regarding factors that 
may alleviate or positively impact the experience of cancer patients and their families. 
The following overarching research question guided the development of this project:  
What role does social support play in the experience of cancer-related financial 
toxicity? 
 
In order to answer this overarching question, the following two sub-questions 
were developed: 
1. For individuals who have had cancer, what is their experience with social support 
in the context of cancer-related financial toxicity? 
2. How does social support influence cancer-related financial toxicity and patients’ 
quality of life? 
 
Project Overview 
To address these research questions, a multiple method paradigm was used. 
Multiple method designs are driven by an overarching question that is answered by two 
or more studies. The results of these studies are intricately intertwined to provide an in-
depth understanding of the inquiry, yet each study remains relatively independent of the 
other (Morse, 2003).  For this project the overarching question was addressed using two 
studies conducted sequentially but each had equal merit (see Figure 1.1 for the design 
overview). First, a study using qualitative methods was conducted identifying the 
existence, use, and need for social support in the given context. This study was followed 
by a quantitative study that sought to statistically identify the role social support played in 
the experience.  
  5 
 
Figure 1. 1 Multiple Method Design 
The data for Study 1 derived from a study that used a qualitative design involving 
semi-structured, in-depth interviews with 26 participants who reported to have 
experienced financial burden during their cancer experience. Interviews were audio 
recorded and transcribed verbatim. Transcripts were initially analyzed using 
constructivist grounded theory (CGT) techniques. From the findings, social support 
emerged as a primary theme.  
Overarching 
Research 
Question
Study 1 
Qualitative 
Design
Abductive 
Theoretical Drive
Pragmatic 
Worldview
26 Participants
In-depth Semi-
structured 
Interviews
Grounded Theory 
Technicques
Theoretical 
Sensitizing Lens -
Social Support 
Theories
Study 2
Quantitative 
Design
Deductive 
Theoretical Drive
Post-Positivist 
Worldview
126 Participants
Computer Based 
Survey
Stress and Coping 
Theory - Stress-
Buffering 
Hypothsis
Moderater &
Mediator 
Analyses
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For Study 1, a secondary data analysis used a generic qualitative approach (Caelli, 
Ray, & Mill, 2003). Theories of social support provided an analytic lens to view 
transcripts. Social supports were identified through the use of a theory-based direct 
approach to Qualitative Content Analysis. In-depth descriptions of types and uses of 
social support in the context of cancer-related financial toxicity were developed. (See 
Chapters 4 and 5 for Study 1 methods and results, respectively.) 
Deriving from the preliminary findings of Study 1, Study 2 was created to further 
explain the presence of social support and patients’ experiences statistically. Study 2 used 
a quantitative approach and relied on the theoretical foundations of the Transactional 
Model of Stress and Coping Theory (Lazarus & Folkman, 1984) and the Stress-buffering 
Hypothesis (Cohn & Wills, 1985). This study involved the development of a survey using 
reliable and valid scales as well as questions created from the qualitative study. Using an 
online platform, the survey was disseminated through several cancer-related 
organizations. A sample of 126 participants was obtained between July 2017 and 
December 2018. Moderator and mediator analyses were then performed using SPSS v25 
statistical software with the Introduction to Mediation, Moderation, and Conditional 
Process Analysis (PROCESS) macro. The purpose of the analyses was to determine if 
social support played a statistically significant role in influencing the objective burden 
and subjective distress caused by cancer care and treatment costs. (See chapters 6 and 7 
for Study 2 methods and results, respectively). 
Multiple methods rationale. The multiple method design selected for this project 
is an equally weighted qualitative then quantitative approach. The approach is driven by 
an overarching inductive drive and is geared toward answering a descriptive overarching 
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question. This design can be used to gain more insight into a topic and can eventually 
lead to the development of a framework or theory (Morse, 2003).  Since little is known 
about cancer-related financial burden and social support, this approach provided a more 
comprehensive understanding of the role social support plays in the given context. 
Although the purpose of this project is not to create theory, it may inform and expand on 
the current framework of financial toxicity as described by Carrera et al. (2018) and 
social support theories. (See Chapter 3 for an in-depth discussion of these theories.)  
Multiple method verses mixed method. Although they sound similar, few 
commonalities exist between mixed method and multiple method designs.  According to 
Morse (2003), a mixed method design is when qualitative and quantitative methods are 
being used with-in a single project. The same question(s) is(are) being answered by both 
the qualitative and quantitative strand of the study. Important to the distinction between 
the two designs, the research in a mixed method design is driven by one theoretical 
assumption. Thus, one strand of the study is dependent on the other, neither being 
considered whole without the other. It is also the expectation that one set of data be used 
to complement and then build on the information obtained from another (Terrell, 2016).  
Alternatively, multiple method designs contain relatively complete qualitative 
and/or quantitative studies within a larger project (Morse, 2003).  Multiple method 
designs are defined as a series of studies that are interrelated by topic with an overarching 
question that defines the project goal. In order to answer this overarching question, each 
component of the project is driven by its own sub-questions and maintains its own 
worldview and assumptions. Unlike mixed method designs, multiple method designs are 
not limited to using one sample population. Using the multiple method designs allows for 
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more flexibility in design allowing the researcher to obtain a broader perspective of the 
phenomena they are researching (Morse, 2003). 
Implications 
The overall aim for this study is to better understand the experience of cancer in 
regard to financial toxicity and social support. Through exploring this experience, we 
may be better able to identify and address financial issues that may result in unnecessary 
burden and distress. It is hoped that the results of this study will further inform patient-
centered care, giving healthcare professionals insight into the influencing effects of social 
support on financial barriers faced by cancer patients. Social work practice is driven by 
ethical standards to ensure the use and implementation of services that will enhance and 
improve the lives of clients served. It is therefore my desire to inform social work 
practice on the impact social support may have on cancer-related financial toxicity to 
further assist in the development of effective and efficient interventions. Lastly, it is my 
hope that this work will inform healthcare research, practice, and policy by adding to the 
existing framework of Financial Toxicity. 
Summary 
This chapter provided a brief overview of this project which identifies the 
function social support plays in easing the impact cancer-related financial burden has on 
patients and their families. It first introduced the problem and purpose geared toward 
exploring the role of social support. Then, with justification for the use of a multiple 
method design, it briefly described the studies that were used to address the overarching 
question.   
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Chapter 2 presents the literature review on cancer-related financial burden 
explaining this multifaceted phenomenon. Then it provides a definition for social support 
relying on the operationalization of social support theories. This is followed by a brief 
literature review on social support in cancer care, thus pointing out the vast array of 
literature existing in this area. Lastly, it introduces the literature on social support as a 
moderator or mediator variable, providing support and justification for proposing that 
social support may play a similar role in cancer-related financial burden. 
The outline for the remainder of this manuscript follows. Chapter 3 provides a 
more in-depth explanation of the Multiple Method Paradigm as well as introduces the 
theoretical perspectives relied on throughout this project. Chapter 4 provides a detailed 
description of the methods for Study 1 with the findings presented in Chapter 5. Then 
Chapter 6 details the methods for Study 2 with the results for Study 2 in Chapter 7. 
Finally, Chapter 8 brings the results from both studies together in an attempt to answer 
the overarching question. It concludes with a summary addressing the limitations of this 
project as well as offering suggestions for further research and implications for current 
social work and healthcare practices. 
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CHAPTER 2: LITERATURE REVIEW 
‘Too many people are forced into a situation of whatever they do have, they bankrupt 
themselves with a medical disaster. It destroys every single cent that they have, because 
they have no resources or ability to counter balance the cost of good health.” 
- Study 1 #26 (66-year-old man, Prostate & Bladder Cancer) 
 
This chapter presents the literature as it relates to the overarching research 
questions:  What role does social support play in the experience of cancer-related 
financial toxicity? Due to the multidimensional aspects of the variables used in this 
research, the chapter is divided into two separate parts. The first part examines cancer-
related financial burden as a social problem due to the exorbitant and rising costs of 
medical care. It presents literature on cancer-related financial toxicity (i.e., objective 
burden and subjective distress), the resulting impact it has on patient care, and addresses 
who is at-risk. In the second part, the literature on social support in cancer research is 
reviewed, which is followed by a literature review of social support as a moderator or 
mediator variable as social support has been shown to have more than a direct effect in 
other situations.  
Financial Toxicity of Cancer      
The financial toxicity of cancer has been a hot topic over the last decade and 
related research has grown exponentially. The following literature review is extensive, 
but not exhaustive. The primary purpose is to provide a foundational understanding of 
this complex, multifaceted issue.  
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The Situation. In the United States, cancer is among the most expensive diseases 
to treat (American Cancer Society, 2012). Cancer patients can expect to pay thousands of 
dollars more in medical expenditures than those who have never had cancer. In 2007, the 
average yearly medical expenses for a newly diagnosed cancer patient was $16,910 with 
an out-of-pocket cost of $2,149 compared to $3,303 with $679 out-of-pocket expense for 
those without cancer (American Cancer Society, 2012). Furthermore, expenses associated 
with cancer continue into the survivorship phase. The post-treatment phase can be riddled 
with expensive follow-up tests, screenings, and costly medications that may last a 
lifetime. Cancer survivors pay $3,293 -$4,187 more per year for health care than those 
without a cancer history (Ekwueme et al., 2014). Consequently, the trajectory of cancer 
treatment-related expenditures may span years, thereby putting cancer patients at risk of 
experiencing long-term financial consequences.  
Indeed, patients face high costs in care for in-patient/out-patient hospital and 
clinic visits, surgery, prescription drugs, medical treatments, lab tests, and home health 
services. These costs are alarmingly on the rise. One study suggests cancer treatment 
costs have nearly doubled in the past few decades (Tangka et al., 2010). A report on 
anticancer drug costs suggests a much greater increase. In 1995, the average cost of 
anticancer drugs for one extra year of life was $54,100; this jumped to $207,000 by 2013 
(Howard, Bach, Berndt, & Conti, 2015). A second study reported similar increases in 
costs associated with treatment duration. Before 2000, treatment costs were less than 
$10,000; by 2012, these costs escalated to over $100,000 (Kantarjian, Steensma, Sanjuan, 
Eishaug, & Light, 2014). The costs associated with cancer are astronomical and are 
expected to continue to increase (Mariotto et al., 2011; Trogdon et al., 2010). 
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Several reasons have been suggested for the rise in costs. Advocates justifying 
higher drug prices indicate the high prices are due to free market demand, as well as 
research and development costs (Kantarjian et al., 2014). Increasing demand, 
improvements in cancer awareness, screenings, and treatment lead to increases in 
diagnoses and survival rates. Currently there are nearly 14.5 million cancer survivors 
(ACS-NCI, 2014). This number is expected to grow to nearly 18 million by 2020 (Weir, 
Thompson, Soman, Moller, & Leadbetter, 2015; Mariotto, Yabroff, Shao, Feuer, & 
Brown, 2011) and 19 million by 2024 (Simon, 2014). With the increase in diagnosis and 
survivorship the demand for oncology services is expected to escalate, taxing the 
healthcare system and resulting in a shortage of oncologists (Yang et al., 2014). This 
increased demand and lack of available services is suggestive of a supply-demand 
situation leading to rising costs of care. 
Increases are also suggested to be due to research and development costs. The 
average cost of development for a new drug is estimated to be $802 million before 
approval and $900 million after approval (DiMasi, Hansen, & Grabowski, 2002). 
Improvements in current treatment, such as the development of targeted chemotherapies, 
are estimated to increase costs (Mariotto et al., 2011). As new drugs and improved 
treatments become available, these costs are passed down to patients (Howard, Back, 
Berndt, & Conti, 2016).  
Regardless of the reason for higher costs, the costs are ultimately passed down to 
patients through higher cost-sharing insurance plans. Insurance providers shift the direct 
medical care costs to patients through higher premiums, deductibles, and copayments.  
Out-of-pocket caps for many insurance plans have been mandated through policy. 
  13 
Although the cap is set for $7150 per individuals and $14,300 per family (ACS, 2017), 
this is still a hefty expense for many American families. In 2015, the Federal Reserve 
reported nearly half of Americans had to borrow or sell something in order to cover an 
unexpected $400 medical emergency (ACS, 2017).   
Inadequate Insurance. Due to the astronomical costs of care, many cancer 
patients are faced with mounting bills. Even patients with insurance can expect to pay a 
significant amount for their cancer treatment. With the passage of the Patient Protection 
and Affordable Care Act (ACA), citizens in the United States were required to have 
insurance; however, this requirement was overturned by the following Presidential 
Administration. Still, the number of those who had insurance increased from before the 
ACA was passed. Nonetheless, possessing insurance does not necessarily equate to 
affordable cancer treatment. An 80/20-medical plan offers decent health coverage with 
the insurance company covering 80% of medical costs and the patient responsible for 
20%. Yet for some cancer treatments, 20% can mean tens of thousands of dollars. Indeed 
12 of the 13 new cancer drugs released in 2012 cost upwards of $100,000 per year (Light 
& Kantarjian, 2013). This could result in a $20,000 out of pocket expense for a patient 
with an 80/20-medical plan.  Consequently, patients experience objective burden as the 
extreme costs of their health care are passed down to them through inadequate insurance 
policies. 
      Out-of-pocket expenses. In addition to high costs of care and inadequate 
insurance plans, cancer patients are often caught unaware of the out of pocket expenses 
(OOPE) that result from direct and indirect costs of treatment. Patients may experience 
increases in indirect costs such as insurance co-payments, monthly premiums and 
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medications costs. In addition, indirect care costs can accumulate, including childcare, 
housekeeping, prosthetic, over-the-counter medications, and travel expenses (Lange et 
al., 2004; Darby, Davis, Likes, & Bell, 2009).  These are costs that are not directly related 
to paying for medical expenses, but are expenses associated with having cancer. Patients 
can expect their OOPE to double what a person without cancer would pay for medical 
care (Short, Moran, & Punekar, 2011). OOPE have been found to augment the experience 
of related financial (objective) burden and lead to increased long-term financial debt 
(Lange et al., 2004; Finelstein et al., 2009; Markman & Luce, 2010; Pisu et al., 2010). In 
this respect, patients are experiencing objective burden as expenditures increase by way 
of increased insurance costs and unexpected out-of-pocket expenses.  
      Time away from work. To complicate the situation, patients may need to take 
time away from work to receive medical care resulting in lost wages (Chrikos, Russell-
Jacobs, & Cantor, 2002; Lauzier, Maunsell, De Koninck, Drolet, & Robert, 2004; 
Bradley et al, 2007; Mehnert, 2010; Zajacova, Dowd, Schoeni, & Wallace, 2015). A 
national study reported that patients experience a decline in employment and income up 
to two years before their cancer diagnosis (Zajacova et al., 2015). This may be indicative 
of a patient’s need to work less due to an impending diagnosis and needing to take time 
off for being sick. They also determined that the likelihood of being employed after a 
cancer diagnosis decreased for up to three years post-diagnosis. The study noted that it 
could take patients four to five years to recover from the financial effects and return to 
their pre-diagnosis economic state. Under these circumstances a family’s income could 
decrease by 20-40% of their annual earnings (Zajacova et al., 2015).  Additionally, some 
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patients are unable to return to work after their cancer experience due to treatment effects 
and physical decline (Stepanikova, Powroznik, Cook, Tierney, & Laport, 2015).  
Bankruptcy. Facing this financially toxic situation, patients may be forced to file 
bankruptcy in order to get out from under the accumulating medical bills (Amir, Wilson, 
Hennings, & Young, 2012). In 2007, medical debt attributed to 62% of bankruptcies. 
Most of these patients were middle-class, well educated, and owned their own home 
(Himmelstein, Thorne, Warren, & Woolhandler, 2007).  Another study found that cancer 
patients are 2.65 times more likely to file for bankruptcy then those without cancer 
(Ramsey et al., 2013). Patients have also noted losing possessions including their homes 
as a result of their experience (Amir et al., 2012). Inevitably cancer can increase a 
person’s risk of financial ruin that could take decades to overcome.  
      With costs of cancer treatment increasing, lack of adequate health insurance 
coverage, costs of OOPE, need for long-term follow-up care, and lost wages, many 
cancer patients are faced with astronomical medical expenses. It is undeniable that these 
costs can result in financial ruin for many individuals and their families. This toxic 
condition can then negatively impact patient’s quality of life (QoL) and feelings of well-
being.  
Psychosocial impact. It is evident that the costs of cancer diagnosis, treatment, 
and follow-up care can cause subjective distress. Further review of the literature indicates 
the detrimental effects on patients’ psychosocial well-being due to the costs of care. The 
following section reviews the psychosocial impact on patients as well as methods used by 
patients to offset cancer care expenses.  
  16 
      Effects of stress. It is well known in health-related research that chronic stress and 
depression can negatively affect a person’s immune system, increase inflammation, 
impede the healing process (Kiecolt-Glaser, McGuire, Robles, & Glaser, 2002) and lead 
to more severe infections or chronic health conditions (Schneiderman, Ironson, & Siegel, 
2005; Godbout & Glaser, 2006; Mohd, 2008). In particular, a study with breast cancer 
patients determined that chronic stress was associated with DNA repair, immune 
function, and tumor growth processes (McGregor, & Antoni, 2009). Furthermore, studies 
with cancer patients have found that patients who experience cancer-related financial 
burden are more likely to experience higher anxiety and depression levels then those who 
do not (Wong et al., 2010; Sharp, Carsin, & Timmons, 2013). As cancer-related financial 
burden increased so did anxiety and distress. Left unaddressed, cancer-related financial 
burden may lead to psychological distress, further health problems and slower recovery 
from cancer treatment. 
      Non-adherence. Another related issue affecting patient health and recovery is 
non-adherence to the treatment plan. It is estimated that more than 2 million Americans 
do not abide by recommended treatment due to costs (Weaver, Rowland, Bellizzi, & 
Azia, 2010). Non-adherence to medical treatment is defined as not taking prescribed 
medication, taking less medication than prescribed, or not filling or partially filling 
prescriptions. Many cancer patients reported that associated financial burden influenced 
their medical decision-making and treatment choices forcing them to make financial 
sacrifices to offset the costs of treatment (Wong et al., 2010). Patients have reported non-
adherence with medical advice and treatment, further jeopardizing their health. In fact, a 
quarter of participants in a national study reported that they did not follow recommended 
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treatment because of the costs associated with that treatment (Weaver, Rowland, Bellizzi, 
& Azia, 2010; Markman et al., 2015). Patients chose to skip medications or only partially 
fill prescriptions (Markman et al., 2015) and forgo other non-essential health care such as 
dental and eye care (Kent et. al., 2013; Bernard et al., 2011; Bullock, Hofstatter, Yushak, 
& Buss, 2012; Shankara et al., 2012; Zafar et al., 2013).  Indeed, patients are being faced 
with difficult financial decisions that can adversely affect their general health, nutrition, 
and recovery, potentially affecting long-term survival.  
     Strategies to offset costs. Faced with financial burden, patients use a variety of 
strategies to offset the costs of treatment and defray expenses. To help pay for their 
medical expenditures, patients resort to using their savings, selling possessions, 
borrowing from others, and relying on credit cards (Bernard, Farr, & Fang, 2011). These 
efforts may result in the patient feeling indebted to others and/or trapped in increasing 
credit card or loan debt. Similarly, patients have sold stocks and investments, and 
withdrawn money from their retirement accounts (Shankara et al., 2012). Other strategies 
used involved cutting back on discretional spending such as decreased spending on 
leisure activities, food, and clothing (Bernard, Farr, & Fang, 2011; Wong et al., 2010; 
Zullig et al., 2013). Although these efforts may be financially beneficial, cutting out 
items an individual enjoys may negatively affect their emotional and social well-being. 
Consequentially, these methods may add to the experienced subjective distress.  
      Furthermore, financial toxicity (objective burden and subjective distress) has been 
shown to negatively affect a patient’s psychosocial well-being and QoL (Ell et al., 2007; 
Meneses, Azuero, Hassey, McNeew, & Pisu, 2012; Gupta, Lis, & Grutsch, 2007; Fenn et 
al., 2014). Patients are forced to make sacrifices that can negatively affect themselves and 
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their families. These compounding effects can negatively affect the overall experience 
and place patients under further stress, thereby complicating their general health and 
financial situation. 
Who Is at Risk for Financial Hardship? Determining exactly which cancer 
patients are at risk for financial toxicity is challenging. The National Cancer Institute 
reports that the type of cancer, it’s level of severity, and treatment type as well as age, 
race, income, job and insurance status can all make an individual susceptible to financial 
toxicity. More specifically, a recent systematic review of 25 peer-reviewed articles found 
that being female, younger aged, lower income, extended therapies and time since 
diagnosis were associated with financial toxicity (Gordon et al., 2017). 
The literature reviewed for this chapter suggest other factors can put patients at 
risk as well. Insurance status showed those with private non-group insurance (Bernard, 
Farr, & Fang, 2011), Medicaid or lacking insurance coverage (Shankaran et al., 2012) 
were at risk. Being older middle-aged (55-64 years old) (Bernard el al., 2011) or older 
then 65 (Negut et al., 2011) put patients at risk. Shankaran et al. (2012) found other 
variables placed patients at higher risk. These included lower educational level, rural 
residency, multiple chronic health conditions, never married or widowed, and one or no 
children. In addition, Kent et al. (2013) reported risk was associated with a history of 
prior cancer treatment, and a shorter time since initial diagnosis. Furthermore, several 
studies agreed that individuals from minority racial groups were more likely to report 
financial burden as well as experience worse health outcomes (Bernard et al., 2011; 
Shankaran et al., 2012; Kent et al., 2013; Chirikos, Roetzheim, McCarthy, & Iezzoni, 
2008). Two studies also reported that work-related status of disability, unemployment, or 
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leaves of absence from work predicted financial burden (Bernard et al., 2011; Shankaran 
et al., 2012). Evidently, attempting to clearly define who is at risk of financial toxicity 
(objective burden and subjective distress) is complicated as few commonalities exist 
among studies. Conceivably the costs of cancer care can affect anyone depending on the 
type of cancer, treatment expenses, resources available, and personal circumstances.  
Impact on family. It is generally accepted that cancer does not only affect the 
individual but can negatively impact the entire family (Bradley et al., 2007; Amir et al., 
2012). Similarly, cancer-related financial toxicity can also plague the patient’s family. 
Family members may need to quit their jobs or take time off to become caregivers (Carey 
et al., 2011). Individuals may need to give up outside employment to take care of their 
loved one. This can have a direct impact on the family member’s financial well-being 
(Grunfeld et al., 2004). The family members may experience loss of access to resources. 
This has been shown to negatively affect a family member’s health and access to health 
care as they may delay their own health concerns or general check-ups due to a lack of 
funds or insurance to access care (Grunfeld et al., 2004).  The financial situation therefore 
contributes to the experience of caregiver burden.  
Social Support in the Literature 
Up to this point, I have cited the literature providing evidence for the impact of 
financial toxicity. The next half of this chapter will cover social support in cancer. The 
breadth and depth of literature on social support is vast and covers a plethora of 
situations. For the purposes of this part of the literature review, articles were retrieved 
that consider social support as a direct influence on health-related outcomes in cancer 
patients and survivors. Then another search was conducted to obtain articles that focused 
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on social support as a moderator or mediator variable in both cancer studies and other 
health-related studies.  
Social Support in Cancer. It is well known that adequate social support serves as 
a protective factor for people facing crisis or traumatic experiences (Cobb, 1976). The 
cancer experience is no exception to this. Several studies have identified social support as 
an important component having a direct relationship with health-related consequences 
over the cancer trajectory.  
In the literature, low social support or lack of social support is associated with 
negative health-related outcomes. Social support has been shown to have a direct 
relationship on cancer disease progression in patients with breast cancer (Nausheen, 
Gidron, Peveler, & Moss-Morris, 2008) and acute myelogenous leukemia patients 
(Pinquart, Hoffken, Silbereisen, & Wedding, 2006). Lower levels of social support were 
found to predict patient mortality in acute myelogenous leukemia patients (Pinquart et.al., 
2006). Furthermore, another study found that patients with lower social support at 
diagnosis were at risk of developing negative physical symptoms such as pain and 
inflammation (Hughes, 2014).   
Social support has also been associated with the emotional well-being of patients. 
Those with lower levels of social support were more likely to experience higher 
depression (Uchitomi et al., 2000; Schroevers, Ranchor, & Sanderman, 2003; Eom, 2012; 
Hughes, 2014) and anxiety levels (Uchitomi et al., 2000). In a longitudinal study with 
cancer patients, those with lower levels of problem-focused emotional support displayed 
higher levels of depression (Schroevers, 2003). Moreover, perceived social support and a 
desire for social support were strong predictors of anxiety and depression symptoms in 
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newly diagnosed cancer patients (Linden, 2009). For those patients with a lower desire 
for support, if support was not present, they experienced increased depression. These 
studies support that the lack of support can be detrimental to patient’s mental and 
emotional well-being. 
Conversely, patients with higher levels of social support appear to gain health-
related benefits. The more emotional support cancer patients had post diagnosis was a 
significant predictor of positive outcomes of treatment up to 8 years post treatment. 
(Schroevers, Helgeson, Sanderman, & Ranchor, 2010). Furthermore, social support has 
had a direct positive relationship with physical exercise and nutrition in cancer survivors 
(Barber, 2012; Coleman, 2014). More specifically, increased perceived social support 
positively influenced physical and mental health related QoL (Westby, 2016) and overall 
QoL (Eom, 2012). Emotional and information support have also been associated with 
increased social, emotional and functional well-being (Kroenke, 2013). In this same 
study, increased tangible supports were related to increased physical, and social well-
being as well as overall QoL (Kroenke, 2013). Interestingly and in support of theory, the 
level of satisfaction with social support was found to be a predictor of patients’ QoL but 
the size of their social network was not (Cheng et al., 2013). This suggests that perceived 
or received social support is more important than the number of individuals available in 
one’s network to provide the support. Furthermore, although no study was found to 
determine the best types of social support, one study showed that received social support 
had a stronger influence and satisfaction than perceived (Schroevers et al., 2010) 
Lastly, in a qualitative study of patients undergoing chemotherapy, several 
benefits of social support emerged in their data. Social support assisted patients in 
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focusing on the bigger picture and adapting to living with cancer. It helped them steer 
from negative thoughts and aspects of cancer as it enabled them to engage in normal 
everyday activities. Furthermore, social support was instrumental in patients finding hope 
and support (Mattioli, 2008). 
Social Support: An Influential Variable. For decades social support has been 
shown to have an influence on QoL by helping to maintain and promote emotional and 
physical well-being (Cobb, 1976; Cohen & Syme, 1985). To further this discussion the 
following section reviews the social support literature in the context of moderator or 
mediator variables. These articles are not specific to cancer although many of them are. 
The purpose of this review is to support the concept that social support can interact as an 
influential variable between the relationships of other variables.  
Social support has been found to be a significant factor in coping with cancer-
related stress. In the prior section social support was shown to have a direct effect on 
health and QoL but it also can moderate or mediate aspects within the cancer experience. 
In breast cancer patients, perceived social support was shown to moderate the effects of 
cancer-related negative thoughts on patient QoL (Lewis et al., 2001). In gynecological 
cancer patients, received social support was shown to moderate the effects of cancer-
related traumatic stress on physical symptomatology; patients with greater perceived 
social supports reported fewer cancer-specific symptoms than those with poorer 
perceived social supports (Carpenter, Fowler, Maxwell, & Andersen, 2010). In a second 
study with breast cancer patients, social support mediated the negative association 
between optimism and distress (Trunzo, & Pinto, 2003). Perceived social support was 
found to mediate optimism and positive affect in non-cancer specific survivors, thus, 
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social supports protected against negative psychological outcomes. This study also 
showed that social supports had a direct effect on positive affect (Hodges, & Winstanley, 
2012).  
Another study considered the impact of social constraint which occurs when 
social support is interpreted by the support received to be negative or non-help. In the 
literature reviewed social constraint was explored in breast and colon cancer patients. In 
this study, social constraint was seen as a mediator variable between optimism and 
patient affect. They also determined that patients who were more optimistic had fewer 
social constraints but did not necessarily have more social support (Lepore et al., 1999). 
In studies focused on general health, received social support has been found to 
buffer the experience of financial stress on psychological well-being in general health 
research. Aslung, Larm, Starring and Nilsson (2014) examined the effects of financial 
stress on the psychological well-being and psychosomatic symptoms of individuals in the 
general population in Sweden. Although financial stress still had a substantial impact on 
emotional and physical well-being, those with more tangible social supports were 
significantly better off than those with less. Additionally, the level of stress increased 
significantly for those who had low social support (Aslung et. al., 2014).  These findings 
are indicative of the buffering effect social support provided for the psychological well-
being of those experiencing financial stress. 
The literature reviewed discussed the importance and value of social support and 
how it can make an impact, both positive and negative, on an individual’s experience. We 
have also observed how social support can act as a direct or indirect variable which can 
interact as a moderator or mediator variable in different situations.  
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Gaps in the Literature 
There have been several studies conducted on the financial burden of cancer. 
Although this is not an exhaustive review of the literature, it provides us with an intricate 
view of this complex issue. Still, there is much to be learned.   There remains an inability 
to truly identify those at-risk. This lack of understanding may lead to unmet patient 
needs, and further exasperate the lack of access to financial assistance. Another issue is 
the lack of understanding of the process by which financial burden occurs. By better 
identifying key time periods in the cancer trajectory, interventions may be employed 
strategically. Another piece to the puzzle may be understanding help-seeking behaviors 
as they relate to financial aspects. Socially, taboo issues have long constrained people 
from talking about such issues as politics, religion, sex, and money. Furthermore, in my 
literature search, I was only able to identify two interventions that have been tested for 
effectiveness in addressing cancer-related financial burden.  
It is apparent that more information is needed to fully understand this 
phenomenon and variables which may play a positive role in relieving the negative 
impact. As viewed through the literature on social support, it is apparent that it plays an 
important role in the cancer experience and has been shown to be a stress-buffer for 
financial strain in other contexts.  In response to these findings, it is my intention to 
expand on the given literature by examining the role of social support in the context of 
cancer-related financial burden. 
Summary 
 Despite awareness and efforts to improve patient care, little is being done to 
address the financial burden that cancer patients endure. Although literature exists on the 
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impact of cancer-related financial toxicity and its effects on QoL, it is evident that we do 
not have a full understanding of the experience faced by many cancer patients. This 
research study strives to add to the literature by exploring the impact of social support as 
an influential factor in the lived experience of cancer. By gaining this knowledge, social 
work practice and research will be better informed to identify and work with those 
individuals at risk. 
As presented in the literature reviewed, social support can have positive effects on 
health and wellness. Furthermore, it can act as a direct or indirect variable having a 
moderator or mediator effect. Nonetheless, there is a lack of knowledge regarding the 
influence of social support on experienced financial toxicity during and after cancer 
treatment. It is apparent that social support has a relationship with patient survival and 
QoL. In addition, social support has also been shown to have an impact on the perception 
of financial stress in another context. However, it is unclear how social support may 
impact an individual’s experienced financial toxicity throughout the cancer trajectory.  
The next chapter will present the theoretical perspectives and frameworks that 
support this project suggesting that social support may indeed play an important role. 
Chapters 4 and 5 provide the methods and results for Study 1 respectively. Likewise, 
chapters 6 and 7 provide the methods and results for Study 2. A final discussion bringing 
the results of both studies to address the overarching questions will conclude in Chapter 
8.   
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CHAPTER 3: MULTIPLE METHOD APPROACH, RESEARCH PARADIGMS, AND 
THEORETICAL PERSPECTIVES 
It is human nature to be inquisitive about the world that surrounds us. We have a 
strong desire to understand why, where, what, and how. We strive to comprehend a 
problem and find solutions. These questions and our desire to find answers to them is the 
driving force behind our research inquiry. In order to answer these questions researchers 
are faced with deciding how best to accomplish this task and are reliant on the 
philosophical and theoretical perspectives with which they align.  
Research is deeply intertwined with these perspectives and the role they assume 
has been much debated with varying degrees of agreement.  It has been my experience, in 
attempting to navigate this philosophical maze, there are multiple ways to philosophically 
approach a research question. This poses a task for the researcher to identify the best way 
to logically approach their question.  Furthermore, they must be able to justify their 
decisions to align with a given design, philosophy, or theoretical perspective. 
In order to address the overarching research question that drives this project: What 
role does social support play in the experience of cancer-related financial toxicity 
(objective burden and subjective distress)? I selected a multiple methods approach. This 
chapter will first present the Multiple Method design and justify its use. The Multiple 
Method approach is structured differently from other research designs as multiple 
independent studies are used to answer the overarching question. Therefore, it is 
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important to understand the overall design of the project before presenting the 
philosophical assumptions for each study component.   
Our philosophical assumptions consist of a basic set of beliefs used to approach a 
study. They suggest how we understand what reality is and dictates our role as a 
researcher to observe or interact intimately with the study.  Philosophical assumptions 
guide our values and ethics suggesting an acknowledgement of presence or absence of 
bias. Furthermore, the philosophical alignment we take dictates the research methods we 
use (Guba & Lincoln, 2005). After presenting the foundational design of this Multiple 
Method project and the use of multiple studies, this chapter will cover the philosophical 
assumptions for each study component.  
The final step in laying down the foundational pieces of this project will cover the 
theoretical perspectives and frameworks that gave steady footing to the project. Theories 
provide us with a way of understanding and explaining human behavior. They can serve 
multiple roles in the research process, such as, guiding the development, implementation, 
analysis procedures, and interpretation of a study (Bradbury-Jones et al., 2014). These 
theories and the work of Hayes (2017) give rise to a conceptual model which will be 
reviewed at the end of this chapter. 
Multiple Method Design 
Mixed Method and Multiple Method approaches are considered to be “in the 
middle of a boom” as an increasing number of researchers are relying on them 
(Seawright, 2016, p.42). Creswell and Clark (2011) suggest such methods are appropriate 
to further understand a phenomenon when using one data source is insufficient, if there is 
a desire to generalize findings, or a second method will further enhance the study’s 
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findings. The use of multiple research strategies will help broaden the breadth and scope 
of understanding and provide a more complete picture of the phenomena (Morse, 2003). 
By combining different research strategies, it is suggested that the strengths of one 
method will compensate for the weaknesses of another leading to more credible outcomes 
(Hunter & Brewer, 2015). However, due to the novelty of this relatively emerging 
approach to research, terminology and methodological expectations are still murky.  This 
section will attempt to provide clarification to the Multiple Method approach relied on for 
this project.  
 As presented in Chapter 1, Multiple Method approach begins with an overarching 
question and is composed of multiple individual studies that attempt to answer that 
question. Each study is considered to be interrelated with another in that they attempt to 
answer the same question, but they are separate and whole. Each study has its own sub-
question and is guided by its own philosophical assumptions (Morse, 2003). For this 
project, two studies were conducted sequentially but had equal importance: first the 
qualitative and then the quantitative. From the qualitative study, social support was 
identified as an important concept. This led to a desire to understand more about the role 
social support played and informed the development of the quantitative study. More 
details about the methods of each study a presented in Chapter 4 (Study 1 Methods) and 
Chapter 6 (Study 2 Methods).  
When designing a Multiple Method project each study component must be 
methodologically independent and executed separately. They must adhere to the specific 
methodological assumptions for each (Morse, 2003). Therefore, the qualitative will meet 
the assumptions consistent with qualitative research and likewise for the quantitative. In 
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addition, the study samples are typically independent from one another adding to the 
concept that these studies are separate from one another.  The final step of a Multiple 
Method design involves bridging the results to form a comprehensive understanding in 
response to the overarching question. (See Figure 3.1 for a depiction of the overall 
Multiple Method design showing the differences in methodology, and philosophical 
assumptions.) 
 
There are several benefits of using a multiple method approach. As stated earlier, 
multiple method approach allows for a comprehensive picture of the phenomenon that is 
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Figure 3. 1 Multiple Method Design Theoretical Focus 
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under investigation. This approach allows for different perspectives on the topic by 
providing opportunities for the use of different theoretical lens and worldviews. By 
collecting multiple forms and different levels of data, a wider variety of conclusions can 
be ascertained. This approach will provide insight into the personal experiences of 
individuals exploring what types of social support helped them during their cancer 
experience. It will also provide statistical significance of social support in this context 
either by moderating or mediating the experience of financial toxicity on quality of life 
(QoL). In turn, this may inform and expand on the current framework of financial toxicity 
presented later in this chapter. 
Weaknesses of the multiple method approach include the risk of placing too much 
credence or weighting to heavily on the results of the studies (Morse, 2003). Therefore, 
similar to other methods, the researcher should not overexaggerate the study finding but 
instead approach them modestly. In addition, Morse (2003) warns of the importance of 
being aware of the theoretical drive at all times in the process. This is dictated by the 
overarching question and design; however, each study component is driven by inductive 
or deductive reasoning depending on the particular aspect and sub-questions of each 
study. Specifically put, if using qualitative methods then inductive reasoning is the 
driving force; whereas, if using quantitative methods then deductive reasoning is relied 
on.  In order to maintain methodological integrity each method must stay intact. It is 
important to not allow the studies to contaminate each other by ensuring their 
independence. Likewise, each study sample should be appropriate for the method used 
and adequate data analysis performed. Morse (2003) also stresses the importance of not 
violating assumptions. 
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In light of these warnings, each component of this project will be conducted 
separately and will align with each respective assumptions and theoretical lenses. Each 
will be driven by their separate theoretical drive and will address appropriate sub-
question(s) for the given method. The qualitative study will use subjective data and an 
abductive theoretical drive involving iterative cycles of deductive and inductive 
reasoning (Graneheim, Lindgren, & Lundman, 2017). The quantitative will use objective 
data, deductive reasoning, standardized measures, and statistical analysis. The following 
section will present the philosophical assumptions relied on for each component of the 
project. 
Philosophical Foundations 
Philosophical assumptions are deeply rooted in the way we think about the world. 
They are ingrained in our thoughts and instilled in us through our education and training. 
Philosophical assumptions used depend on our approach to address a particular problem 
or social phenomenon.  There are four philosophical assumptions used in the research 
process: ontology, axiology, methodology and epistemology. Ontology refers to reality 
and how it is the researcher knows and understands what reality is. Axiology conveys the 
role values and ethics play in the research process. This helps the researcher understand 
the use or hindrance of their biases. The stance the researcher takes in regard to Ontology 
and Axiology dictates the epistemology. The epistemology refers to the researcher’s role 
and their understanding of the interaction between themselves and what is being studied. 
These philosophical assumptions lead to the way the research is conducted, namely the 
methodology and the specific methods used (Creswell et al., 2011). Each of these four 
  32 
elements (ontology, axiology, epistemology, and methodology) are woven together and 
provide a philosophical foundation referred to as an interpretive framework.  
An interpretive framework conveys a basic set of philosophical assumptions. 
Heeding the warnings presented by Morse (2003) in the prior section, each study will be 
conducted separately using the interpretive framework that best serves the aims of each 
study. The overarching question and Study 1 will use a pragmatic interpretive framework 
and Study 2 will rely on the post-positivist stance.  See Table 3.1 for an at-a-glance view 
of the philosophical assumption for each interpretive framework used. 
Table 3. 1Philosophical Assumptions of Two Worldviews (adapted from Creswell et al., 
2011). 
 Ontology 
(what is 
real) 
Axiology 
(values & 
ethics) 
Epistemology 
(role) 
Methodology 
(theoretical drive) 
Pragmatism 
(Overarching 
Project, 
Study 1) 
Both Single 
& Multiple 
Realities 
Multiple 
Values & 
Perspectives 
Focuses on 
Whatever 
Answers the 
Question 
Dependent on the 
Question 
(Inductive or 
Deductive 
Reasoning) 
Post-
Positivism 
(Study 2) 
 
Focused on 
Single 
Reality 
Researcher 
Eliminates 
Biases  
Quantitative 
Methods 
Deductive 
Reasoning 
 
Pragmatic Worldview. The pragmatic worldview is primarily focused on finding 
answers to the research question. In regard to Ontology, the pragmatist takes the view 
that reality can be both a single reality and/or multiple (Creswell et. al., 2011). Reality is 
a creation between what is in the world and how we react to it; therefore, what we know 
and understand of the world is based on what we have found to be proven useful (Ritzer 
& Stepnisky, 2013). Similarly, pragmatic axiology (role of values) proposes that an idea 
is neither good nor bad, but value depends instead on the success of its outcome 
(Hookway, 2016).  The researcher can therefore use whichever epistemological design 
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will answer the question. Methodologically a pragmatist is not limited to viewing a 
phenomenon one directionally but instead is open to the any possibility the data presents 
(Hookway, 2016). Essentially, the pragmatic worldview appears to be sitting on a 
proverbial fence selecting from either side of the continuum what will best help them 
answer their question. 
Due to a seemingly flexible stance, the pragmatic approach works well for the 
Multiple Method design. The focus is therefore on the question being asked and the 
respective outcomes of the individual studies, not necessarily on the methods used to 
obtain them (Creswell et al., 2011). In this project the results from both the qualitative 
and quantitative studies are triangulated to answer the overarching question. The 
theoretical drive, methodological stance, is inductive which is in line with the 
overarching question format and conception of bringing the findings from both studies 
together to form an overall interpretation. 
Pragmatism also informs the philosophical beliefs for Study 1. A generic 
qualitative approach allows for the use of varying epistemologies and methodologies. 
Caelli et al. (2003) propose that each qualitative approach be evaluated in congruence 
with its epistemological and methodological stance. Qualitative research should aim to 
address: 1) the theoretical position, 2) methodology and methods, 3) rigor and 
trustworthiness, and 4) the analytic lens used to examine the data (Caelli et al., 2003). A 
pragmatic perspective supports drawing from both deductive and inductive theoretical 
views using an abductive theoretical stance. Similarly, a pragmatism allows for multiple 
analyses methods and tool to be incorporated and used. Rigor and trustworthiness in a 
generic qualitative approach can be established by similar efforts used in other forms of 
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qualitative approaches as well. Furthermore, a pragmatic worldview allows for the 
reliance on multiple theories informing the analytic lens.  
Postpositivist Worldview. The post-positivistic worldview is a logical stance for 
quantitative research (Creswell et. al., 2013) and will be relied on for Study 2. It seeks to 
establish causal relationships by concentrating on established variables. The ontology is 
focused on a singular reality which can be derived through scientific methodology and 
driven by a deductive process (Creswell et al., 2013). Using measures that are proven 
reliable and valid helps the research to establish claim that a phenomenon does exist as a 
common, singular reality. Established measures also assist the researcher in eliminating 
biases (axiology) which can also be addressed through the study design and aspects of 
rigor.  This, therefore, allows the research to remain impartial and allowing the 
presentation of the data to dictate the findings. Through the use of structured theoretical 
perspective/frameworks, this quantitative study relied on philosophical assumptions of 
Post-positivism: deductive reasoning, standardized measures, and statistical analysis.  
Theoretical Perspectives 
Theories are intimately interwoven into the research process. They serve as 
frameworks for understanding what we observe and how we make sense of it. They guide 
our research development leading us to ask important questions. They can postulate a 
basic concept and lead us in a common direction. Theories can also be created and 
emerge from our own research findings. The way theories are used in the research 
process is determined by the goals of the research project, and the methods used 
(Bradbury-Jones, Taylor, & Herber, 2014).  
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The theories I relied on can be classified as substantive and formal theories. 
Substantive theories are those that are specific to a given topic and based on empirical 
findings; whereas, formal theories are conceptually derived (Glaser, & Strauss, 1967). 
These theoretical perspectives were relied on to develop, implement, and interpret the 
findings of this project. 
Financial Toxicity. The Financial Toxicity framework (Carrera & Zafar, 2018) 
was used in both studies of this project. In a recent publication, Carrrera et al. (2018) 
present their framework for the financial toxicity of cancer care. (See Figure 3.2 for a 
replication of Carrera’s et al. (2018) interpretation of the financial toxicity framework.)  
This framework provides a conceptual understanding of the objective burden and 
subjective distress associated with the costs of cancer care. This framework served as a 
foundational piece for conceptualizing the problem and understanding how social 
supports fits into the process.  
 
 
   
Figure 3. 2 Framework on Financial Toxicity (Carrera & Zafar, 2018). 
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Financial Toxicity refers to the financial objective burden and subjective distress 
experienced as a result of a cancer diagnosis and treatment. From an objective standpoint, 
patients face financial burden due to direct and indirect costs associated with their cancer 
care (Carrera et. al., 2018). As presented before, the costs of cancer care are astronomical, 
and many patients are faced with unexpected out-of-pocket expenses. Financial barriers 
exist such as being underinsured or uninsured which can be further complicated by forced 
changes in employment status.  Patients make financial sacrifices such as selling 
belongings, reducing household spending and using savings. They may borrow money 
and use credit cards leading to increased financial debt which may result in bankruptcy. 
Subjectively the costs of care impact the patients experience and psycho-social well-
being (Carrera et. al., 2018). Research has shown that patients report feelings of anxiety 
and distress. Furthermore, this multi-complex phenomenon (financial toxicity) not only 
impacts the patient, but it adversely effects the family as well.  
These subjective and objective experiences of financial toxicity lead to potentially 
overall worse outcomes for patients and their families. As a result, a patient may choose 
to be non-adherence to medical treatment which may result in poorer health-related 
outcomes (Carrera et. al., 2018). Furthermore, financial toxicity can lead to worse quality 
of life. (Details on financial toxicity and supportive literature are presented in Chapter 2.) 
Social Support Theories. Social support is a term used to describe the product of 
one’s support network and interactions. It is well known in the cancer literature that 
social support plays a critical role in physical health, psychological well-being, social 
functioning and emotional adjustment among survivors and those living with cancer.  For 
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the purposes of this research project it is conceptualized as: the emotional, informational, 
and instrumental supports perceived and/or received from formal and informal support 
networks.  
According to Sarason, Sarason, and Piece (1990) there are three models of social 
support: 1) network of support, 2) received supports, and 3) perceived supports. Each of 
these models describes important information about social support and helps to provide a 
more comprehensive conceptualization of the concept. The first model, network of 
support, often looks at the number of people who surround the individual and the types of 
those relationships. This is a laborious process for the study participant, time consuming 
for the researcher, and does not necessarily yield a connection between social support and 
health outcomes (Sarason et al., 1990).  Given these concerns, I focus attention on the 
other two models: received and perceived supports. The extent to which networks are 
explored in this project is limited to whom the participant receives support from or 
perceives to be supported by.  
      A support network is made up of the social relationships that surround the 
individual and is composed of family, friends and community members (Laireiter, & Urs, 
2013). This is composed of the people an individual interacts with. These relationships 
are considered formal or informal depending on the social role the network member 
plays. Formal support network members are typically from distant roles including 
individuals such as health care professionals and organizations. They typically perform 
more informational or instrumental support services (Cohen, 2013). Informal supports, on 
the other hand, are intimately close relationships consisting of family members and 
friends. They may provide informational, instrumental and emotional types of support. 
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Interestingly, whether or not a behavior is perceived as supportive is dependent on the 
provider of the support as well as the timing of when the support occurs (Cohen, 2013). It 
is important to be aware of the social role the supporter plays, the timing of the received 
social support and the support receiver’s perception of the supportive act.  
      As noted, social support can be perceived or received. The perception that social 
support exists is based on the viewpoint of the receiver. In general, the receiver thinks or 
feels that support is available. Received support can be objectively measured either by 
self-report or reported by others (Laireiter et al., 2013). From the receiver’s perspective 
these are social supports that are actually received. Both perceived and received supports 
can be in the form of emotional, informational, or instrumental.  
      Emotional support refers to the understanding that one is accepted, cared for and 
valued (Cohen & Syme, 1985). It can exist in the form of empathy, encouragement, 
reassurance, or feelings of being understood, accepted and loved (Langford, Bowsher, 
Maloney, & Lillis, 1997; Wong et al., 2016). Emotional supports may be received 
through others communicating support or having someone who is willing to listen and 
understand. It can also be a perception of knowing someone cares and would be available 
if needed.  
      Another category of support is informational support. This is defined by Cohen 
and Syme (1985) as one’s ability to find knowledge and information to better understand 
the problematic event. Informational supports are most needed when a stressful event, 
such as a cancer diagnosis, exceeds the knowledge and problem-solving abilities of that 
individual. Therefore, the individual is required to seek advice, knowledge, and guidance 
from others. Examples of received informational support are problem-solving advice, 
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receiving resource information and referrals. Informational support can be a perceived 
sense of support in the form of knowing that access to information or advice is available 
if requested (Langford et al., 1997; Wong et al., 2016). Ultimately, individuals need to 
know where to find the information or who to ask.  
      The final form of support that will be considered is instrumental support which 
consist of provided assistance with tasks, tangible, and material support (Cohen & Syme, 
1985). Instrumental support for the issue of cancer-related financial toxicity may be in the 
form of financial assistance, providing material goods such as food and other daily-living 
necessities, or assistance with completing household chores. Similar to the other two 
forms of support, access to instrumental support can be a perception that this type of 
assistance and resource is available if needed, or it can be actually received. 
Conditions of social support. To add another layer of complexity, certain 
conditions need to be met before social support is requested by the individual or provided 
by a network member. For a person to request assistance the request cannot be something 
that would potentially harm the relationship and the individual must feel comfortable in 
the relationship to make a request. The network member must know enough about the 
stressor, be capable of providing support and not overreact to the request being made. If 
the network member overreacts, the individual may feel embarrassed or ashamed of 
asking. The need for the request must be socially acceptable and perceived as a legitimate 
stressor. Socially taboo stressors may cause feelings of guilt or shame which may prevent 
the individual from requesting help or the network member from providing it. 
Additionally, if social norms dictate the necessity of providing support, then support will 
likely be provided. (Cohen, 2013). Therefore, the giver feels on obligation to provide 
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support. Lastly, in order for social support to be most effective the support received must 
match the need (Cutrona & Russell, 1990). If the support does not match the need, the 
need will still remain leaving the individual feeling unsupported. 
Social constraints. Ideally, social support provides one with positive elements that 
help to provide feelings of comfort, encouragement, helpful information or usable items; 
however, social support can also be perceived or interpreted as negative (Lepore & 
Ituarte, 1997; Lepore & Revenson, 2007). Network members may say or do things that 
are interpreted by the individual as inappropriate, critical, or insensitive (Hobfoll, & 
Stephens, 1990; Cohen, 2013). They may attempt to minimize the stress-event or perhaps 
avoid and abandon the individual all together (Hobfoll et al., 1990; Veiel & Baumann, 
2013). Life events such as having cancer may elicit avoidant or minimizing behaviors 
from network members (Veiel et al., 2013). This may complicate the situation further 
making it difficult for individuals to talk about their problem or ask for help.  
Feeling socially constrained, patients keep their thoughts and feelings private. 
They become less likely to share or disclose their emotional and physical needs. They 
may feel they cannot talk to anyone about what is causing them distress (Veiel et al., 
2013). This leads to the individuals feeling isolated and unsupported. Ultimately, the 
individual may experience mental health issues (Lepore et al., 2007) such as depression 
(Schroevers et al., 2003), increased distress and mood disturbances (Norton, 2005).  
Stress and Coping Theory. The Transactional Model of Stress and Coping 
Theory (referred to as Stress and Coping Theory) developed by Lazarus and Folkman 
(1984) was designed to explain how individuals experience a stressful event, assess 
related risks, and select coping methods. This is a process-oriented approach for dealing 
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with stress that involves cognitive assessment of a stressful event through the appraisal 
process and then selection of the best coping method. The effectiveness of the coping 
mechanism, in turn, dictates the outcome (Lazarus, & Folkman, 1984; Folkman, 1997; 
Folkman & Greer, 2000; Folkman, 2010). When new information is acquired, re-
appraisal of the event occurs creating the reselection of coping mechanisms and potential 
effects on outcome (Folkman, 1997; Folkman, 2010). The following section will briefly 
review components of this theory within the context of cancer-related financial toxicity 
(objective burden and subjective distress). Refer to Figure 3.3 for a depiction of the Stress 
and Coping Theory in the context of cancer-related financial toxicity. 
 
 
 
 
 
 
 
 
 
  
 
Stress event. According to Lazarus and Folkman (1984), stress is a response to a 
stimulus that induces a stressful physiological and behavioral response. It results when 
these demands overburden the individual, exceeding their available resources, and 
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potentially risk the person’s sense of stability and well-being. For example, the stress-
causing event may be a risk of harm, or unexpected demand placed on the individual. In 
the context of this study, the initial stress events are cancer and the costs of cancer care. 
Initially, patients experience increased expenditures related to their cancer care (objective 
burden). The actual costs or an anticipation of the costs of care may become 
overwhelming and result in effects on psycho-social well-being (subjective distress). 
 In time, the patient may experience a secondary stress event which occur through 
the feedback loop. Objectively, patients may be unable to work resulting in reduced 
income and potential job loss causing an additional stress event. Furthermore, a job loss 
could impact insurance availability and ability to cover medical and basic daily needs. 
Cancer patients may also face an accumulation of medical bills and related expenses. 
These stress events may then be interpreted to cause harm which in turn leads to use of 
coping mechanism resulting in an outcome.   
      In addition, the outcome can result in the subjective distress aspect of financial 
toxicity. The effects of stress on cancer patients have been well supported in the 
literature. As noted in Chapter I, research has shown that cancer patients who experience 
financial burden have increased anxiety, depression (Sharp et al., 2013) and distress 
(Markman et al., 2010; Lange et al., 2004). Patients have also reported long-term 
financial strain as a result of related OOPE (Darby, Davis, Likes, & Bell, 2009).  The 
subjective distress could also lead back to the appraisal process through the feedback 
loop and becoming another stress event.  
      Appraisal. Once a person experiences a stress event, he/she engages in the 
appraisal processes. This is a cognitive process where the individual contemplates the 
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stress event and desired outcome. During the appraisal process a person gains an 
understanding of a given situation and assesses whether the stress event is benign or 
threatening to their feelings of well-being (Lazarus et al., 1984; Folkman, Lazarus, 
Gruen, & DeLongis, 1986).  
      The appraisal of a stress event occurs during three phases: primary, secondary, 
and re-appraisal (Folkman, 1997). The primary and secondary appraisal processes can 
occur simultaneously. During the primary appraisal a person will assess if a situation is 
irrelevant, benign-positive or stressful. Then during the secondary appraisal, the 
individual determines what, if anything can be done. The individual assesses what coping 
options are available, and which will be effective. Then they determine if they have the 
ability to effectively execute that particular coping method. The final phase of appraisal 
occurs when the individual becomes aware of any new information that may affect the 
situation. This is referred to as the re-appraisal process since the individual re-assesses 
the situation through both the primary and secondary processes.  
 In the context of this study, individuals experience the stressor (initial cancer and 
cost, secondary objective burden and subjective distress) and then in the first appraisal 
process they assess the stress event as harmful or overwhelming. This may follow or 
occur simultaneously with the second appraisal process where the individual determines 
the best course of action to gain the best possible outcome given their available coping 
mechanisms and resources.  
      Coping. Once the stress event has been appraised, the individual engages in a 
coping response.  Coping responses include anything a person thinks or does to manage 
the stress-event. Coping responses are influenced by the uniqueness of the individual and 
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may be good or bad depending on the interaction between the individual and their 
environment (Lazarus et al., 1984; Folkman et al., 1986; Folkman and Greer, 2000; 
Folkman, 2010).   
Coping responses for those experiencing cancer-related financial toxicity are well 
documented in the literature. Many of these responses are not beneficial to a patient’s 
overall health and mental wellness. In one study, patients reported skipping or delaying 
medical treatments (Darby et al., 2009). Medical non-adherence is not uncommon among 
individuals who experience cancer-related financial toxicity. Patients will also base 
medical decisions based on the costs associated with the doctors’ appointments and 
medical treatment (Markman et al., 2010; Wong et al., 2010; Shankaran et al., 2012). 
Other coping methods used by patients involved cutting back discretionary spending, 
selling possessions, using saving and retirement funds (Shankaran et al., 2012), 
borrowing money, and increasing debt (Bernard et al., 2011). Although these types of 
coping methods may temporarily alleviate the stress allowing the patient to get through 
the cancer experience, arguably they can result in negative outcomes impacting overall 
quality of life. 
      Outcome. The outcome is the result of the appraisal and coping processes 
(Lazarus et al., 1984). Depending on the effectiveness and the available coping resources, 
individuals may be able to carry on with their everyday activities or they may be 
immobilized and in a state of crisis. For the purpose of this proposed study, quality of life 
will be used as the outcome variable. 
Understandably financial toxicity can impact multiple domains of quality of life: 
social, emotional, functional, physical and economical. For example, social well-being 
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may be affected when individuals cut back on discretionary spending. They may not be 
able to afford to engage in social activities causing them to potentially lose social 
relationships. Likewise, this could affect their functional well-being. Individuals may not 
be able to afford to do things they once enjoyed doing. In the emotional domain, financial 
toxicity may cause an increase in sad or hopeless feelings when coping strategies are not 
effective. Individuals may feel powerless as their financial situation negatively affects 
their economic well-being.  
Quality of life is often used as an outcome variable in research on cancer-related 
financial toxicity. Several articles have shown that cancer-related financial burden has a 
negative relationship with quality of life (Ell et al., 2007; Gupta, Lis, & Grutsch, 2007; 
Fenn et al., 2014). As patient financial strain increases, their quality of life decreases.  
Stress, coping and financial toxicity. The stress and coping theory provides a 
basic model for understanding the effects and outcomes of cancer-related financial 
toxicity (objective burden and subjective distress). See Figure 3.3 (presented earlier) 
which illustrates how the initial stress events (cancer and cost of care) enacts the primary 
and secondary appraisal processes. Financial toxicity (the objective burden and subjective 
distress) is appraised and coping resources are assessed which leads to the coping 
response which in turn leads to patient outcomes and/or reassessment through the 
feedback loop.  
Stress-Buffering Hypothesis. The stress-buffering hypothesis can be used to 
suggest that social support buffers the individual from adverse effects of a particular 
stress event. It builds upon the conceptualized framework of Stress and Coping Theory. 
(See Figure 3.4 for the addition of social support as a stress buffer to the Stress and 
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Coping Theory in the context of financial toxicity). According to Cohn and Wills (1985), 
social support may intervene with the stress and coping process during the appraisal 
process and/or the coping response.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
    
First, social supports may buffer the interaction between the stress event and the 
appraisal process (Cohen & Wills, 1985). Due to perceiving or receiving adequate 
support, individuals may not perceive the stress event to be as harmful or threatening as it 
would without those supports. A second point of support intervention may occur during 
the coping response process (Cohen & Wills, 1985). This may then cause the re-appraisal 
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Figure 3. 4 Social support on financial toxicity interpreted by Stress and Coping Theory 
and Stress-buffering Hypothesis. 
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process to occur due to the acquisition of new information. This new information could 
be in the form of problem-solving advice, information or resources that may ease or 
eliminate the stress.  
      It is important to note that in order for the social support to be an effective buffer, 
the support provided must match the demands of the stress event (Cohen & Wills, 1985). 
Therefore, in the context of this proposed study, social support that helps to alleviate 
financial toxicity would act as a buffering agent. Currently there is no empirical support 
defining what this type of social support would be; however, the benefits of social 
support on health have long been established (see the literature review in Chapter 2 for 
more details).    
Conceptual Model 
There are two different ways a third variable can act as a buffer, either as a 
moderator or a mediator. A moderator variable will regulate the relationship between the 
independent variable and the dependent variable. The moderator variable may change the 
direction or the magnitude of the IV, maximizing or minimizing its effectiveness on the 
dependent variable. For study 2, social support will be examined to determine if it is a 
moderator variable regulating the relationship between financial toxicity and quality of 
life. Figure 3.5(a) displays the conceptual interpretation of social support as a moderator 
variable. 
In addition to this framework, a moderated moderator model will further examine 
the moderator effects by adding social constraint to the model. Social constraint has been 
shown by the works of Lepore et al. (1999) to negatively impact the benefits of social 
support. See Figure 3.5(b) for social support as the moderated moderator model (Hayes, 
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2017). In this model, social constraint is conceptualized to regulate the interaction 
between financial toxicity and social support; therefore, the relationship between 
financial toxicity and QoL is moderated by social support which in turn is moderated by 
social constraint. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Alternatively, a mediator creates a mechanism through which the independent 
variable is able to influence the dependent variable. According to Hayes (2017), 
mediation offers a causal explanation for what is occurring in the phenomenon. It 
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Figure 3. 5 Social support as a moderator variable, adapted from the work of Hayes 
(2017). 
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assumes the relationships in the analysis are causal. It therefore assumes financial toxicity 
has a direct causal relationship with QoL and an indirect effect on QoL through the 
mediator variable, social support. In this mediator relationship, financial toxicity leads to 
an increase in social support which in turn effects QoL. In this study, I will not be able to 
unequivocally establish causality due to the study design and the data available for this 
analysis. That will be noted as a limitation of this study; however, the analysis for a 
mediation variable will allow for some interpretation. (See figure 3.6 (a).)  
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Figure 3. 6 Social Support as a Mediator Pathways. 
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Furthermore, social constraint will be examined in the mediator analysis as well. 
This analysis will use a moderated mediator model (Hayes, 2018). It examines the impact 
of social constraint on the relationship between perceived social support and quality of 
life. (See Figure 3.6 (b).) 
Summary 
Researchers are tasked with identifying the best method to use to answer their 
research questions.  For the purposes of answering the overarching question presented in 
Chapter 1, I chose to conduct a Multiple Method approach. This approach allowed me to 
draw conclusions from both qualitative and quantitative methods allowing for different 
perspectives and procedures to inform the discussion. As noted, there is a gap in the 
literature in regard to social support and cancer-related financial toxicity accordingly this 
multiple method approach will help to provide a broader perspective.  
In addition, this chapter has addressed the foundational components underling the 
development of this project. The Multiple Method design requires that the individual 
studies be whole and complete. This requires the use of the appropriate philosophical and 
theoretical perspectives to answer the study questions.  The assumptions, theoretical 
perspectives and frameworks for each study were presented, each providing the 
individualistic approach to each study component.  
The next chapter provides detailed descriptions of the methods used. To remain 
true to the Multiple Method design as described by Morse (2003), each component of the 
project will be discussed as separate studies. The first part of Chapter 4 covers Study 1 
(qualitative) followed by Study 1 results in Chapter 5.  Chapter 6 and 7 presents the 
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methods and results for Study 2. Then Chapter 8 presents a final discussion drawing on 
the finding from both studies to answer the overarching questions. This will also include 
concluding remarks and implications for social work practice.  
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CHAPTER 4: STUDY 1 METHODS 
The overarching question that drives this research project is: What role does 
social support play in the experience of cancer-related financial toxicity? To answer this 
question a multiple method approach was used. Two studies were developed each 
answering an aspect of the overarching question. To stay true to the assumptions of the 
multiple method approach as presented in Chapter 3, each study was conducted 
separately and is considered to be solely complete by itself. Study 1 is presented first as it 
was the first study to be completed and aspects of the findings were used in the 
development of Study 2. The present chapter details the methods used for Study 1.  
Study 1 - Qualitative  
Study 1 was a secondary data analysis of a qualitative study that explored the 
lived experiences of 26 cancer survivors who self-reported experiencing financial burden 
and distress (financial toxicity) due to the costs of their care. Secondary data analysis of 
qualitative data is not a common practice but has been acknowledged in the literature as 
an acceptable method (Smith, Ayanian, Covinsky, Landon, McCarthy, Wee, and 
Steinman, 2011).  I was involved with the original study (LEFT study) from its inception 
and participated in all aspects of the process. Social support emerged as a primary 
category, so the research team granted me permission to use this data.  
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Purpose  
The specific aim of my analysis was to better understand the existence and use of 
social support within the lived experience of cancer-related financial burden. It 
specifically explored the research question: For individuals who have had cancer, what is 
their experience with social support in the context of cancer-related financial toxicity? 
Pragmatism. Pragmatic philosophical assumptions were relied on in order to 
seek and understand this phenomenon. (Refer to Chapter 3 for in-depth details on the 
pragmatic worldview). The pragmatic worldview is focused on answering the research 
question through whatever tools or methods are most appropriate. This viewpoint allows 
for the use of multiple theories which not only provide the foundational support for the 
study but also informs the analysis and interpretation of the results.  
From a pragmatic stance, I used a generic qualitative approach informed by Caelli 
et al. (2003). Since the generic qualitative approach does not align with any specific 
epistemology or methodology it is acceptable to use with pragmatism. Caelli et al. (2003) 
states that the epistemology and methodology used should be congruent. This leaves the 
researcher tasked with clearly identifying and substantiating their research according to 
four key issues: 1) a well-defined analytic lens, 2) a clear theoretical position, 3) 
congruence between epistemology, methodology and selected methods, and 4) establish 
rigor and trustworthiness (Caelli et al., 2003).  
The analytic lens used for this study was social support theories. (For in-depth 
details on the conceptualization of these theories refer to Chapter 3.)  This involved a 
back and forth process between social support theories and the data analysis process. 
Relying on a theoretical abductive drive, processes of deductive and inductive reasoning 
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were incorporated (Graenheim et al., 2017).  Through the analysis procedures, a primarily 
deductive approach was used to categorize the data. This process was followed with an 
inductive approach of developing in-depth definitions for each category. (Further 
explanation of these steps will be provided later in this chapter.) It is through this 
inductive process that a greater understanding can emerge (Charmaz, 2014). Calling on 
pragmatic roots, multiple methods of iterative processes that can occur through the data 
analysis phase. These iterative processes will highlight similarities and differences in the 
data (Miles and Huberman, 2014). Furthermore, the generic qualitative methodology 
allows for selecting methods which will inform and answer the study questions.  
For this study, Qualitative Content Analysis (QCA) was the most appropriate 
method and remained congruent with the methodology (generic qualitative approach). 
Content analysis must be “systematic, methodologically based, and transparently 
reported” (Drisko & Maschi, 2016, p. 4). It can be used for secondary data analysis and 
can be driven by inductive and/or deductive coding approaches (Drisko & Maschi, 2016). 
Furthermore, it QCA uses deductive methods to organize data into categories and 
inductive methods to create definitions of those categories (Mayring, 2000).  
Data in this study are organized into categories through a direct approach. The 
purpose of the direct approach is to validate or expand on a given theoretical framework. 
The direct approach uses a theory-based approach to coding where codes are informed or 
developed through using theory or relevant research findings (Hsiu-Fang & Shannon, 
2005). These codes can remain manifested, meaning that they are grounded in the data 
staying true to the participants’ words. On the other hand, the codes can be latent in 
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nature allowing the researcher to immerse in the data and identify hidden, underlying 
meanings (Bengtsson, 2016). 
Congruent with pragmatism, the generic qualitative approach and QCA, 
trustworthiness can be established through multiple methods. Results for the QCA can be 
displayed in a table format to give readers a quick glance at the material. In addition, 
quantification of sub-categories and categories can occur through counting occurrences of 
the identified unit of analysis (Bengtsson, 2016). Quantification can increase the 
magnitude of the phenomena being studied. However, according to Mayring (2000), 
QCA follows the rules of content analysis except it does not require the quantification of 
the data. Further efforts to establish trustworthiness can be borrowed from other 
qualitative methods such as those proposed by Lincoln and Guba (1985).  
Study Sample. Sampling methods that were used to obtain participants include: 
criterion, snowballing and purposive. Initially, patients were obtained from a recruitment 
announcement posted in cancer centers, cancer support organizations, churches, and the 
University of Louisville daily e-news. It became clear that there was not much 
representation from the older adult population so purposive sampling was used to acquire 
more older adults. A total of 26 participants met the criteria and participated in the 
interviews.   
Inclusion criteria. In order to participate, participants needed to be age 18 or 
older, had a cancer diagnosis and received treatment in the past 5 years. They also needed 
to perceive that they experienced financial hardship due to the cancer experience.  
Data Saturation. Data collection was conducted until the research team 
determined saturation of data was reached. The process of determining data saturation 
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involved multiple discussions regarding the data that had already been collected.  The 
team of researchers conducted initial data analysis and identified common categories 
among all the interviews. Then conducted an assessment of the age ranges of the 
participants. It was determined that the sample was missing representation of older 
adults; therefore, the researchers purposely requested participation of individuals who 
were over 60 years old. Once an adequate representation of all age groups was achieved, 
the research team determined that the study had reached saturation.   
Data Management. In order to ensure study integrity and confidentially for 
participants, data were carefully maintained. Audio files were transcribed and then 
destroyed. All identifiable information was removed from transcripts and data were kept 
in a password protected computer. The transcripts were also maintained in DedooseTM 
which is an online qualitative analysis program. DedooseTM provides a secure online 
platform for handling qualitative work.  
Study Procedures. The following section begins by detailing the steps taken by 
the research team in the Origins section. It details how the initial categories of the larger 
qualitative study were determined using a theory-based approach and how Gaps in 
Support emerged from the analysis. This is followed by a description of my analysis 
process found in the Social Support Analysis section. 
Origins. Financial burden associated with cancer treatment was identified as 
being a topic that dramatically affects patients and their families. After conducting a 
literature review, a research team was assembled to develop a study proposal. Once 
developed, study procedures were reviewed and approved by the Institutional Review 
Board. A call for study participation was sent out through various means: university 
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system announcements, cancer related organization emails and area church 
correspondence. Interested participants responded by email or telephone and went 
through a screening process. Participants were asked a series of questions to determine if 
they met the study criteria (presented below). Those who met criteria were scheduled for 
an interview.  
A team of researchers, consisting of three university professors, two doctoral 
students and a research assistant, conducted 26 one-on-one interviews. Interviews were 
conducted in a private setting convenient to the participant. Interviews took place over 
Skype if the participant was located in a different city than the interviewer. Other 
locations included participants’ homes or their workplace offices, as well as offices 
located on the university campus.  
Prior to each interview the participant was provided the consent preamble (see 
Appendix A for details). For those meeting over an online format, the preamble was 
emailed to them prior to the interview. Each interview began with a brief explanation of 
the study then participants were asked a series of semi-structured interview questions 
designed to elicit in-depth information regarding their related experience (see Appendix 
B for the interview schedule). Participants were asked about their cancer experience and 
when they first began to feel financial hardship. They were asked about their 
understanding of their medical expenses and insurance as well as how they coped with 
the financial stress. Interviews were recorded, professionally transcribed, and analyzed 
using qualitative data analysis software, DedooseTM.  
After the completion of the interview, participants were asked to complete a 
questionnaire (see Appendix C). This questionnaire consisted of measures for 
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sociodemographic information including age, gender, marital status, ethnicity/race, 
marital status, number of dependent children, income, job status before and after cancer, 
occupation, insurance status before and after cancer, and cancer disease characteristics. 
Other standardized measures were used as well and included quality of life, health 
literacy, and financial toxicity.   
Using a constructivist grounded theory (CGT) approach as described by Charmaz 
(2014) and Corbin and Strauss (2008), data collection and analysis were conducted. Once 
a few interviews were conducted, data analysis began with line-by-line coding. Each 
member of the team assisted in this process initially. Focus codes were developed by 
grouping similar initial codes and then a codebook was established using the more 
frequent codes. The first ten interview transcripts were coded in DedooseTM using the 
codebook. After a discussion of the interview transcripts and coding process, a finalized 
codebook was established by the research team.  
After each interview and coding session, the research team met to debrief, 
discussing the interviews and reflecting on the individuals’ experiences. During each 
meeting, the research team would evaluate the questions and interview format to ensure 
that the interviews were obtaining the richest information possible.  
All members of the research team engaged in the coding process for all of the 
interviews. Throughout this process, researchers engaged in inter-rater reliability checks 
to ensure rating consistency. A feature of DedooseTM analysis software assists researchers 
in building and maintaining inter-rater reliability (Sociocultural Research Consultants, 
LLC, 2014). Through this feature an initial pooled Cohen’s kappa statistic of 92% was 
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achieved. After differences were discussed and raters came to agreement on variances, a 
Cohen’s kappa statistic of 100% was reached.   
Moving beyond the coding process, themes were identified. The research team 
decided to divide the themes among the members of the team for further analysis. Social 
support was one of the themes identified and given my interest in social support as well 
as my active participation in the study, the research team provided me with the task of 
further exploring this component.  
Social Support Analysis. The following section details the analysis of the data 
that I conducted for Study 1. 
Overview. This section will provide a brief overview of the steps I carried out 
after receiving permission from the team to further analyze. 
1. IRB approval was current for the original study; therefore, I did not need 
to request approval. The data were used in accordance with their oversight. 
2. Interview transcripts were read multiple times and then uploaded to a new 
DedooseTM file for analysis.  
3. Categories were informed and developed from social support theories 
using the theory-based direct approach of QCA (Hsiu-Fang & Shannon, 2005).  
4. Using the theory-based categories, transcripts were first analyzed in 
DedooseTM and meaningful excerpts were identified (Mayring, 2000; Drisko & Maschi, 
2016, Bengtsson, 2016).  
5. Excerpts were extracted from the data and transferred into an Excel 
workbook. They were then analyzed using a Partially Ordered Meta-Matrix table for 
cross-case analysis (Miles, Huberman & Saldana, 2014). 
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6. I engaged in several forms of memo writing throughout the data analysis 
process (Charmaz, 2014; Corbin & Strauss, 2013; Miles et al., 2014). 
7. Data interpretation and drawing conclusions involved developing links 
within and between subcategories based on social support theories (Creswell, 2013; Miles 
et al., 2013).  
8. Subcategories were consolidated when appropriate and in-depth 
descriptions and definitions of each category and subcategory were created (Bengtsson, 
2016; Hsiu-Fang & Shannon, 2005; Mayring, 2000). 
9. Situational mapping (Clarke, 2005). 
10. Development of Trustworthiness through the use of multiple techniques 
(Bengtsson, 2016; Creswell, 2013; Lincoln & Guba, 1985; Padgett, 1998). 
Detailed analysis. I created a new project in DedooseTM and uploaded the 26 
interview transcripts from the LEFT study. I decided to start with clean transcripts instead 
of going back to the ones originally used with all the prior codes. This allowed me a 
fresh, unhindered look at the data.  
First, I started with reading and re-reading the transcripts. As I did, I began to 
recognize patterns that resembled social support theories.  Participants clearly spoke 
about receiving information, emotional, and instrumental support as well as experiencing 
social constraints. Simultaneously, I recognized a clear distinction within the excerpts of 
who provided the support. In most situations, individuals spoke specifically about the 
person who provided the support. These excerpts were further organized on a system 
level by support provider: family, friends, medical professionals, work, and other 
organizations. In social support theories, whether or not an action is considered 
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supportive is in part dependent on who the person is that provides the support. Therefore, 
it made sense to me to further delineate quotes into these network categories. In response 
to observing these patterns, I selected to use a theory-based direct approach to coding 
(Hsiu-Fang & Shannon, 2005). Therefore, the codebook was developed to reflect social 
support theories. (See codebook in Table 4.1). In addition to these theoretical codes, other 
codes were created to fully capture interviewees’ experience. 
Table 4. 1 Theory-based Codebook Used in DedooseTM 
Category Sub-
category 
Network Member 
Sub-category 
Description 
Helpful 
Support 
Emotional Support   
 
Family - Spouse  Emotional support from spouse that is helpful and 
supportive. 
 
Family - Parent  Emotional support received from a Parent that is 
considered to be helpful and supportive. 
 
Family - Sibling  Emotional support received from a Sibling that is 
considered to be helpful and supportive. 
 
Family - Child  Emotional support provided from the Child that is 
considered to be helpful and supportive. 
 
Family Member  Emotional social support from a Family Member Not 
Otherwise Specified that is considered to be helpful 
and supportive.  
 
Friends  Emotional support from Friends is considered to be 
helpful and supportive. 
 
Medical 
Professional - 
Nurses  
Emotional support provided by Nurses that is helpful 
and supportive. 
 
Work/Employment  Emotional support provided by an employer, boss, 
work agency that is considered to be helpful and 
supportive. 
  
Organizations  Emotional support provided by a Professional 
Organization that is considered to be helpful and 
supportive. 
Informational Support   
 Family - Spouse  Information received from Spouse. 
 
Family - Parent  Information received from a Parent that is helpful and 
supportive. 
 
Family - Sibling  Information received from a Sibling that is considered 
to be helpful and supportive. 
 
Family - Child  Information provided by the Child that is helpful and 
supportive. 
 
Friends  Information received from Friends considered to be 
helpful and supportive. 
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Medical 
Professional - 
Doctors  
Information received from Doctors that is considered 
to be helpful and supportive. 
 
Medical 
Professional - 
Social Worker  
Information received from a Social Worker that is 
considered to be helpful and supportive. 
 
Medical 
Professional - 
Hospitals/Cancer 
Centers  
Information received from Hospital/Cancer Center is 
considered to be helpful and supportive. 
  
Organization  Information provided by a Professional Organization 
that is considered to be helpful and supportive. 
Instrumental Support   
 
Family - Spouse  Instrumental support from a Spouse that is helpful and 
supportive. 
 
Family - Parent  Instrumental support from a parent that is considered 
to be helpful and supportive. 
 
Family - Sibling  Instrumental support from a Sibling that is considered 
to be helpful and supportive. 
 
Family - Child  Child provides an instrumental support that is helpful 
and supportive. 
 
Family Member  Instrumental support received from a family member 
that is not otherwise specified and is considered to be 
helpful and supportive. 
 
Friends  Instrumental support provided by Friends that is 
helpful and supportive. 
 
Medical 
Professional - 
Doctors  
Instrumental support provided by Doctors that is 
considered to be helpful and supportive. 
 
Medical 
Professional - 
Financial 
Counselor  
Instrumental support provided by a financial 
counselor that is considered to be helpful and 
supportive. 
 
Medical 
Professional - 
Nurses  
Instrumental support provided by Nurses that is 
considered to be helpful and supportive. 
 
Medical 
Professional - 
Social Workers 
Instrumental support provided by Social Workers 
considered to be helpful and supportive. 
 
Medical 
Professional - 
Hospitals/Cancer 
Centers  
Instrumental support provided by the Hospital/Cancer 
Center that is considered to be helpful and supportive.  
 
Work/Employment  Instrumental support that is provided by an employer, 
boss, work agency that is considered to be helpful and 
supportive. 
  
Organization  Instrumental support provided by a Professional 
Organization that is considered to be helpful and 
supportive. 
Non-
helpful 
Supports 
Social Constraint   
 
Family - Spouse  Emotional support from a spouse that is not helpful or 
supportive.  
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Family - Spouse  Instrumental support from a spouse that is not helpful 
or supportive. 
 
Family - Parent Emotional support from a Parent that is not helpful or 
supportive. 
 
Family - Parent Instrumental support from a Parent that is not helpful 
or supportive. 
 
Family - Sibling  Emotional support from a Sibling (brother/sister/in-
laws) that is not helpful or supportive. 
 
Family - Sibling Instrumental support from a sibling that is not helpful 
or supportive. 
 
Family - Child  Instrumental support from a child that is not helpful or 
supportive. 
 
Family - Child   Emotional social support from a Child that is not 
helpful or supportive. 
 
Family Member  Social support from family members that is not 
helpful or supportive. 
 
Friends Social Support from Friends that is not helpful or 
supportive. 
 
Medical 
Professional - 
Doctors  
Social support from Doctors that was not helpful or 
supportive. 
 
Medical 
Professional - 
Nurse  
Social support from a Nurse is not helpful or 
supportive. 
 
Medical 
Professional - 
Social Workers  
Social support from a Social Work is not helpful or 
supportive. 
 
Medical 
Professional - 
Financial 
Counselor  
Social support from Financial Counselor/Navigator 
that is not helpful or supportive. 
 
Medical 
Professional - 
Hospital/Cancer 
Center  
Social support from the Hospital or Cancer Center 
that is not helpful or supportive. 
 
Work/Employment  Social support from coworkers or employers that is 
not helpful or supportive. 
  
Organizations Comments on social support from organizations that 
are not helpful or supportive. 
Gaps in 
Support 
Missing Support   
 
Family Expected social support from a family member is not 
available. 
 Friend Expected social support from a friend is not available. 
 
Medical 
Professional - 
Doctor  
Social support that could have been provided by 
Doctors. 
 
Medical 
Professional -Nurse  
Expected social support from a Nurse is not available. 
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Medical 
Professional -
Social Worker 
Expected social support from a Social Worker is not 
available. 
 
Medical 
Professional -
Financial 
Counselor  
Expected social support from a Financial Counselor is 
not available. 
 
Medical 
Professional -
Hospital/Cancer 
Center 
Expected social support from a Hospital/Cancer 
Center is not available. 
 
Work/Employment  Social support that could have been provided by 
employers. 
  
Professional 
Organizations  
Expected social support from Professional 
Organizations is not available. 
Miscellaneous Categories   
 
Desire for Help Statement about wanting help, services, resources 
from any level of support. 
 
Difficulty Asking 
for Help 
Expressed difficulty talking to others and asking for 
help. 
 Embarrassing Stated financial situation caused embarrassment. 
 
People don't want 
to talk about it 
Expressed feelings that others did not want to talk 
about financial concerns.  
  
Supports Needed  The expressed desire for social support. Provided 
advice to improve services: Instrumental & 
Informational.  
 
To ensure all excerpts of social support were captured by the analysis, I re-read all 
the transcripts once excerpts were selected. In addition, in order to maintain integrity with 
the original analysis, all excerpts of social support initially identified were compared to 
those identified in my analysis. There were only a few differences which were discussed 
with another research team member then included in the analysis.  
The next analysis step was to create a partially ordered meta-matrix in Excel 
described by Miles and Huberman (2014). This heuristics technique, used for exploring 
qualitative data, assists the researcher by condensing large overwhelming amounts of data 
into a visual “at-a-glance” format. The process provided another method to use to reflect 
on the data and draw conclusions from them.  
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A partially ordered meta-matrix displays the participants case-by-case and in 
joining cells condenses relevant data. In order to do this, I downloaded excerpts from 
DedooseTM and compiled them into four different Excel workbooks organized by the type 
of person who provided the support (support provider). The four excel workbooks were 
each labeled: 1) Family, 2) Friends, 3) Medical Professionals, and 4) Organizations & 
Work. The first spreadsheet in each Excel workbooks provided an at-a-glance overview 
of the analysis using the sensitizing lens of social support. The first column contained a 
box for each participant code with demographic information. Then additional columns 
were created for each category of social support: instrumental, emotional, information, 
perceived, and negative support (social constraint). As I engaged in this analysis process 
a sixth column was created to include when social support was missing. For example, 
participant #1 indicated that she did not have anyone to talk to about her financial 
concerns. This was indicated in the sixth column. At this point, I systematically marked 
who provided that type of support by putting the person’s role in the column of the type 
of support that was provided. (See Appendix D for visual examples of the partially 
ordered meta-matrix.)  
To further help with the organization of the analysis, I created individual 
spreadsheets for the Family, Medical Professional, and Organization Excel workbooks 
breaking down each category further by support provider role. For example, spreadsheets 
in the Family Excel workbook included spouses, parents, children, siblings and other 
members.  On these excel sheets, the participant and their specific quote about social 
support was inserted. I also used this form to provide additional thoughts on the quotes 
and shorten notation of what the quote was about. These processes and at-a-glance charts 
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allowed for a deeper understanding of the what, who, and most importantly the gaps 
found within the experiences of these participants.  
Through further reflection, I began to recognize commonalities between each of 
the support provider groups. The additional thoughts and shorten notations that I had 
made on each quote became concepts of which to collapse the data cohesively together. 
Using an inductive process, descriptions of each category and subcategory were created 
with the assistance of memo writing activities (Bengtsson, 2016; Hsiu-Fang & Shannon, 
2005; Mayring, 2000). The outcomes that evolved through this process are discussed in 
the result section found in Chapter 5. 
Memo writing. Charmaz (2014) emphasizes the importance of memo writing as it 
helps the researcher to remain active and stay engaged in the data. Memo writing serves 
several functions such as forcing the researcher to work conceptually and enabling them 
to work creatively giving insight into the data. Memos offer clarity, magnify important 
ideas and generate meaning (Corbin & Strauss, 2015). Memos can be done in different 
ways and serve numerous purposes. First and foremost, the memo writing that I engaged 
in throughout the data analysis and interpretive process was a methodological journal. 
This allowed me to keep an ongoing record of the analytical steps I was engaging in.  It 
provided me with a safe space to explore fleeting thoughts and engage in reflexivity to 
maintain data integrity. Other memos took on a more structured purpose. For these types 
of memos, I followed direction and prompts provided by Charmaz (2014, p.183) and 
Corbin & Strauss (2015). See Appendix E for the outline used for memo writing 
activities and an example of one of my memos. The exercise of memo writing helped to 
provide connection and tease out distinctions within the data. Many of my memo writing 
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excerpts were elaborated on and used in the results and interpretation section of this 
manuscript.  
Data interpretation. Interpreting the findings of the data is an active process of 
making sense of the phenomenon. According to Creswell (2013), several forms of 
interpretation can evolve from the researcher’s engagement and understanding of the 
data. Personal perspective as well as social constructs emerge from the data analysis and 
memo writing processes. Here the researcher is tasked with deciphering links within and 
between subcategories (Creswell, 2013; Miles et al., 2013). These links, according to 
Glaser (1978), are based on a deductive theoretical process. Charmaz (2014) takes this 
process deeper to state that it needs to emerge from the data; therefore, the focus is on the 
emerging theory or knowledge not on the imposing framework.  
During the interpretation process of this study, I actively used social support 
theories as frameworks to understand the context and experiences of the study 
participants. This required building and constructing an understanding of the data 
informed by the categories and subcategories. This was accomplished through the memo 
writing processes as well as using situational mapping technique described by Clarke 
(2005). See Appendix F for examples. The process of using deductive and inductive 
reasoning to interpret the data was a useful way to show that social support theories exists 
in this context and allowed for other findings to emerge (see findings in Chapter 5).  
Trustworthiness. In order to ensure the findings are valid and genuine I used 
several forms of trustworthiness. The development of trustworthiness for this study has 
been guided by criteria established by Lincoln and Guba (1985). Careful consideration 
was given to establishing these key concepts of trustworthiness: credibility, 
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transferability, dependability, and confirmability, where possible (Cohen & Crabtree, 
2006).  
The concept of credibility is to have confidence in the outcomes of the analysis 
and to believe that these finds are indeed correct and true (Lincoln et al., 1985). Lincoln 
and Guba (1985) offer several ways to accomplish credibility in qualitative processes. Of 
these options, I engaged in peer debriefing and negative case analysis. The peer 
debriefing process requires the researcher to discuss research analysis procedures and 
findings with a peer.  The peer listens and asks questions of the researcher, the findings, 
and the processes in an attempt to keep the researcher honest and true to the data 
(Creswell, 2013). Throughout the analysis process I met weekly with a colleague who 
was not involved in the original study. This was a mutually supportive process where we 
both provided feedback and guidance to each other in our analysis processes. This 
process assisted me in remaining true to the participants voices and gaining a clearer, 
deeper understanding of the data.  
Another technique for credibility that was used is negative case analysis. I 
identified several cases that did not have excerpts of social support from specific people 
such as a spouse, family, and medical professional category.  In addition, I documented 
instances of negative social support. These negative cases were pinnacle in the 
examination of social support in this context.  These cases were reviewed for insight into 
why supports were deemed to either be missing or negative.   
In addition to peer debriefing and negative case analysis, I compared the social 
support excerpts from the original analysis with the excerpts derived from my analysis.  
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Any discrepancies were reviewed and re-evaluated. They were then discussed with 
another member from the reach team and either included or excluded from the analysis.  
Although the purpose of qualitative work is not to generalize the findings, Lincoln 
and Guba (1985) suggest that it is still possible to show that the outcomes of the study 
can be applicable in other contexts.  Thick descriptions are a technique used by 
qualitative researchers to establish transferability (Lincoln, et al., 1985; Cohen & 
Crabtree, 2006). This allows for the researcher to understand the multiple dimensions of 
the phenomenon; therefore, lending itself to be transferable to other times, people, and 
setting (Cohen, et al., 2006). This was attempted through the multiple stages of the memo 
writing (Corbin, et al., 2015) where each additional memo on the specific topic was 
further thought about and elaborated on. Then a concise definition of each theme was 
created attempting to provide a thick and rich definition. 
Another concept to establish trustworthiness is dependability. The purpose for this 
is to show that the findings of the study are consistent and repeatable. Lincoln and Guba 
(1985) suggest using what is called an external or inquiry audit. This process can be very 
time and labor intensive as it calls for an outside researcher not involved with the study to 
evaluate your work. I chose instead to take other steps to establish dependability. As 
noted earlier in the detailed analysis section, I re-analyzed the transcripts to ensure that 
all excerpts on social support were captured. When inconsistencies were found, I 
discussed these with a colleague to ensure what I was capturing was correct. In addition, 
all analysis work was provided as an audit trail.  
The final concept of trustworthiness addressed by Lincoln and Guba (1985) and 
presented here is confirmability. This is the degree to which the findings arise from the 
  70 
interviewee and not a result of researcher bias. Three methods were used to establish 
confirmability: triangulation, audit trail and reflexivity. Triangulation can be used to 
establish a study’s credibility and confirmability. It is the process of using multiple 
methods, theories, data, and analysis (Creswell, 2013). Triangulation occurred in this 
study at the theory level, forms of data analysis and methods used. Several theories led to 
the development and underlying understanding of financial toxicity and social support. In 
addition, I engaged in several techniques of data analysis as described earlier in the data 
analysis section. The second method used to establish confirmability is an audit trail. An 
audit trail allows for others to repeat and/or confirm the study findings (Lincoln & Guba, 
1985; Padgett, 1998). To fulfill this technique, the steps and procedures used were closely 
documented and recorded. The final confirmability method, reflexivity, is an exercise a 
researcher engages in to identify any pre-conceptions, judgments or biases they may have 
prior to engaging in the analysis process. I engaged in this process by reflecting on me as 
a researcher, and my own personal experience with family members who have had cancer 
and their experiences with related financial concerns. I also reflected on my own 
perception on financial struggles. The product of this activity is presented in Appendix G.  
Ethical Considerations. The University of Louisville Institutional Review Board 
(IRB) approved the larger qualitative study from which this study stemmed. I continued 
to work within the guidelines of that approval. Although I did not directly come in 
contact with human subjects during my analysis of the social support category, I was 
working with data that originated from human subjects. This required attention to 
confidentiality and sensitivity in the handling of this information.  Steps were taken to 
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insure confidentiality, as names and identifiers were removed or changed prior to my 
analysis. There were no risks for emotional distress or harm done.    
Summary 
Chapter 4 entailed an in-depth description of the qualitative methods, including a 
step-by-step description of the analysis procedures and memo writing exercises. It also 
covered issues of trustworthiness and a personal reflective exercise to establish study 
rigor. The results for study 1 can be found in Chapter 5 with examples of analysis 
materials located in the appendices referenced. Study 2 methods and results can be found 
in chapters 6 and 7. The final chapter 8, summarizes the overarching question, study 
implications and future research ideas.  
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CHAPTER 5: STUDY 1 RESULTS 
“We had people go out and buy groceries and drop them off, making food and that kind 
of thing. That helped alleviate some of the cost as well as trying to figure out throwing 
together dinner when you're going through chemo and feeling awful and smells are 
making you sick. That was very helpful. Support of family and friends has really helped.” 
- Study 1 #23 (middle aged female, Multiple Myeloma) 
 
"I didn't let anyone know I was sick, but it cost me mentally and emotionally."   
-Study 1 #2 (65-year-old female, Breast Cancer) 
 
Study 1 was used to gain perspective on what patients’ experiences were in regard 
to social support and cancer-related financial toxicity (objective burden and subjective 
distress). It sought to answer the question: For individuals who have had cancer, what is 
their experience with social support in the context of cancer-related financial toxicity? 
Using data analysis techniques outlined in chapter 4, I took an in-depth look at social 
support expressed through the stories of 26 cancer survivors who experienced financial 
hardship due to their costs of care. Several categories, subcategories and dimensions were 
identified through the analysis. It revealed supportive issues that participants faced such 
as barriers to accessing and missing support. This chapter first presents the sample 
characteristic which is followed by the identified categories and subcategories. The 
chapter will end with a brief interpretation of the results.  
Characteristics of Participants 
A qualitative approach was used to explore the lived experiences of cancer survivors 
(N=26) who perceived financial hardship as a result of their cancer treatment. Tables for 
the demographic characteristics have been published in a prior article by Head, Harris, 
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Kayser, Martin and Smith, (2018). These can be found in Tables 5.1 and 5.2 as well. 
Interviewees ranged from 30 to 67 years of age with a mean average of 50.6 years. 
Twenty were female (77%) and 6 were male (23%). The sample was primarily white 
(73%) and married (61%).  
Table 5. 1 Demographics (Head et. al., 2018). 
Characteristic N (26) % 
Gender 
     Male         6  23  
     Female        20  77 
Race 
     Black          5  19 
     White        19  73 
     Hispanic         2   8 
Marital Status 
     Single/Never Married       1   4 
     Single with Significant Other      1   4 
     Married        16  61 
     Separated/Divorced       6  23 
     Widowed         1   4 
     No Response        1   4 
  Income 
     Less than $25,000        7  27 
     $25,001 – $40,000        5  19 
     $40,001 - $60,000        2   8 
     $60,001 - $80,000        4  15 
     Over $80,000        7  27 
     No Response        1   4  
© LEFT Study 
 
Many interviewees experienced a job change from before and after their cancer 
experience. Prior to their cancer diagnosis 23 were employed full-time (88%), 2 were 
employed part-time (8%) and only 1 was unemployed (4%). After their cancer experience 
only 5 were employed full-time (19%), 6 worked part-time (23%), 8 were on disability 
assistance (31%), 2 retired (8%), and 2 were unemployed (8%). See Table 5.2 for more 
details on occupation and insurance status. 
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Table 5. 2 Job Status, Occupation, Insurance Status (Head et. al., 2018). 
Characteristic N (26) % 
Job Status Before Cancer 
     Employed Full-Time                       23  88 
     Employed Part-Time                     2   8 
     Unemployed                      1   4  
Job Status After Cancer 
     Employed Full-Time                      5  19 
     Employed Part-Time                      6  23 
     Unemployed                       2   8 
     Homemaker                       1   4 
     Disabled         8  31  
     Retired         2   8 
     No Response        2   8 
Occupation 
     Homemaker                       4  15 
     Manager          2   8 
     Professional/Technical      11  43 
     Sales/Services        6  23 
     Manufacturing/Trade                     2   8 
     No Response        1   4 
Insurance Status at the Time of Diagnosis 
     Through Employer      19  73  
     Self-Purchased        3  11 
     No Insurance        3  11  
     No Response        1   4  
Insurance Status During Cancer 
     No Changes - Same Insurance      13  50 
     No Changes – No Insurance                     1   4 
     Lost Insurance Due to Job Loss      6  23  
     Eligible to Medicaid                      1   4  
     Eligible for Medicare       2   8  
     Lost Insurance Due to Job Loss – Now Self-purchased   1   4 
     No Response        1   4  
© LEFT Study 
 
Interviewees presented with several different types of cancer diagnosis. Two types of 
cancers were more prominent than the others: breast cancer n=8 (31%), and blood 
cancers n=6 (23%). Other cancer types that were represented include: Colorectal n=2 
(8%), Head and Neck n= 2 (8%), and 1 each (4%) of appendiceal, brain, lung, ovarian, 
pancreatic, prostate/bladder, and synovial sarcoma. (Profiles on each participant can be 
viewed in Table 5.3.) 
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Table 5. 3 Characteristics by Participant Number (Head et. al., 2018). 
Pt 
# 
Age Sex Race Marital 
Status 
Education Income @ 
diagnosis 
Cancer 
Type 
1 58 F White Married Bachelor’s <$25,000 Breast 
2 65 F Black Widow Postgraduate >$80,000 Breast 
Reoccurrence 
3 54 M White Married Bachelor’s $25,000- 
$40,000 
Oropharynx 
4 52 F Black Sep/div Postgraduate $25,000- 
$40,000 
Hodgkin’s 
Lymphoma 
5 35 F White Married Postgraduate >$80,000 Breast 
6 60 F White Sep/div Postgraduate $60,000- 
$80,000 
NSCL 
7 50 F White Married Some College >$80,000 Breast 
8 67 F White Married Postgraduate $40,001-
$60,000 
Parotid Adenocytes 
9 30 F White Married Some College >$80,000 Ovarian 
10 35 F No 
response 
Single Postgraduate  <$25,000 Leukemia 
11 55 M White Married High 
School/GED 
$60,001-
$80,000 
Glioblastoma Brain 
12 51 F Black Married Some College $25,001-
$40,000 
Breast 
13 58 M White Married Bachelor’s $40,001-
$60,000 
AML 
14 64 F White Sep/div Some College <$25,000 Breast 
15 56 M White Married High 
School/GED 
<$25,000 Synovial Sarcoma 
16 55 F Hispanic/ 
White 
Sep/div Some College >$80,000 Colorectal  
17 41 F White Sep/div High 
School/GED 
<$25,000 Rectal 
18 * F Black Single * * * 
19 37 F White Sign. 
other 
Some College $25,001-
$40,000 
Breast 
20 53 F Hispanic/ 
Black 
Married High 
School/GED 
$40,001-
$60,000 
Pancreatic 
21 36 M White Married Some College <$25,000 Lymphoma 
22 62 F White Married Postgraduate >$80,000 Breast 
23 * F White Married HS $60,001-
$80,000 
Multiple Myeloma 
24 49 F White Sep/div Some college <$25,000 Lymphoma 
25 32 F White Married Bachelor’s $25,001-
$40,000 
Appendiceal 
26 66 M White Married Bachelor’s >$80,000 Prostate & Bladder 
*Not Reported 
 
Qualitative Findings 
 All 26 interviewees commented on social support to some extent and the data 
reflected social support theories. Interviewees commented on received emotional, 
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informational, and instrumental support. They also provided examples of social constraint 
and suggested missing supports. These findings fell into three major categories: Helpful 
Supports, Non-helpful Supports, and Gaps in Support.  These categories contain 
subcategories which are further delineated into dimensions (see each section below for 
details). 
Quantification occurred at the subcategory level. All excerpts were tabulated to 
display the magnitude of the social support discussed by interviewees. Refer to Table 5.4 
to see a breakdown of the number of interviewees who commented on each type of 
support and how many comments were made throughout the interviews. 
Table 5. 4 Social Support Comments by Social Network 
       
 Helpful Supports 
 Received  Perceived 
 Emotional Informational Instrumental   Instrumental 
Social Network Interview
ees 
Excerp
ts 
Interview
ees 
Excerp
ts 
Interview
ees 
Excerp
ts 
 
Interview
ees 
Excerp
ts 
Family 7 18 4 4 26 65  1 1 
Friends 7 8 10 10 8 26  0 0 
Med Prof 2 2 10 11 13 23  0 0 
Organizations/W
ork 5 8 9 16 21 34  0 0 
Total 21 36 33 41 68 148   1 1 
          
 
Non-Helpful 
Supports Gaps in Support    
 Social Constraint Missing Support Barriers    
 
Interview
ees 
Excerp
ts 
Interview
ees 
Excerp
ts 
Interview
ees 
Excerp
ts 
  
  
Family 10 11 3 3 0 0     
Friends 4 4 5 5 0 0     
Med Prof 2 2 14 20 11 14     
Organizations 
/Work 0 0 3 4 4 4     
Total 16 17 25 32 15 18       
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The individuals who provided the support were categorized into five different 
social network categories: family, friends, medical professionals, work, and 
organizations. Refer to Table 5.5 for delineation of each social network category and the 
individual roles included in each network group.  
Table 5. 5 Social Network Categories. 
Social Network Category Network Member 
Family Spouses 
Parents 
Siblings 
Adult Children 
Other Family 
Friends Church Members 
Co-workers 
Neighbors 
Medical Professionals Doctors 
Nurses 
Social Workers 
Financial Counselors 
Hospital System Staff Members 
Work Employer 
Agency/Company 
Organizations Non-profit Organizations 
Social Programs 
   
Before presenting the themes of this analysis, it is important to note that when 
interviewees talked about social supports, they did not always make a clear distinction 
between financially-related social supports and those that were generally provided during 
their cancer experience. For example, in the below excerpt interviewee #9 (a 30-year-old 
female with ovarian cancer), discusses how her family members advocated for her.  
“My husband and sister were wonderful advocates for me, because I was totally 
unable to advocate for myself. And really pushing him to check why I was so sick 
in the hospital.” #9 (30-year-old female, Ovarian Cancer) 
 
The family members action was geared toward finding medical answers or solutions not 
specifically toward assisting her with the financial aspect. Although the interview script 
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did not specifically ask about financial social support, these broad responses lead me to 
question the extent to which patients compartmentalize their experiences. Perhaps 
financial toxicity and social support overlap into all aspects of their lives.  
Helpful Support 
 Helpful Support was the largest theme consisting of the three major categories 
found in the data. These included subcategories of received support (emotional, 
informational, and instrumental) and perceived (instrumental) support. Each subcategory 
is discussed providing thick descriptions of dimensions within each subcategory. 
Meaningful excerpts supporting these dimensions can be found in corresponding tables.  
Received Emotional Support. As discussed in Chapter 3, emotional supports are 
supports that make a person feel or believe they are cared for and appreciated (Cohen et 
al., 1985). Some of the subcategories of emotional support intertwined with received 
informational and instrumental supports. Subcategories revolved around the concept of 
someone else taking control over part of the situation while others show emotional 
support being communicated through being presence during difficult events such as 
attending surgeries or treatments. By providing these other supports, the support provider 
reinforces the person’s feelings of being loved, understood, and cared about. See Table 
5.6 for a list of emotional support subcategories and example excerpts.  
Table 5. 6 Received Emotional Support.   
Dimensions Excerpt 
Acts of 
Service 
“It was emotional support more so than financial. I didn't have to worry about him 
taking off work to take me to treatment, because my church members they were all 
there to do that, but I didn't let it be known that other things were going on.” #12 (51-
year-old female, Breast Cancer) 
 
Reassurance My husband said, "Give that bill to me. I will call them. I will take care of them. You 
don't worry about it. We can manage this… He just kept saying, "I'll handle this. This 
I can do something about.". #22 (62-year-old female, Breast Cancer) 
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“My husband actually took over and he just told me to calm down and not worry.” #25 
(32-year-old female, Appendiceal) 
“I didn’t realize how expensive, but I knew it was expensive because I would ask 
questions about how much a specific my chemo was or whatever. They would be like, 
‘It’s not too bad.’ They try not to worry people. They really try to work with cancer 
patients. They don’t want people to be fretting.” #17 (41-year-old female, Rectal 
Cancer) 
 
Someone to 
Talk To 
 “I feel like the women in the support group are like my new best friends because they 
get it, and they understand what is going on.   Some of them have had money 
problems but some of them haven’t so they don’t, I don’t know if they quite 
understand that, but they understand the cancer stuff.” #1(58-year-old female, Breast 
Cancer) 
“My only source of socialization right after my diagnosis became [support group].” #6 
(60-year-old female, Lung Cancer) 
“We would joke about it, especially like a [support group]. People would be like, ‘Oh, 
how do you handle all the bills?’ I'm like, ‘I have two filing systems, the kitchen 
garbage and the living room garbage.’ That's pretty much where the bills go when 
they come in. They're too overwhelming. There's no way I can pay them. I can't even 
feed my kids. I'm not going to pile them up somewhere and look at them every day, so 
I chucked them.” #21 (36-year-old male, Lymphoma) 
 
Supportive 
Presence 
“Then my other daughter, she doesn't have the money but she's the one that moved right 
in with me. Came home from Arizona, moved in with me. I told her and her fiancé 
could move in too and they were my caretakers.” #14 (64-year-old female, Breast 
Cancer) 
“My husband, he has also attempted to go to appointments with me and support me and 
be there when I needed him.” #22 (62-year-old female, Breast Cancer) 
“[My son] went to every doctor’s appointment with me b/c he was afraid for his mom 
and he took notes to make sure that if I didn’t get it, he got it.” #2 (65-year-old 
female, Breast Cancer) 
“My sister lives out of town in upstate New York. She came into town for my initial 
surgery and was here for two weeks, she’s flown back and forth several times.” #9 
(30-year-old female, Ovarian Cancer) 
“She's been there every [time]. She went to the surgeon here with me.” #8 (67-year-old 
female, Parotid Adenoid Cystic) 
 
 
Acts of Service. Acts of service are received instrumental or informational 
supports that when provided in turn have an emotional impact on the individual. The act 
of support can alleviate additional worry or concern relieving the patient from having to 
do one more thing. In providing this assistance, patients may feel supported and confident 
that someone else can take care of something for them while they focus on their treatment 
and survival. For example, one interviewee (#12) discussed how receiving transportation 
to and from her medical treatments alleviated the need for her husband to take time away 
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from work to do so. She commented that the act of providing transportation was an 
emotion support.  
Feeling understood. A few interviewees spoke about feeling understood by 
others. Having someone available who you can relate to and who understands what you 
are going through can be emotionally supportive. Most comments were associated with 
organizational social network members such as employment (employer, colleagues) and 
support groups. One interviewee (#19) spoke about her employer understanding her 
experience because she had had the same type of cancer. Another interviewee (22) shared 
how her colleagues did not make her feel bad and expressed sympathy for her situation. 
Additionally, support groups can provide a safe environment free from judgment where 
participants can share their experiences leading to feelings of acceptance and being 
understood. One interviewee (#1) commented that she did not talk to her friends about 
her financial concerns because she felt they would not understand; however, she could 
share them in a support group with others who were going through similar situations. The 
idea that other people do not understand or get the financial hardship experience because 
they have not experienced it is not a new concept in the context cancer. The loss or 
distancing of friends due to cancer has been well-known. In addition to this idea we see 
cancer-related financial toxicity as another component that may play a part in distancing 
cancer patients from others. (This idea is further discussed in Gaps in Support.) 
Reassurance. In this subtheme, we see the support provider reinforcing the idea 
that things will be okay and that they (support provider) will take care of an additional 
stressor such as the medical bills or getting additional services. This in turn relieves the 
support receiver from concern or worry related to something other than their treatment. 
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Several interviewees spoke about family members reassuring them. This was often a 
behavior expressed by a spouse; however, for those who were single or lacked a 
supportive spouse/significant other, a family member would sometimes provide this 
support. One interviewee (#10) spoke about her mother assuming legal control to manage 
her financial responsibilities while she was in the hospital. Medical Professionals were 
also noted for attempting to provide assurance to patients to not worry about their costs of 
care. Although this final example was an attempt to reassure patients that things would be 
okay, it overlaps with the Non-helpful Support category: having good intentions that 
were ultimately not helpful. This may in turn lead to Gaps in Support as missing 
information or create barriers to patients seeking financial assistance.  
Someone to talk to. Talking to other people about your concerns has long been 
known to provide a sense of support and well-being. It helps one to feel closer to other 
people and fosters relationship bonds. It can relieve stress and allow others to offer 
solutions or help. This can provide the support receiver with feelings of comfort and 
reassurance that things will be okay or that they are not alone in this situation.  
Few participants commented on having someone to talk to about their financial concerns. 
One interviewee (#7) stated she talked to her sister, but it was followed by an expression 
of concern and desire to not want to burden her sister about her financial concerns.  
Alternatively, several interviewees found a safe place to talk about their financial 
concerns through organizations offering support opportunities. In these spaces, patients 
can talk about what they are going through without the fear of being stigmatized or 
judged. They can relate to the stories and experiences of others which allows them to feel 
part or a group and not isolated. Patients feel heard, understood and encouraged to keep 
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going. Support groups, through organizations such as Gilda’s Club and Cancer Support 
Community, provide opportunities for patients and caregivers to share these difficult 
experiences in a controlled and safe environment. 
Supportive presence. Under this subcategory, interviewees explain ways in which 
family and friends were there for them. One interviewee (#14) directly commented that 
her daughter could not help her out financially, but she moved home and provided 
comfort in being present through the experience. Family and friends provided a 
supportive presence by attending medical appointments and taking notes. Some even 
traveled from out of town to be there for important surgeries and to help with caretaking 
during the healing process. Although these supports are not directly financially related, 
their presence within the data and the discussions offered by participants lends support to 
their importance within the total experience. In the context of experiencing cancer-related 
financial toxicity, receiving emotional support is not solely financially connected. Here 
participants received encouragement, assistance, and care from family and friends in 
other ways that brought comfort to their experience assuring patients that they were not 
alone in this experience.  
Received Informational Support. Informational support occurs in response to a need for 
knowledge, advice or guidance. Throughout the analysis there were a few examples of 
informational support; although, not many. See table 5.7 for dimensions and excerpts. 
The missingness noted in this subcategory led to the development of one of the 
subcategories under the theme Gaps in Support which is explored later.  
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Table 5. 7 Received Informational Support 
Dimensions Excerpts 
Financial 
Advice & 
Information 
“My brother is a financial or wealth manager, so he told me that he wasn’t going to let 
me touch your 401K if it came to that, so it didn’t come to that. I was fortunate 
enough to not have to explore any of the other options.” #3 (54-year-old male, 
Throat Cancer) 
“One of the ladies, when her husband had throat cancer, she said ‘well what I did was 
once I got all of my EOBs, separated them all, I put them all, like, in an order and 
then when the bill came, I would line it up with that. Then she said don't pay 
anything until you make sure it's been through the insurance. They guide me on 
don't pay this, don't pay that. Kind of leading me and helping me along.” #13 (58-
year-old male, Leukemia) 
“They had a social worker come in and laid out everything that was available through 
them, through Medicaid, and through the Lymphoma/Leukemia Foundation.” #24 
(49-year-old female, Lymphoma) 
 “They also connected me with the Leukemia/Lymphoma Society because they 
apparently have some programs for financial aid, too. We started the process for 
that, but we felt like we were in a position at that point that we didn't need to take 
that money away from somebody else that might need it.” #23 (middle aged 
female, Multiple Myeloma) 
“Then when I went to the clinic in [location], they recommended doing the Livestrong 
prices for the clinic treatments, but they recommended the Walgreens grant for the 
medicine.” #5 (35-year-old female, Breast Cancer) 
“I went to a doctor at [location], and one of his residents said, ‘I think there might be a 
grant that helps pay for some of this,’ but didn't know the details…so then I started 
researching.” #5 (35-year-old female, Breast Cancer) 
 
Navigating 
Systems 
“I was talking to the social worker I said, ‘I don't even know how much we have to 
pay.’ So, she looked into it for me… [Someone at the cancer center] said I should 
probably know all that, but she [the social worker] looked into it.” #15 (56-year-
old male, Synovial Sarcoma) 
“It was really the oncology office who you know, calls you in and kind of explains to 
you this is what's covered, this is what's not covered, insurance will pay for this. 
They're the ones that kind of schooled me on what was going to be covered, and 
I'm thankful for that because at least I knew my chemotherapy was covered at a 
hundred percent.” #15 (56-year-old male, Synovial Sarcoma) 
“My doctor, my orthopedic oncologist said to go ahead and put application in for 
disability.” #15 (56-year-old male, Synovial Sarcoma) 
“The social worker is very helpful. She asks us to begin with if financially [we wanted 
assistance]. Did I want to consider going on disability for social security? I didn't 
want to do that unless I had to.” #8 (67-year-old female, Parotid Adenoid Cystic) 
 
 
Financial advice and information. Advice is defined as information that is 
provided for the purpose of providing guidance or recommendations. A few interviewees 
commented on receiving advice. Those that did received it from family, friends, and 
medical professionals. Having family members or friends with financial knowledge or 
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insider information on navigating the healthcare system is a great resource that few may 
have access to. One interviewee (#3) had a brother who worked in finance. He was able 
to get guidance on how to manage his finances through this challenging experience. 
Another interviewee (#13) shared her confusion over managing her insurance and 
medical bills. She was not aware that she should wait for the insurance to cover their 
portion and needed help in understanding how to ensure that process had been properly 
completed. Fortunately, a friend told her when to make payments and when not. 
Receiving advice on navigating the insurance and medical billing process is basic 
information that patients may need. This sharing of ideas and providing guidance on how 
to navigate the system or just interpret the forms can be helpful as long as the advice is 
good, sound advice. 
Medical professionals are positioned to provide accurate and timely information 
on medical billing and insurance processes as well as resource information. Some 
interviewees were fortunate and were provided a wealth of information at the time of 
their diagnosis. Although medical professionals do not have all the resources and 
information needed for every patient, they can offer direction on what might be available. 
For example, one interviewee (#5) shared how a doctor/resident was aware of a grant to 
assist with fertility treatment expenses. This information led her to seek out more 
information and find needed resources to assist with the high costs of fertility treatments.  
Navigating systems. Medical professionals have a complex understanding of 
medical diagnosis and treatment, and a familiarity with the healthcare systems. One 
interviewee (#15) shared how she did not know what her deductible and was told by 
someone at the hospital that she should know that information. She asked a social worker 
  85 
who was able to quickly look into it and provided her the information. Finding this 
information may be fairly simple for people who know where to look or ask questions; 
however, to the average person, medical systems and insurance programs can be 
complicated and arduous.   
Interviewees also shared stories about how medical professionals provide 
assistance regarding when to apply for government assistance programs like Medicare 
and Social Security Disability. One interviewee (#15) discussed receiving guidance and 
information from his doctor about applying for Medicaid. Another interviewee (#8) 
shared how a social worker offered assistance and information about social security 
disability. The participant was given the information needed to decide to apply or not.   
The average individual is likely unaware of government assistance program 
qualifications; therefore, patients could benefit from having some guidance on when and 
how to apply for assistance. Medical Professionals may be able to provide that 
information. If a patient is advised to apply for disability when their diagnosis and 
treatment meet program requirements could potentially prevent undue financial hardship.  
Received Instrumental Support. Instrumental support was the most abundantly 
discussed type of support. Supports in this category were tangible items and services. All 
types of support providers were commented on as providing instrumental supports. See 
Table 5.8 to view the dimensions of support and who provided those supports. Further 
detailed discussion on each of these themes are provided below. 
Table 5. 8 Received Instrumental Support 
Dimensions Excerpts 
Advocate  “She [mother] got it from calling around and asking, because she had to do the 
same thing for my father who is disabled. So, she kind of knew the avenues.  
For me she went in there.” #10 (35-year-old, female, Leukemia) 
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“She's really good at helping me advocate and encouraging me to use my voice 
because when you're in the middle of it's a whole different story. #6 (60-year-
old female, Lung Cancer) 
“I felt like my healthcare system was an advocate.” #22 (62-year-old female, Breast 
Cancer) 
“Yes, she has become more of a friend and an advocate because she got on the 
phone and was talking to them and they paid attention to her.  I can barely 
walk—but I can’t use a walker or a cane—but she got on the phone and made 
them pay attention about it like the wheelchair back in December.  So that I can 
get around without being stuck in the house.” #2 (65-year-old female, Breast 
Cancer) 
 
Childcare 
Assistance 
“My dad's very supportive, he helps take care of our daughter when we're not 
having good days. He's very supportive.” #25 (32-year-old female, 
Appendiceal) 
“And my sister moved in with me to help take care of my daughter when I was in 
and out of the hospital. So, she’s okay.” #10 (35-year-old female, Leukemia) 
 
Monetary 
Assistance 
“I still have one in college, but my parents started [paying for grandchild’s tuition] 
just a couple of years ago, now that they have money. You know. Telling me 
now ‘we never paid for your college so let us pay tuition for the last one so.” #3 
(54-year-old male, Throat Cancer) 
“She was feeding me, buying me food, paying [utilities] for me to be here.” #18 
(middle-aged female, type of cancer not provided)   
“My daughter sings. She did a little singing one night, sang twice at night one night 
twice and the tips she gave to us, uh, one night it was $91.00 and, uh, one night 
it was, uh, like $107, so anyway she gave us her tips.” #13 (58-year-old male, 
Leukemia) 
“Then of course family would bring me food and give me 20 or 30 dollars here or 
$100 to help me out when they could. That was a help.” #4 (52-year-old female, 
Lymphoma) 
“We had had a couple of friends give us like, you know, $50 here or $50.” #20 (53-
year-old female, Pancreatic Cancer) 
“We had a friend start a fundraiser for us that raised $19,000 that will cover my out 
of pocket max for last year and this year. My brother in law is one of the people 
who helped set up the fundraiser.” #9, (30-year-old female, married) 
“[A non-profit agency] did have a piece where you could fill out an application and 
on a monthly basis and get some reimbursement. I did utilize that for a while 
especially those times when I only got paid for two days.” #6 (60-year-old 
female, Lung Cancer) 
 “I applied for their financial assistance regarding some of the out of pocket. I 
would say that they pretty much covered at least my hotel expenses when I was 
there. They paid for mine and they paid for our meals while we were there. That 
was nice.” #6 (60-year-old female, Lung Cancer) 
 “One of the pharmaceuticals helped with the one shot--$500 a pop—something that 
I had to have for two weeks. I didn’t have $500 to shell out daily for 2 weeks.” 
#4 (52-year-old female, Lymphoma) 
 “I was off work until July and I was able to tap into the shared leave program” #4 
(52-year-old female, Lymphoma) 
 “In fact, my office has been fabulous. When I ran out of sick days, they have 
donation sharing for sick days, so employees donated sick days, so that covered 
me, so I was able to maintain a full paycheck each time.” #5 (35-year-old 
female, Breast Cancer)  
Managed Finances “My husband said, ‘Give that bill to me. I will call them. I will take care of them. 
You don't worry about it. We can manage this." #22 (62-year-old female, 
Breast, Cancer) 
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“'My husband actually took over and he just told me to calm down and not worry. 
We have very supportive family members that helped, too.” #25 (32-year-old 
female, Appendiceal) 
“I guess the second week when I was in the hospital … my mom really kind took 
over as a power of attorney so that she could go into my bank account and pay 
all my bills and get everything set up.” #10 (35-year-old female, Leukemia) 
 
Resolving System 
Issues 
“The insurance company put me in a panic. It was the social workers and the nurses 
at the cancer center that kept me from going over the edge.  They were helpful. 
‘Tell us what they said. OK, we will take care of it. Breathe and relax. We will 
take care of it.” #4 (52-year-old female, Lymphoma) 
“I got my first disability check. I was approved the first time. My doctors all helped 
push it, get it through.” #15 (56-year-old male, Synovial Sarcoma) 
 
Small Stuff “My husband had to do all the cooking, all the cleaning with the assistance of my 
parents, so for the first six weeks and then when I was going through chemo...” 
#5 (35-year-old female, Breast Cancer)    
“They gave the number to my daughter, the guy’s number, and my daughter helped 
me take care- she said, ‘mom don't worry about it, you take care of dad, I'll take 
care of the ramp.’" #13 (58-year-old male, Leukemia) 
“Then my other daughter, she doesn't have the money but she's the one that moved 
right in with me. Came home from Arizona, moved in with me. I told her and 
her fiancé could move in too and they were my caretakers” #14 (64-year-old 
female, Breast Cancer) 
 “My friend, I called my friend who was a nurse and said, ‘Could you stay with 
me?’ She works 7 PM to 7 AM, so I said, ‘Could you stay with me for 3 days 
because I'm going to be.’ I didn't know how bad I was going to be. I really 
couldn't open my eyes. I couldn't do anything, and so she did.” #8 (67-year-old 
female, Parotid Adenoid Cystic) 
 “We had people go out and buy groceries and drop them off, making food and that 
kind of thing. That helped alleviate some of the cost as well as trying to figure 
out throwing together dinner when you're going through chemo and feeling 
awful and smells are making you sick. That was very helpful. Support of family 
and friends has really helped.” #23 (middle-aged female, Multiple Myeloma) 
'"Oh, can we get you some groceries? Oh, let's cook dinner. Oh, can we help with 
the kids? Here's a little gas money." #21 (36-year-old male, Lymphoma) 
 “My kids became my primary caregivers. At 17, it was hard with that. At 15, 17 
years old, she’s buying groceries and paying bills and helping me get in and out 
of the shower. It changed her in that way. She had to grow up faster than she 
probably should have as a grown up.” #17 (41-year-old female, Rectal Cancer) 
 
Transportation “They would take me places where I couldn’t drive. For instance, we went to the 
‘Look Good, Feel Better’.” #2 (65-year-old female, Breast Cancer) 
 “I have two neighbors that are retired and another friend that's retired so they can 
give me rides and another neighbor doesn't go to work until two o'clock in the 
afternoon so if I needed something, she can help me out. Another neighbor 
offered to come you know, water my plants.” #16 (55-year-old female, 
Colorectal Cancer) 
Work Allowances “I had a period of time where I wasn't able to do any work due to my condition, and 
then when I was able to start gradually working from home on my laptop, my 
work allowed me to do that until I could come back to the office.” #5 (35-year-
old, female Breast Cancer) 
“For the most part, when I was going through my treatments, I happened to have a 
great immediate manager. The president of our company had prostate cancer 
and was going through exactly the same treatments as I was. I was able, for 6 
weeks, to have every afternoon off. I was going through radiation at that time, 
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and working half days for 6 weeks, in a period which I don't know if most 
companies would ever have been patient enough to go through that process.” 
#26 (66-year-old male, Prostate & Bladder) 
“My husband’s work let him take an unlimited number of days off without charging 
him vacation time without docking his pay for it or anything like that…if I was 
in the hospital he was there. So, if I was in the hospital for 40 days, he missed 
40 days of work.” #9 (30-year-old female, Ovarian Cancer) 
“They've been very generous with him here at work in that they have allowed him 
to work from home when he needed to the first couple of days of my recovery.” 
#22 (62-year-old female, Breast Cancer) 
 
 
Advocate. Advocating is an act of service provided by the support provider to 
ensure the well-being and needs of the support receiver are met. A life threatening or 
severe disease, such as cancer, can cause a patient to feel vulnerable and physically 
exhausted due to the effects of the illness and treatment; therefore, patients could benefit 
from having someone to advocate for them. It allows them to take a step back and let 
another person have control over part of the situation. The patient can then focus on their 
health and well-being without having to spend time and energy on getting needed 
services. By advocating for the patient, support providers are a voice for the patient 
speaking up for their overall wellbeing, medical care, and needed health service.  
In this instrumental support subcategory, we see that family members (spouses, 
parents, adult children, siblings) and medical professionals (nurses or other providers) 
served as advocates. Having another person available to attend appointments and assist in 
treatment decisions can alleviate some responsibility and burden from the patient. Several 
interviewees spoke about their spouse fulfilling this role. Other family members provided 
this support as well. One interviewee (#10) commented on how her mother’s past life 
experiences with the medical system proved to be useful in getting her the services she 
needed. Knowing the avenues to take when seeking medical treatment or navigating the 
insurance world can provide valuable assistance and guidance. Another interviewee (#6) 
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discussed how her adult child encouraged her to have a voice in her medical care and 
decision-making processes. From the perspective of social support theory, Medical 
Professionals are in the formal support provider categories and expected to provide 
information and instrumental supports. A few interviewees commented on their medical 
professionals advocating for them and helping them to get the services they needed. 
Childcare assistance. For families of young children, childcare assistance is an 
important service. Parents care for the well-being of their child(ren) and want to make 
sure they are in good hands when they are unable to care for them. Paying for childcare is 
also noted in the literature as an often-unexpected expense that adds to the objective 
experience of financial toxicity. For some interviewees, childcare was provided as a 
support yet for others, it became a social constraint as seen in Good Intentions with 
Financial Consequences. 
Monetary assistance. Several participants commented on receiving tangible 
financial assistance in the form of money or provided assistance that could lead to 
obtaining money. These instrumental supports were provided by family members 
(parents, adult child, siblings), friends, medical professionals and organizations. For some 
interviewees, their parents were in a financial position that allowed them to help 
financially. It is generally accepted that as you get older you have more financial means 
due to working longer and having more equity or investments. Other interviewees 
received assistance from their adult child(ren). One interviewee (#13) shared how his 
daughter gave what she could. Adult children are often still trying to financially establish 
themselves and often do not have access to the financial resources that older adults would 
have. No matter how small or big the monetary assistance was, interviewees commented 
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on how helpful and supportive these acts were. Some family members and friends 
assisted in helping to organize fundraisers or benefit events to generate funds to help 
cover medical expenses. Interestingly, interviewees who talked about this type of support 
were typically younger adults and as discussed in Non-helpful Support, receiving 
supports of this nature were not always supported by others.  
Applying for grants from organizations or financial assistance/forgiveness 
programs through the medical system appeared to be more widely commented on than 
other network categories. Several interviewees commented on organizations and 
programs offering assistance with food, paying small monthly bills and daily living 
expenses. A few received funding to pay for the cost of out-of-state travel for medical 
purposes. Yet another interviewee commented on receiving assistance with fertility 
treatment costs.  Some interviewees found assistance through their medical centers which 
offered financial assistance program to help cover medical expenses. These provided a 
huge relief from the hefty medical expenditure. Medications assistance from 
pharmaceutical companies provided some financial relief as well. A few interviewees 
were also able to tap into programs provided through work. Some employers offered 
programs that provided financial assistance to their employees such as shared leave 
programs or donated sick time.  
In this subcategory there are several examples of participants receiving financial 
assistance from all social network groups. Consequently, patients need to know about 
these programs in order to apply for assistance. This informed the development of the 
category Missing Information. Furthermore, seeking these resources can be time 
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consuming and physically taxing on patients as noted in the Run Around subcategory of 
Barriers to Support.  
Managed finances. This subcategory points to the importance of having a 
primary support person who can help manage the financial piece. Only a few participants 
commented on having someone who would take on the responsibility of managing the 
bills and household finances. This support was provided by spouses and parents. Taking 
on the responsibility of managing the finances appeared to be an attempt by the support 
provider to alleviate the worry or concern a support receiver had over their financial well-
being. In this case, the instrumental support provided overlapped with the emotional 
support received. Ultimately, having this support can relieve a big burden from patients, 
allowing them to focus more on themselves and surviving cancer.  
Resolving System Issues. Medical professionals are ideally positioned where they 
can provide needed assistance to patients when dealing with complicated systems such as 
insurance and disability. In this subcategory, support providers engage in action-oriented 
instrumental support in an attempt to resolve barriers. For example, one interviewee (#4) 
shared how a social worker and nurse were instrumental in resolving complications with 
the interviewee’s insurance company. Another interviewee (#15) talked about how his 
doctor assisted him with applying for medically-related disability. Insurance companies 
and the social security disability system are notorious for having complicated and tedious 
systems often causing most people to struggle when dealing with them. Medical 
professionals can be instrumental in helping patients resolve complicated issues within 
each of these systems. 
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Small stuff. When facing a life-threatening disease, like cancer, patients can be 
overwhelmed with simple life tasks. In this subcategory, family and friends were noted 
for taking over the general organization and running of daily life activities. These 
activities can include cleaning, cooking, general caretaking activities, and managing 
medical care at home. Friends also provided assistance in caregiving and household 
management for short periods of time. One interviewee (#8) shared a story about her 
friend, who was a nurse, came and stayed with her for 3 days after her treatment. Tasks as 
simple as preparing meals, buying groceries or gas, and mowing the lawn or taking the 
garbage out, helped patients financially, physically and emotionally.  
Sometimes these tasks and responsibilities are more time consuming and can have 
a negative effect on the family member providing the assistance. In the case of one 
interviewee (#17), her two teenaged children took on the primary caregiver roles in place 
of a significant other or other family member. She shared the negative impact her cancer 
had on her children. 
Transportation. Research has shown that transportation causes a barrier to care 
for many patients due to the cost of paying for gas, taxi service or compounding travel 
expenses. Interviewees commented on family members and friends assisting them with 
getting to and from appointments or to other cancer-related events. 
Work allowances.  It is noted in the literature that many cancer patients 
experience a reduction in monthly income prior to diagnosis and during their cancer 
experience. This is likely due to the need for patients to take time off to address negative 
physical effects of their illness or treatment. Some interviewees commented on their 
employers being flexible with their work schedules and allowing them to work from 
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home or maintain their positions at a part-time status. In additions, the employers of 
caregivers were also noted for being flexible with working hours. A few interviewees 
shared how their spouses’ employers were lenient allowing the caregiver to take off time 
when needed so they could be present during treatment or recovery periods. Having an 
employer who understands (crossing over to emotional support) and is flexible to work 
with alternative schedules or work from home options (instrumental support) can make 
an impact on not only patients’ financial outcomes but the overall experience as well.  
Perceived Instrumental Support. The perception that emotional, informational 
or instrumental supports were available (which is considered different from the support 
received being told the resources were available), did not have a strong presence in the 
data.  I came across one excerpt that eluded to perceived instrumental support. This was 
in response to a probing question about whether an interviewee’s spouse or anyone else 
helped her manage the medical bills and other finances. The interviewee responded: 
“I'm sure he would have if I had needed his help, but I was able to keep track of 
all the finances myself.” #5 (35-year-old female, Breast Cancer) 
 
The absence of perceived support may have been due to the lack of a direct question or 
perhaps due to the post-experience design of the study.  
Non-helpful Support 
 Non-helpful support is made up from the social constraint.  Social support can be 
interpreted as a negative experience or as non-supportive action depending on the 
outcome or how that support is interpreted by the support receiver. 
Social Constraint. Social constraint occurs when a support provider does 
something that they may believe is helpful, but the recipient does not interpret the action 
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as supportive. See Table 5.9 to view the three dimensions of social constraint that and 
excerpts.   
Table 5. 9 Social Constraint  
Dimensions Excerpts 
Good Intentions 
with Financial 
Consequences 
“She lives with me. When she first moved here, she didn’t have anything. She just 
started the job that she’s at now.  This is the first time she has had a 
permanent job—it goes back about 3 years. Before she had temporary jobs, 
this was a permanent job, but she felt that she couldn’t take a lot of time off to 
help me, but she was able to contribute more to help me out with the rent and 
the phone, food and that sort of thing.” #4 (52-year-old female, Lymphoma) 
“It's been a big stress. Big stress. You know, I was having to feed him and for 
helping you know. I felt like it was my duty to feed him and not charge him 
anything to live here. He was helping me, but when the help stopped, that's 
when it was, became very, very, very stressful for me and then I just said you 
know, you know how I feel about drugs, you've got to go.” #16 (55-year-old 
female, Colorectal Cancer) 
  
“Even my own sister charged me to watch my kids … I would have to pay her to 
come pick the kids up or $20 in gas money to come 10 miles down the road 
and get the kids for me while I had him in the emergency room. It was always 
something. There were times when I just sat in the car and just cried. 
Overdraft fees, that was a big one. I was constantly over-drafting the bank 
account.” #21 (36-year-old male, Lymphoma) 
 
Good Intentions 
Not Helpful 
“My oldest daughter who's an LPN … I saw her interact with my doctor and I told 
her, ‘That's why you're not my medical power of attorney.’ It's that nurse 
thing that thinks the doctor is God or something. It's like no, you have to 
argue with the doctor sometimes.” #6 (60-year-old female, Lung Cancer) 
“I got a package from my sister in the mail and I opened it and there were pictures 
on top of when I was growing up and pictures of my mom, grandmother and 
family and then after all that there was a ribbon that I had given my mom and 
some of my mom’s belongings that were intimate belongings.  So, I put that 
aside and I pulled out my mom’s cosmetic bag.  For crying out loud, why did 
she send this to me? My mom’s make-up when she was in her end days.  I 
opened it and in the top was her hairbrush and it still had her hair in it. I took a 
deep breath – it’s my mom. I lifted that out and mom’s prosthetic boobs were 
in the bottom. I thought oh my god what did she send these to me for.” #7 (50-
year-old female, Breast Cancer) 
“We were all sitting around talking about it. My mom was very cynical and just 
not helpful. She's like, ‘Well nobody's going to donate to that. You're just 
wasting your time. You're just going to embarrass yourself.’ I was like, ‘You 
know what? It's my kids. It's his health. If it doesn't work, it doesn't work.’ 
What's the worst that can happen? It doesn't work." Really, the Go Fund Me is 
basically what got us through.” #21 (36-year-old male, Lymphoma) 
“It came back in September, and they started talking transplant, and I mentioned 
to his oncologist ‘well, maybe they can do it this year because we have 
already met our deductible.’ He was like ‘oh honey, it’s not going to matter 
what your deductible is because you’re going too far exceed it next year too.’ 
So, I was like oh, ok. Here we go again… I was like thanks.” #11 (55-year-old 
male, Glioblastoma)  
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“I didn’t realize how expensive, but I knew it was expensive because I would ask 
questions about how much a specific my chemo was or whatever. They would 
be like, ‘It’s not too bad.’ They try not to worry people. They really try to 
work with cancer patients. They don’t want people to be fretting. You know 
what I mean? On top of trying to care of you. I would say how much is this 
costing or whatever and they would be like, ‘It’s not too bad. It’s not bad.’ I 
didn’t have any real clue what’s the real cost of some of this stuff was.” #17 
(41-year-old female, Rectal Cancer) 
 
Ineffective Support “My husband at the time was theoretically also doing that, but I think that he was 
also like, ‘Oh, crap. My wife has cancer.” #19 (37-year-old female, Breast 
Cancer) 
“I moved out and I had to take a really - Like everyone who gets divorced, I think, 
I had to take a really hard look at finances.” #19 (37-year-old female, Breast 
Cancer) 
 
 
Good intentions with financial consequences.  This subcategory is characterized 
by a support provider engaging in an instrumental support such as childcare or attending 
treatment, but the supportive attempt was a financial expense for the patient. For 
example, one interviewee (#4) had her sibling move in with her under the expectation 
that she would provide caretaking and household assistance. Initially when the sibling 
moved in, she did not have any money and was financially dependent on the interviewee. 
This was a financial burden until the sibling was able to secure a permanent job. 
However, once the sibling secured a position, she was no longer available to assist around 
the house. In a second example, an interviewee’s (#16) son moved in with her when she 
was diagnosed with cancer. This was initially helpful but then he got involved with drugs. 
Ultimately, this caused more stress, both emotionally and financially. Eventually the 
interviewee had to send him out of town. Similarly, two other interviewees spoke about 
the financial consequences when family or friends helped them out during their cancer 
treatment by being present during or after treatment, or by providing childcare.  
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By providing acts of social supports, friends and family may feel they are being helpful; 
however, in these examples the helpful act came at a financial cost which further 
exacerbated the financial hardship. 
Good intentions that are not helpful. There were several examples throughout 
the interviews of family, friends and medical professionals attempting to do something 
helpful, but those acts were not interpreted as helpful. For example, one interviewee (#7) 
shared that she had received a package from their sibling. The content of the package was 
disturbing for the interviewee as it contained items from when her mother had cancer. 
The sibling may have thought the recipient could use the items left after their mother had 
passed away; however, the receiver was baffled by the gesture. In another example, the 
interviewee (#21) was considering creating a Go-Fund-Me account to raise money to help 
pay for her treatment. The interviewee’s parent made negative remarks about doing so. 
These comments were interpreted as negative and critical putting the patient on the 
defense; however, it is possible that the parent had intended to protect them from 
engaging in something she felt was socially taboo. This behavior may have been an 
attempt to prevented them from the embarrassment of asking others for financial help and 
crossing socially acceptable norms. Another interviewee (#6) had her daughter, with a 
medical background, attend her medical appointments. The interviewee, however, felt 
like the daughter was just agreeing with the doctor and not being an advocate for her.  
This is also an example of how the support that is provided needs to match the support 
that is needed. If the support provided does not match the needs of the support receiver, 
then the support receiver will not interpret the support provided as supportive. In this case 
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the daughter is providing support by being present at the appointments; however, the 
interviewee wanted her daughter to advocate for her.  
Interviewees shared experiences of social constraint from Medical Professionals 
as well. For example, one interviewee (#11) shared his story about getting a second 
diagnosis and treatment information from his doctor. The interviewee had already 
experienced tremendous financial hardship during the first cancer experience and had 
suggested they do the transplant before the year ended because he had already met their 
deductible.  The doctor responded that it was not going to matter because they would 
most like meet the deductible the following year as well. The way in which this 
information was presented was interpreted by the interviewee as insensitive; however, 
that was likely not the doctor’s intent. Furthermore, the medical industry is often 
criticized for being focused on curing the disease while neglecting to look beyond the 
recovery phase. Several interviewees commented on receiving reassurance from medical 
professionals, encouraging them to not worry about the costs even when they asked for 
the information.  In the end these patients were left with a stack of medical bills and 
overwhelming feelings of financial hardship due to the costs they were encouraged to not 
worry about.   
 In these excerpts it is apparent that the topic of finances and financial struggles 
can evoke different reactions from patients and those around them.  Acts meant to buffer 
the patient from stress or benign comments attempting to illicit humor are not meant to 
cause harm but can be interpreted as hurtful, insensitive and non-supportive.  
Ineffective support. The act of receiving support is beneficial when the support 
is reliable and helpful; however, there were a few instances that interviewees shared 
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where the support provided ended up putting the interviewee in a worse situation or 
provided them with unhelpful information or ideas. For one interviewee (#19), her 
husband was supposed to take care of the finances during her cancer experience; 
however, in her opinion, he did not do a very good job. The interviewee’s statements 
appeared to be resentful toward how those finances were managed. This could be due to 
the fact that her marriage dissolved after her cancer experience, but before her medical 
debt was paid. The divorce further complicated her financial well-being. Another 
interviewee shared how she was advised to only take half the medication prescribed. 
Receiving inaccurate and unhelpful support can further complicate a person’s situation.   
Gaps in Support 
 The final theme is Gaps in Support. This theme is made from two categories: 
barriers to support or missing support. These categories evolved from direct comments, 
and interpretations of what was not said. 
Barriers to Support. Several barriers to accessing supports were identified. See 
Table 5.10 for an overview of dimensions and interview excerpts.  
Table 5. 10 Barriers to Support  
Dimensions Excerpts 
Missing Timely Information  “I think I was in my second or third month before it clicked that there 
was financial assistance available. If they could bring that to the 
table right away that would be wonderful.” #24 (49-year-old 
female, Lymphoma) 
“No one came out and said ‘hey, you qualify for this’. I stumbled on 
that.” #13 (58-year-old male, Leukemia)  
 
Personal Barriers “I can't say, ‘Well, I don't have any lights today,’ or ‘Refrigerator's 
empty.’ I can't do that. It's different for everybody.” #12 (51-year-
old female, Breast Cancer) 
“There's some places that can help you with assistance like food or 
electricity and things like that. You know, do I ever want to take 
advantage of that? I don't know, it's kind of like I don't know.” #16 
(55-year-old female, Colorectal Cancer) 
“Then I don’t tell anyone about the money thing because to me it’s 
like embarrassing.” #1 (58-year-old female, Breast Cancer) 
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“If you don’t have money or know how to navigate the system or 
know how to get the most of it paid. The ones who are supposed to 
be the advocates at the hospital, the ones who want to get most of 
it paid, they don’t care.  It’s like you get flipped off. I had a 
question for someone, and they said, ‘I don’t have to deal with you 
anymore, you have Medicare.’ She said this in the hallway. I asked 
her to meet her in her office.  She says this in the hallway in front 
of all of these people and she said, “I don’t have to see you 
anymore.” #2 (65- year-old female, Breast Cancer) 
 
Support That is Not Needed “When I ask about something, it's like, ‘Well, you can just go to the 
resource center.’ When I would say something, of course the nurse 
navigator just kind of disappears after the first visit or so. They 
told me that I could get a wig and they told me there were books 
and I could get all that at the resource center." #6 (60-year-old 
female, Lung Cancer) 
“The cancer centers, they always are like, ‘You can have free art 
therapy because you're a cancer survivor,’ and ‘You can have free 
massage and acupuncture.’ I'm like, ‘give me some free financial 
advice. Give me a free session with somebody that can tell me how 
to pick up these pieces and pay for all this stuff.’ That would be so 
much more useful, nothing against art therapy.” #19 (37-year-old 
female, Breast Cancer) 
“Here's the Resource Center. Go talk to them. Oh yeah, here you can 
get a massage every other month for free. Yeah, that was great, but 
at the end of the day it wasn't what was needed most. They didn't 
come out and tell you about the other stuff.” #21 (36-year-old 
male, Lymphoma) 
“I was told I could call a counselor and I did speak to [person’s name] 
on the phone and she said that she would send me forms, I could 
fill them out, and they probably would just write it all off, which 
would be wonderful. I'm telling you the truth, between filling out 
all these disability forms for ten hours while I was going through 
all this sickness and trying to move in the middle of chemotherapy, 
all I could do was sit in the floor and try to pack boxes. I was so no 
help. You're not allowed to lift, that's so awful. You're so sick with 
all those forms and then I filed my own divorce. That's fun forms 
about this thick. By the time I did all that I was wore out and I 
thought, you know when her forms came, I'm sorry, I apologize. I 
started filling them out, I never finished them.” #14 (64-year-old 
female, Breast Cancer) 
 
The Run Around “But I was paying them and when I inquired to see if I could get help, 
they said we are not funding breast cancer right now – we’re 
funding colorectal cancer or this cancer but not breast cancer right 
now. So, I did check with two resources given to me and it didn’t 
help.” #7 (50-year-old, female Breast Cancer) 
“I don't know who it was, but somebody gave me some pamphlet 
about this organization. They said, ‘Here, call them. They always 
help pay for prescriptions.’ I called them to try to get help. They 
were like, ‘Well, you don't qualify because you didn't have the 
right kind of cancer. After a while you burn out of resources 
because it doesn’t take very long to go through the few places that 
does offer the scholarships for people with this." #17 (41-year-old 
female, Rectal Cancer) 
  100 
“I’ve caught buses in the snow to get to [appointments] for these 
people from the United Way to the people for financial help in the 
hospitals. And I’ve waited and waited until they were finished 
with their lunches and chit chat to help me fill out forms that were 
foreign to me. One reason they were foreign to me was I expected 
one thing, they expected one thing and we never met in the middle.  
All because of a zip code. I expected you to talk to me like a 
person and you expected me to know the game and I don’t know 
the game so consequently you didn’t talk to me like a person. I 
would sit there and have a meltdown before anybody would look 
at me like a person.” #2 (65-year-old female, Breast Cancer) 
“I've applied for grants. Nobody has any grants or anything for that 
drug. I called literally 20 different places to find assistance.” #16 
(55-year-old female, Colorectal Cancer) 
 
 
Missing timely information. Receiving information when the information is 
needed and will benefit the patient is the premise of the next subcategory. Receiving 
information in a timely manner may make a difference in how patients manage their 
resources. One interviewee (#24) shared how she came upon information about financial 
resources that could have benefited her months earlier. It was not until the second or third 
month into her treatment that she realized financial assistance was available. Similarly, 
another interviewee (#13) several months into his treatment said that the day he was 
diagnosed he automatically qualified for Medicare and Social Security Benefits. He could 
have applied immediately for assistance. In both of these examples, these individuals had 
no idea they qualified for disability benefits. Instead they continued to tap the minimal 
resources they had and struggled financially.  To complicate the matter further, it can take 
several months before a patient actually receives financial payments after they have been 
approved. This can further lead to more financial distress. Receiving information about 
financial resources and government assistance programs could benefit patients more if 
they made aware of these programs at the beginning of their diagnosis.  
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Personal barriers. Barriers to accessing financial resources and assistance can be 
due to personal barriers as well. A few interviewees expressed a sense of pride that 
prevented them from asking others for financial help and resources. Another interviewee 
(#1) expressed embarrassment about her financial struggles. These personal barriers can 
get in the way of patients talking with others and sharing their concerns. Patients may 
fear being judged by others. Our society is based on individualism and we pride ourselves 
on “picking ourselves up by our own bootstraps”. It is not common place to openly talk 
about your financial situation. Talking about finances is considered to be one of the top 
socially inappropriate subjects to discuss in public. Due to this social stigma, patients 
may not feel comfortable admitting to others that they are struggling financially and need 
help. 
 Further complicating the situation, is that some individuals feel stigmatized when 
they ask for financial assistance. One interviewee (#2) shared how she attempted to get 
help but was treated poorly. Ultimately, she was unable to access the resources she 
needed and felt stigmatized because she was black and lived in the wrong neighborhood. 
Receiving messages such as these could negatively impact how patients proceed through 
the medical system and whether or not they seek further assistance. This could further 
lead to a state of learned helplessness. 
Struggling with fears of stigma, embarrassment or pride can prevent patients from 
accessing and receiving needed financial assistance. These barriers can be further 
reinforced by issues of social constraint.  Encouraging patients by normalizing their 
financial condition and providing a safe non-judgmental environment for them to express 
their financial concerns will help them to overcome these personal barriers.  
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Support that is not needed. According to social support theory, in order for a 
support to be interpreted as helpful it needs to reflect the support requested. That was true 
for participants in this study. Some interviewees who sought out resources and 
information received resources that were not what they needed or wanted. Not receiving 
the information and resources needed can further complicate their situation and frustrate 
patients as they are trying to seek help. As a result, the supports provided can be 
perceived as not supportive. Several interviewees commented on requesting financial 
assistance and guidance but were instead told about free monthly massages or art therapy, 
a wig, books or other services that were not what was needed. For one interviewee (#14), 
she shared how she needed assistance with completing the paperwork associated with 
getting financial assistance. She was overwhelmed with her cancer experience which was 
complicated by a divorce and having to move. She did not have the energy or capacity to 
complete the paperwork. Instead of applying for financial assistances she found it easier 
to file for bankruptcy. When patients are so overwhelmed with their financial situation, 
trying to survive cancer, and whatever else life has thrown at them, they may need help 
completing simple tasks such as filling out paperwork. This theme brings attention to the 
importance of providing resources and services that meet the requests of the patients. Not 
all patients need or want the same services. So those in the Medical Professional network 
should attempt to identify what those needs are and assist patients in locating requested 
resources or services.  
The run around. Some participants who received assistance and information on 
resources reported to hit dead-ends. They spoke about receiving information and leads on 
where to find resources. However, for some, when they followed up with these resources, 
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they were denied access. Some were told they did not have a specific type of cancer or 
did not live in the right zip code. Finding and accessing resources can be an exhausting 
and defeating process for patients further complicated when those resources are not 
accessible. The initial hope that aid and relief is available is quickly dashed by rejection 
after rejection becoming a defeating experience.  
Missing Support. Dimensions in this section refer to lacking emotional, 
informational, and instrumental supports. Missing support was largely informed by 
participants stories, but these subcategories were also informed from the silences within 
the data. See Table 5.11 for a brief overview of subcategories and excerpts.  
Table 5. 11 Missing Support 
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Dimensions Excerpt 
Diminishing 
Help 
 
“Things settle off. Everybody else goes on and lives their life, yet this is our life. The 
help and the concern drift off, and then you're left with still all of these stressors 
and financial issues. You had so much help from people, you don't want to just say, 
‘I need more help,’ or, ‘Can you do this?” #21 (36-year-old male, Lymphoma) 
 
Lacking a 
Confidant. 
“It was emotional support more so than financial. I didn't have to worry about him 
taking off work to take me to treatment, because my church members they were all 
there to do that, but I didn't let it be known that other things were going on.” #12 
(51-year-old female, Breast Cancer) 
“I have a best friend that I have known her for over forty years and she’s wonderful, 
but she has never had cancer and she just, she doesn’t quite understand it. I don’t 
want to scare her or burden her so there are things I hold back you know and the 
same way with my family, there are things that I hold back. I don’t tell them all 
everything. Then I don’t tell anyone about the money thing because to me it’s like 
embarrassing.” #1 (58-year-old female, Breast Cancer) 
 
Missing 
Information 
“I cut back some hours when I was in chemo. I took like three weeks off when I had 
surgery. If I had taken one more week off, I would have been able to qualify for 
short-term disability, but my HR person didn't know that. They didn't tell me that, 
so I just came back after three weeks, like, ‘I'm just going to do my best.’ People 
don't really know.” #19 (37-year-old female, Breast Cancer) 
“I was kind of in a catch 22, because when I started the whole process, I had like 
fourteen weeks of sick time and vacation time banked up in my account. I thought, 
Oh, that's great because then it will cover any kind of short-term disability but 
didn't realize that people couldn't donate to me because I already had too much 
PTO. Once I got through those twelve weeks, I didn't have any PTO but then they 
couldn't donate to me because I wasn't on FMLA anymore. We were just in a bad 
spot I guess, timing wise.” #23 (middle-aged female, Multiple Myeloma) 
“The last time when I had to take 6 weeks off during my school year time, I became 
aware of the program whereby school district employees can volunteer their sick 
days.  I got like 23 sick days given to me and it covered everything I needed to 
make it through the last phase.  But the first ones I didn’t have anything. Nobody 
said anything.” #7 (50-year-old female, Breast Cancer) 
“No and in fact I have made a few phone calls to see if there is anybody in their office 
to talk to me about it because I get online, and they say talk to the social worker at 
the hospital. There is no social worker at the hospital that will talk about that. At 
least not that I’ve heard.” #1 (58-year-old female, Breast Cancer) 
“No, but that would have been helpful” [to have someone sit down and talk about 
costs… It would be really nice if there was some kind of counselor to help you 
figure it out.” #1 (58-year-old female, Breast Cancer) 
“No, we are lucky they gave us side-effects of the drugs… So, there wasn’t a lot of 
education, especially the financial part. No one ever even asked.” #11 (55-year-old 
male, Glioblastoma) 
“I feel like nobody tells you that. I really can’t remember talking to anybody in my 
cancer center about insurance filing or financial help or anything like that.” #19 
(37-year-old female, Breast Cancer) 
“I don’t know that anyone ever sat down and went through the financial part of it with 
me and even being a financial professional it is not the first thing on your mind 
once you, you know. You think well you know I have insurance and you worry 
about the other stuff.” #3 (54-year-old male, Throat Cancer) 
“They didn’t go over pretty much anything with the cost of that.” #23 (middle-aged 
female, Multiple Myeloma) 
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Diminishing Help. During the diagnosis and treatment phase patients may 
experience a lot of support from those around them; however, as time passes the help and 
assistance from others declines. Others may have been made aware of an initial need for 
support and are motivated to help where they can. For those who have cancers that 
require a lengthier treatment schedule or additional complications, help may decline and 
fade over time. This may be due to others being unaware of a need still existing.  One 
interviewee (#21) commented on experiencing guilty over repeatedly asking for 
“Finances have never been mentioned by any of my providers or social workers with 
the hospital or nurse navigators or anything… no one at any of the doctors or 
hospitals ever talked to me about finances or insurance.” #5 (35-year-old woman, 
Breast Cancer) 
“We wanted to talk to someone…and all the social worker said was ‘oh we have art 
therapy.” #9 (30-year-old female, Ovarian Cancer) 
“when you go in and ask for information it wasn’t specific. It’s like, ‘Well, here’s a 
website.’”  #6 (60-year-old female, Lung Cancer) 
“I didn’t realize how expensive, but I knew it was expensive because I would ask 
questions about how much a specific, like, say, my chemo was or whatever. They 
would be like, “It’s not too bad.” They try not to worry people…They don’t want 
people to be fretting. On top of trying to take care of you. I would say how much is 
this costing or whatever and they would be like, “It’s not too bad. It’s not bad.” I 
didn’t have any real clue what’s the real cost of some of this stuff was.” #17 (41-
year-old female, Rectal Cancer) 
“Didn't understand the prognosis so didn't feel she needed the services. Then I was 
going through home care they suggested I apply for disability or contact a Social 
Worker. I opted not to because I figured I'd just go back to work by the time that 
any paperwork could be filed.” #25 (32-year-old female, Appendiceal) 
“I was in my second or third month before it clicked that there was financial assistance 
available. If they could bring that to the table right away that would be wonderful.” 
#24 (49-year-old woman, Lymphoma) 
“He was two years in before we even found out that they had a gas card program that 
could help us just with gas and getting back and forth to treatment.” #21 (36-year-
old male, Lymphoma) 
“When the bills started coming in, to be able to have that contact person to say, ‘Okay, 
what can I do with this,’ would have been really nice.” #6 (60-year-old female, 
Lung Cancer) 
 
Missed 
Opportunities 
 
“I try not to say a whole lot about finances to people. In some ways, you have to 
because you don't have a normal life anymore. Other friends and people, even 
when he's feeling good, they're going out to dinner, going out to do things and we 
can't go simply because we can't afford to go like everybody else can.” #21 (36-
year-old male, Lymphoma) 
“Then I don’t tell anyone about the money thing because to me it’s like embarrassing.” 
#1 (58-year-old female, Breast Cancer) 
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continued support and help. When a need for support is not expressed support diminishes 
potentially leaving needs unmet.   
Lacking a confidant. Few interviewees made comments about sharing their 
financial concerns with others.  For most of the interviewees there was silence regarding 
having someone to confide in about their financial struggles. One interviewee (#12) 
shared that she had other forms of support such as transportation to treatments, but she 
kept her financial concerns secret. A few participants provided insight into why they did 
not share their financial concerns with others. One interviewee (#7) explained that she did 
not share her financial concerns with her sister because she didn’t want to worry her. 
Another interviewee (#1) stated she felt embarrassment over her situation and that is why 
she did not confide in others. This subcategory of missing a supportive confidant overlaps 
into the Barriers of Support as well.  The embarrassment and desire to not worry others 
becomes a personal barrier for some people.  
Missing information. A commonality among several of the interviews was that 
many lacked information that could have assisted in preparing them for the costs of their 
care or possibly taking steps to alleviate that impact.  Several of the examples provided 
by interviewees were directly work related. Human Resource (HR) departments are key 
to explaining how policies and employee benefits work. Knowing what is available and 
timing the implementation of when to use these programs can possibly be tricky but 
could work in favor of the employee. One interviewee (#19) shared how she could have 
benefited from guidance from her HR on when to return to work. If she had stayed away 
from work another week, she could have tapped into her short-term disability benefits. 
Instead she returned to work even though she was not physically ready to do so. Another 
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interviewee (#23) could have benefited from advice on how to navigate the use of her 
paid time off (PTO), Family Medical Leave Assistance (FMLA), and the agencies PTO 
donation program. Similarly, another interviewee (#7) was unaware of her employer’s 
PTO donation program until her last treatment phase. Initially no one told her the 
program existed. For each of these interviewees, having access to information about these 
programs earlier and being given guidance on using them might have alleviated some of 
the financial hardship they experienced.   
Interviewees also lacked information from their Medical Professionals. In 
response to a probing question about whether or not someone talked to them about their 
medical costs, many responded negatively. Not all patients are interested in knowing how 
much their medical treatment will cost, but some are. A few interviewees shared how 
they requested the information from several of their medical providers but were not given 
it. Some were told to not worry about it which, as discussed, overlaps into the Helpful 
and Non-helpful Support categories.  
Receiving timely and accurate information could be beneficial to patients. It is 
important for patients to have an accurate understanding of their situation and what 
resources are available so they can make financial decisions or take actions that could 
soften the financial impact. For one interviewee (#6), the bills started to come in after 
treatment was completed, and she did not know who to ask for help. Knowing who to ask 
questions of when the bills are flooding in could perhaps help patients to cope with their 
financial situation by developing a plan for repayment.  
Missed opportunities. As noted in the literature, financial toxicity can lead to 
changes in a person’s social life as they cut back on entertainment and discretionary 
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spending. One interviewee (#21) talked about cutting back on going out to dinner with 
friends because they could not afford it anymore. There friends still engaged in activities 
but without them. By not engaging in these activities’ friendships are at risk of dissolving 
missing the potential opportunity to let others know that help is still needed. As noted 
earlier in this chapter, some patients do not disclose to others their financial concerns. 
Similarly, not talking about financial struggles can compound a patient’s experience of 
being isolated and cut off from others who can and would provide help. Ultimately, they 
may miss out on social supports that could be available if others were aware of the need.  
Brief Interpretation 
In support of social support theories, cancer survivors in this study experienced 
received social support (emotional, informational, and instrumental) and social constraint. 
Emotional support was mostly provided by family members and friends; although, there 
were examples of emotional support from the medical professionals and organizations 
(mainly work). Emotional support is often seen intertwined or a result of a received 
instrumental support. Benefiting from acts of service or being relieved of a stressful 
responsibility can provide feelings of being cared about. Furthermore, having someone to 
talk with and share your financial concerns can provide feeling of being understood and 
can normalize the experience making cancer patients and survivors feel not so alone in 
their experiences.   
In addition, informational supports were provided by family members, friends, 
and medical professionals. Cancer patients and survivors can benefit from advice on how 
to organize and understand their medical bills and insurance. Understanding medical and 
insurance forms and knowing when to pay medical bills or how to file appeals for 
  109 
insurance denials could give patients more control over their financial situation. 
Likewise, receiving timely information on accessing financial assistance or advice on 
when to apply for government assistance programs could ultimately have an impact on 
the financial outcomes for patients. 
More noticeably, received instrumental support had a strong presence in the data 
and were provided by all social network members (family members, friends, medical 
professionals, and organizations). Monetary support or support that could have an 
economic value (childcare, transportation, food), no matter how small the assistance, can 
indeed provide some relief from the objective and subjective perspectives of financial 
toxicity.  
As evident by the literature, cancer patients can be in a financially precarious 
situation due to their cancer costs. This condition can be further augmented by the 
presence and pressures of social constraint. Support providers may not take into 
consideration the financial implications of the support they offer. As was evident in the 
subcategory Good Intentions with Financial Implications where supportive efforts came 
at a financial expense for the cancer patient or when support was just bad support further 
complicated the patient’s financial well-being. Moreover, cancer patients are susceptible 
to receiving supports that are not helpful or otherwise not wanted. Receiving advice that 
is critical or not generally helpful, can put unwanted social pressure on patients and may 
prevent them from seeking help or talking to others about their financial concerns.  
The third category, Gaps in Support, gave insight into areas where support is 
needed: missing support or barriers to accessing support. Cancer survivors in this study 
lacked timely and accurate information that could have helped them steer through some 
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of the financial healthcare maze. Receiving information on how to balance employment 
related benefits to take the most advantage of those programs, or information on 
accessing agency or government assistance programs could have major financial benefits. 
Likewise, addressing personal barriers could alleviate patients’ feelings of stigma or 
embarrassment about disclosing their financial concerns which in turn may improve their 
help-seeking and receiving behaviors.  
In essence, this study brings to light that there are social supports that can and do 
benefit the financial well-being of cancer patients. Moreover, cancer patients and 
survivors may experience unmet needs and barriers to accessing support. This study 
opens up a discussion on ways to improve the system for future patients which will be 
addressed in the final chapter.    
Summary 
 This chapter presented the findings for Study 1. It provided insight into the types 
of social support available and used by a sample of cancer survivors who self-reported 
cancer-related financial burden and distress. The next two chapters (6 and 7) will present 
the methods and findings for Study 2, respectively. This will allow further elaboration on 
how social support impacts the experience of financial toxicity. Chapter 8 will intertwine 
the interpretations from both studies for a final synopsis exploring implications for 
practice, research, and policy.  
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CHAPTER 6: STUDY 2 METHODS 
This chapter presents the methods for the second study conducted to answer the 
overarching question: What role does social support play in the experience of cancer-
related financial toxicity? Relying on quantitative methods, study 2 used a cross-sectional 
survey design. Similar to study 1, study 2 relied on the understanding of financial toxicity 
as presented in the Carrera et al. (2018) framework and social support theories as well as 
the by the Transactional Model of Stress and Coping Theory (Stress and Coping Theory) 
and the Stress Buffering hypothesis (see Chapter 3 for more details on these theories). 
These theories provided guidance and direction to determine if social support played a 
moderator or mediator role in the relationship between financial toxicity (objective 
burden and subjective distress) and quality of life (QoL). The present chapter details the 
methods used for study 2. 
Purpose 
Study 2 is the second study used in this multi-method project to gain a better 
understanding of the impact social support has on the financial toxicity of cancer care. 
The question that drives this study is: How does social support influence cancer-related 
financial toxicity and patient’s quality of life? This question attempts to determine the 
path by which social support impacts the relationship between cancer-related financial 
toxicity and QoL, whether by mediating or moderating processes. The two specific aims 
and corresponding hypotheses are listed below.  
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 Specific Aim 1: To determine if received and perceived social support moderates 
the relationship between cancer-related financial toxicity, and quality of life controlling 
for the effects of cancer treatment, education, employment, insurance status, marital 
status, and social constraint. (Quality of life will be considered under two conditions: 1) 
quality of life as determined by the FACT-G scale; and 2) quality of life with economic 
well-being using the FACT-G scale plus the Economic Well-being scale. Scales will be 
further explained in the Measures section below.) 
Hypothesis 1.1: Received social support will moderate the relationship between 
financial toxicity and QoL. 
Hypothesis 1.2: Perceived social support will moderate the relationship between 
financial toxicity and QoL. 
Hypothesis 1.3: Received social support will moderate the relationship between 
financial toxicity and QoL including socio-economic well-being scale (Plus 
SEW). 
Hypothesis 1.4: Perceived social support will moderate the relationship between 
financial toxicity and QoL Plus SEW. 
Specific Aim 2: To determine if received and perceived social support mediates 
the relationship between cancer-related financial toxicity and QoL controlling for the 
effects of cancer treatment, education, employment, insurance status, marital status, and 
social constraint. 
Hypothesis 2.1: Received social support mediates between financial toxicity and 
QoL. 
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Hypothesis 2.2: Perceived social support mediates between financial toxicity and 
QoL.  
Hypothesis 2.3: Received social support mediates between financial toxicity and 
QoL Plus SEW. 
Hypothesis 2.4: Perceived social support mediates between financial toxicity and 
QoL Plus SEW. 
Baron, et al., (1986) comments that it is acceptable to begin with a moderator-
oriented perspective that evolves into a mediator process; therefore, I first explored the 
moderator-oriented perspective (specific aim 1) and then the possibility of a mediator 
process as described in specific aim 2. The analysis procedure is outlined in the Data 
Analysis section below and results can be found in Chapter 6.  
Study Design 
 Study 2 was a cross-sectional survey design as data was gathered at one time 
point for each participant. Cross-sectional study designs are appropriately used for 
measuring outcomes and determining associations between variables.  
Human Subjects Protection. Study 2 was approved by the University of 
Louisville Institutional Review Board (IRB). The study required direct contact with 
human subjects; therefore, it needed to meet ethical standards. All participants were 
provided a consent preamble informing them of the purpose of the study and their rights 
to not participant in the study at any time. See Appendix H for the consent preamble. 
Study sample. Participants were recruited using a convenience-sampling method. 
Multiple cancer-related agencies were asked and agreed to send out the call for 
participants through social media platforms, websites, emails and online monthly 
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newsletters. See Table 6.1 for a complete list of agencies used, method of dissemination 
and number of participants obtained. If participants were interested in participating, they 
could follow the weblink provided in the correspondence. See Appendix I for the IRB 
approved call for participants. 
Table 6. 1 Dissemination Methods and Responses by Agency. 
Organizations Method of 
Dissemination 
Potential 
Exposure 
Number 
Responses 
Percent 
Adelphi Newsletter ~2000 1 .9 
Atlanta Cancer 
Foundation 
Newsletter Unknown 1 .9 
Website Unknown 1 .9 
ACS-Cancer Support 
Network 
Announcement 
Website 
Unknown 3 2.8 
Breast Friends Email/Newsletter ~5000 56 52.8 
Friends for Life Email ~350 15 14.2 
Facebook ~2568 0 0 
Twitter ~6991 0 0 
Komen Foundation 
Kansas City 
Unknown ~8000 1 .9 
Facebook ~20,000 2 1.8 
Research Match Email 1324 Contacted 
74 Initial 
Response 
22 20.8 
UofL Kent School Website Unknown 1 .9 
Other: Referred by 
friend or agency that 
was not enlisted. 
Unknown Unknown 3 2.8 
 
Inclusion criteria. Participation criteria required individuals to be 18 years and 
older, who had a breast or blood cancer diagnosis and/or treatment in the past 5 years.  
Power consideration. Since a moderating variable may interact directly and/or 
indirectly with the outcome variable, it is difficult to detect an effect when statistical 
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power is too low. The Sample Size application by Abu-bader (2014) was used to 
calculate required sample size for a multiple regression analysis. This application 
calculates the sample size necessary to achieve .80 statistical power for various statistical 
analysis. For a three-factor logistical regression, a sample size of 77 is required for an 
alpha level at .05 with a medium effect size.  Three factors are consideration in a 
moderator analysis because there are two independent variables that interact, The 
interaction variable is considered to be the third factor. A sample size of at least 100 
participants was sought to allow enough power to control variables that may have an 
influence on the relationship during the analysis.  
After the sample was collected a second power analysis was conducted using 
G*Power (Faul, Erdfelder, Lang, & Buchner, 2007; Faul et al., 2009) to determine how 
many control variables may be used in the analyses to maintain a medium effect size.  
With the sample size obtained for this study at least 11 factors could be used (n=123).  
Study Procedure 
The survey was developed using initial data analysis from Study 1 as well as the 
theoretical frameworks of Lazarus et al. (1984), and Cohen et al. (1985). Standardized 
instruments were used to ensure validity and reliability of the measurement ofquality of 
life, financial toxicity and social support. In addition, questions pertaining to the use and 
type of social support, as well as demographic information, cancer type, and cancer 
treatment received were collected.   
After receiving IRB approval, the survey was created in the Blue survey 
management system. The call for participants was sent out by participating cancer-related 
agencies (see Table 6.1). Participation was voluntary. If participants were interested in 
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participating, they could follow the link to the questionnaire where they would first be 
presented with the consent preamble and then questions (see Appendix H for the consent 
preamble and Appendix J the survey questions). Surveys were collected through the Blue 
online survey platform between July 2017 to December 2018.  
Data management. Data were initially collected in the Blue online survey system 
which is a password protected program licensed with the University of Louisville. After 
the data were collected, they were downloaded and transferred into an IBM SPSS v25 
software file on a password protected and encrypted computer.   
Measures. Variables were operationalized based on peer-reviewed literature and 
published books (see Appendix K). Standardized instruments were selected based on 
validity and reliability as well as their use in similar literature. Scales and questions were 
selected to gain the most accurate information with the least respondent toxicity. In 
addition, questions pertaining to the use and type of social support, as well as social 
constraints, demographic information, and disease specific information were collected. 
An overview of variables, measures, level of measurement and estimated time 
requirement can be viewed in Appendix K.  
 Clinical Questions. Questions were created to first gather cancer specific 
information about participants’ diagnoses and treatments since these variables may be 
associated with other variables of interest. 
      Financial toxicity – independent variable (IV). Financial toxicity is the subjective 
distress and objective burden due to cancer treatment costs and related expenses. The 
COST-PROM was used to measure cancer-related financial toxicity. This is a 
comprehensive instrument designed to consider the effects of direct and indirect costs 
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caused by a cancer diagnosis and treatment. Examples of some of the items are: “I feel 
financially stressed”, “I feel I have no choice about the amount of money I spend on 
care”, and “I feel in control of my financial situation”. The COST-PROM is an 11-item 
self-reporting inventory rated on a 5-point Likert scale (0 = not at all; 5 = very much). 
The scale has been shown to have excellent internal consistency with Cronbach alpha = 
0.9 in other studies (DeSouza et al., 2014).  For this sample reliability was good (alpha = 
.81). A high score on this scale indicates higher level of toxicity.  
      Social support – moderator or mediator variable. Social support is the emotional, 
informational, and instrumental support perceived and/or received from formal and 
informal support networks. The measures used to assess perceived social support are the 
PROMIS Instrumental, Informational and Emotional Support instruments (PROMIS, 
2015). Each instrument has 4 items that are rated using a 5-point Likert scale (1= never to 
5 = always). Items are summed for a raw score and then converted to t-scores. Higher 
scores reflect more support.  
• The NIH PROMIS Emotional Support SP4a instrument measures the perception 
of being cared for and valued. Examples of items include: “I have someone who 
will listen”, and “I have someone to confide in”. This scale had excellent internal 
consistency (Cronbach alpha = 0.904). 
• The NIH PROMIS Informational Support SP4a instrument measures the 
perception of available information and advice (PROMIS, 2015). Items include: 
“I have someone to give me good advice”, and “I have someone to turn to for 
suggestions”. The scale had excellent internal consistency (Cronbach alpha = 
0.96).  
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• The NIH PROMIS Instrumental Support SP4a instrument measures the perception 
of availability assistance with tasks, and material resources (PROMIS, 2015). 
Questions include: “Do you have someone to run errands if you need it”, and “do 
you have someone to help with your daily chores”. This scale had excellent 
internal consistency (Cronbach alpha = 0.95). 
     Received social support – moderator or mediator variable. The short version of 
the Inventory of Socially Supportive Behaviors (ISSB) assesses received social support 
within the past month. This is a 19-item scale graded on a 5-point Likert scale ranging 
from “not at all”, “once or twice”, “about once a week”, “several times a week” to “about 
every day”. This scale assesses received Informational and Instrumental support for the 
past month and included responses to a prompt asking how often someone provided 
specific activities such as: “gave you information”, “helped you understand”, and 
“suggested some action”. Internal consistency for reported studies is excellent (Cronbach 
alpha between 90 – 94) and for this study was excellent (Cronbach alpha = 0.904) 
(Barrera, Sandler, & Ramsay, 1981).  
 Quality of life – dependent variable (DV). Quality of life is a multidimensional 
concept that encompasses a person’s perception of their overall well-being. Well-being is 
defined as the personal perception of how well life is going and the degree to which it is 
enjoyed. Quality of life was assessed using two version of the Functional Assessment of 
Cancer Therapy (FACT-G) scale: 1) FACT-G and 2) FACT-G Plus which adds in the 
socio-economic well-being subscale (Head & Faul, 2008). The quality of life domains of 
the FACT-G includes physical, emotional, social, and functional. The FACT-G is a 28-
item scale rated on a Likert scale (0 = Not at all; 4= Very Much). Internal consistency is 
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reported good with a total Cronbach alpha = 0.89 (Cella et al., 1993). For this sample, the 
FACT-G showed excellent reliability (Cronbach alpha = 0.91). The Socioeconomic Well-
being scale is 17-item scale rated on a 5-point Likert scale (0 = Not at all; 4= Very 
Much). Respondents are asked to indicate how a statement applies to their situation and 
include statements such as: “I believe that being sick will hurt me financially” and “I am 
able to make enough money to pay for my healthcare.”  In other studies, the subscale has 
had excellent internal consistency (Cronbach alpha = 0.92) (Head, et al., 2008). For this 
sample the reliability was excellent (Cronbach alpha = .94). These scales assess domains 
of well-being for the past 7 days. Higher scores indicate increased quality of life. 
Social Constraint – IV. Research has shown that social constraint may influence 
feelings of support (Lepore, 2002) and therefore should be considered in the analysis. 
The Social Constraint scale is a 15-item scale rated on a 5-point Likert scale (0 = Not at 
all; 4= Very Much). Examples of questions include: “How often did it seem that other 
people did not understand your situation” and “how often did other people avoid you”. 
This scale has shown good internal consistence (Cronbach alpha = 0.89). For this sample 
internal consistence was excellent (Cronbach alpha = .946).  
Participant burden and time consideration. Scales and questions were selected to 
gain the most accurate information with the least respondent burden. It is generally 
accepted that an inventory instrument with 30 to 40 items should only take the respondent 
a few minutes to complete (Wills & Shinar, 2000). To complete this questionnaire, it took 
an estimated 20 minutes.  
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Data analysis 
Data cleaning. Once data were uploaded to SPSS the database was prepared for 
analyses. See Appendix L for specific steps taken for database preparation and tests for 
assumptions.  Data were assessed for missing responses and outliers. Each standardized 
instrument provided instructions for handling missing data. Scales for social support, 
financial toxicity and QoL were calculated as instructed by specified guidelines. A 
composite variable was created for perceived social support using the three PROMIS 
scales. The PROMIS scales met expectations for a meaningful grouping and were not 
highly correlation (Song, Lin, Ward, and Fine, 2013). Further justification and steps for 
creating the composite perceived social support variable (emotional, informational, and 
instrumental) can be viewed in Appendix L.  
      Descriptive statistics. Basic descriptive analysis provided general information 
about the sample (mean, median, standard deviation, frequency and percentages of 
ordinal measures, normal data distribution). Frequency distributions were run in SPSS for 
sample characteristics included basic demographics, before/after job status, before/after 
insurance status, and cancer-related characteristics.  
Bivariate Analysis. Pearson’s bivariate analysis was conducted to determine the 
relationships between continuous predictor variables (age, social constraint). Pearson’s 
correlation will report if items are negatively or positively correlated. See Appendix M 
for specific steps and Cohen conversion values. 
For IVs that are nominal or ordinal level data, One-way Analysis of Variance 
(ANOVA) tests were conducted with the DV being quality of life. See Appendix N for 
steps. An ANOVA can be used as an independent sample t test for IVs that have 2 group 
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levels (Lawson et al., 2014).  Dummy variables were created for ordinal level data See 
Appendix L for steps. 
Specific aim 1. The first aim was to determine if received and perceived social 
support moderates the relationship between cancer-related financial toxicity and QoL 
controlling for treatment, education, employment, insurance status, marital status, and 
social constraint. As discussed, QoL is measured using the FACT-G and the FACT-G 
plus. 
If social support is a moderator, it will influence the relationship between the IV 
and the DV. Introducing a moderating variable will change the direction or magnitude of 
the relationship between the IV and DV. There must be a significant interaction effect 
between social support and financial toxicity (Meyers et al., 2013). Refer to chapter 3 for 
the conceptual model of a moderator effect based off Baron et al. (1986). Holmbeck 
(1997) discusses two analytical methods used to determine moderator effects: multiple 
regression and structural equation modeling (SEM). A sample size of at least 200 is 
needed for SEM. Since the sample size is only 126, multiple regression methods were 
used. 
The equation for the multiple regression analysis is as follows:  
Ypred=a+b1X1+b2X2+b3X1X2     (1)   
This analysis will test if the interaction of X1X2 (i.e., financial toxicity, social support) is 
related to the remainder of Y (QoL) after X1 (financial toxicity) and X2 (social support) 
have been used to predict Y (McClelland & Judd, 1993). If the interaction variable is 
significant then it can account for some of the variance in the outcome variable and 
therefore moderates the relationship.  
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Data Analysis. To conduct the analysis for a moderator effect the Introduction to 
Mediation, Moderation, and Conditional Process Analysis (PROCESS) macro for SPSS 
was used. PROCESS is a modeling tool for SPSS and SAS that enables the analysis of 
moderator and mediator effects (Hayes, 2017). It is a robust tool and has been used in 
several peer-reviewed journal articles since 2014. The PROCESS method was selected 
because the Baron and Kenny (1986) method is no longer the preferred methodologically 
approach (Hayes, 2017). PROCESS implements simultaneous multiple regression 
analyses to determine if a moderation effect is present (Hayes, 2018). The PROCESS 
macro automatically centers the predictor variable to avoid multicollinearity, computes 
the interaction term, and runs simple slope analyses using ordinary least squares (Fields, 
2013).  
 Assumptions that need to be considered for multiple regression analysis include 
sample size, multicollinearity of predictor variables, outliers, excluded variables and 
misspecification of variables. To avoid issues of multicollinearity created by the 
interaction term between social support and financial toxicity, the variables were centered 
before the interaction term was created centered (Meyers et al., 2013; McClelland & 
Judd, 1993; Holmbeck, 1997; Hayes, 2018). As stated, PROCESS automatically centers 
the variables to avoid issues with multicollinearity. Next, data should be homoscedastic 
meaning the variance between the residual of each predictor variable should be fairly 
consistent. Potential issues with heteroscedasticity (opposite of homoscedasticity) are 
handled automatically through the PROCESS macro using bootstrapping techniques. 
Bootstrapping is the process of generating a large number of replications from the data 
(Tabachnick & Fidell, 2013); essentially random samples from the data set multiple 
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times. This allows for the computation of confidence intervals and determination of 
significance (Fields, 2013).  Lastly, data for the predictor, moderator and outcome 
variables should be continuous, interval or ratio form. Tabulated data from the scales are 
in interval form. Any control variable should be in dichotomous form (entered in SPSS as 
0, 1). 
Hayes (2018) argues there is ultimately no difference between a hierarchical 
stepwise regression and a simultaneous entry.  Several scholars have commented further 
on whether or not a stepwise or simultaneous method should be used. Holmbeck (1997), 
states that if the variables are considered equal in the theoretical model then it is 
appropriate to use a simultaneous process. Additionally, using a step-wise method relies 
on chance which may lead to an unstable equation (Lawson et. al., 2014). Furthermore, 
when there are less then 15 variables the simultaneous method will provide as good or 
better model fit; however, if there are more then 15 variables then the stepwise methods 
may be useful (NCSS & Hintze, 2007).  
It is my understanding that the PROCESS macro simulates the simultaneous 
multiple regression. The PROCESS macro provides the DR2 which is the variance in Y 
due to the moderation of X by the moderator variable (M) and it uses ordinary least 
squares (OLS) to evaluate model fit including R2 and overall F-test. In addition, it 
provides bootstrap confidence levels and provides the Johnson-Neyman technique for 
probing interactions.  
The PROCESS macro was used to conduct the moderation analysis (using 
simultaneous multiple regression analyses) for hypothesis 1.1 – 1.4 to determine if social 
supports behaved as a moderator variable in the relationship between financial toxicity 
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and QoL. For the analyses that showed significant moderator effects, control variables 
(age, cancer treatment, education, employment, insurance status, and marital status) were 
added to the model to determine if social support continued to moderate the relationship 
between financial toxicity and QoL.  
Final analysis was conducted to determine if social constraint had an influence in 
the relationship. Social constraint was added using a moderated moderator model as 
described by Hayes (2017). Specific steps in PROCESS for conducting these analyses 
and an example of the SPSS output can be viewed in Appendix O.  Results are presented 
in chapter 7. 
Specific aim 2: Aim 2 sought to determine if received and perceived social 
support mediates the relationship between cancer-related financial toxicity and QoL 
controlling for cancer treatment, education, employment, insurance status, marital status, 
and social constraint. QoL is determined using two variations of the FACT-G scale: 1) 
FACT-G and 2) FACT-G plus socio-economic well-being scale. The following equation 
represents the statistical analysis for a simple mediation model. 
M = iM + aX + eM 
Y = iY + c’X + bM +eY (Hayes, 2017) 
To test for mediator effect four conditions must be met through a series of 
regression analyses. (See figure ___ for pathway notation.)  
1) The IV must be significantly associated with the DV: financial toxicity to 
quality of life (path C). 
2) The IV must be significantly associated with the mediator: financial toxicity 
to social support (path A). 
  125 
3) The mediator variable must be significantly associated with DV: social 
support to quality of life (path B). 
4) The impact of the IV on the criterion variable should be smaller when the 
mediator is included: financial toxicity à QoL, control for social support 
(Field, 2013; Hayes, 2017). 
 
 
 
 
 
 
 
 
 
Data Analysis. In order to analyze the data for these conditions a series of 
correlations and linear regression analyses can be used to determine the relationships 
(Meyers, Gamst, & Guarino, 2013; Field, 2013); however, I again used the PROCESS 
macro to determine if a mediator effect exists (Hayes, 2017). The PROCESS macro can 
be used to conduct 92 different moderator and mediator analyses. For this analysis, 
models 4 and 14 were used (see Hayes, 2017 and Chapter 3 for models). PROCESS 
implements bootstrapping techniques to calculate standard errors and confidence 
intervals. Confidence levels were used to determine at a 95% confidence that the true b-
value falls between the lower level and the upper level.  
Stress Event 
-Costs of Cancer 
Care  
Social Support 
-Perceived 
-Received 
Emotional, Informational  
Instrumental 
 
Patient 
Outcome  
- Quality of 
Life 
-Financial 
Well-being 
Financial 
Toxicity 
-Subjective Stress 
-Objective Burden 
 
A 
B 
C 
Figure 6. 1 Diagram of mediation model, adapted from Hayes (2017). 
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The data assumptions to use this analysis are: interval or ratio level of 
measurement, predictive relationship must be linear, and variable distribution must be 
normal. Issues of multicollinearity should be considered (Meyer, et al., 2013); however, 
social support and financial toxicity were not highly correlated. The assumption of 
misspecification will occur when there are irrelevant variables included in the model. 
Variables were added to the model when justified by theory and reason.  (See steps for 
analysis in Appendix P). Results are presented in chapter 6. 
Dissemination 
      Preliminary results have been disseminated through conference presentations and 
workshops to oncology providers including social workers, physicians, nurses, financial 
counselors, and administrators.  I presented a poster at CSWE in 2017 on the topic of 
addressing financial toxicity in the educational process for oncology social workers. This 
poster pointed out the importance of education professionals engaging in important 
conversations about finances with cancer patients. Presentations were also made at the 
American Cancer Society Doctoral workshop, 2017 and 2018, for fulfillment of grant 
recipient responsibilities. Attendees for this workshop included other doctoral grant 
recipients and professional oncology social work researchers.   In addition, I was invited 
to present on a cancer care access panel supported by a PCORI grant with the University 
of Kansas Medical Center in January 2019. This webinar was attended by medical 
professionals, patients and caregivers. I presented on the topic of financial toxicity 
pulling in preliminary results from study 2.  
 Future dissemination of this material will include peer-reviewed journal 
publications and the development of educational materials on addressing financial 
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concerns for medical professionals. Creation of a program to highlight the importance of 
engaging in financial conversations to ensure all available resources to assist patients are 
accessed in a timely manner.  I will address future research and development plans in 
more detail in the discussion section. 
Summary 
      This chapter provided the research methods that were used for Study 2. Study 2 
was driven by quantitative methods and analysis. Specific aims and hypotheses were 
presented along with sample collection procedures and detailed steps for cleaning data 
and statistical analysis (located in corresponding Appendices).  The results from Study 2 
are presented in Chapters 7. An in-depth discussion on the interpretation and finding are 
presented in Chapter 8.   
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CHAPTER 7: STUDY 2 RESULTS 
“I’m told I make too much money to qualify for financial assistance. I pay $50 a month. 
They state it isn’t enough. I gross $770 a month. How am I to pay more? I’ve asked them 
why they save patients if they are going to kill them with the stress they are creating.”   
- Study 2 #88 (58-year-old female, Breast Cancer) 
 
The primary purpose of this research was to determine if social support played a 
role in the complex issue of cancer-related financial toxicity and if so, how does it impact 
the situation. In Study 1, we see that social support is present and commented on by most 
of the participants in that study. Many reported to benefit from received instrumental 
support. However, there was a clear lack of the presence of received informational and 
emotional support. There were also very few comments on perceived social support. 
These results led to more questions about patients’ experiences and how that can be 
improved.   
This chapter will present the results from Study 2 which examined the 
relationships between financial toxicity, social support, and quality of life (QoL). This 
study used quantitative methods, described in Chapter 6, to answer the driving question: 
How does social support influence cancer-related financial toxicity and patient’s QoL? 
Specifically, I was interested in whether or not social support acted as a moderator or 
mediator variable in the relationship between financial toxicity and QoL. This chapter 
first presents a description of the sample characteristics followed by the results of each 
hypotheses for the study aims.   
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Sample Characteristics 
There were 131 cases downloaded from the Blue survey system. One case was 
deleted for missing excessive amounts of data. Four cases were deleted because they did 
not meet study criteria for type of cancer. The remaining sample consisted of 126 
participants who reported to have had breast cancer (n = 104) or blood cancer (n = 20) 
diagnosis and treatment in the past 5 years. The age of participants ranged from 30-83 
with a mean of 54.6 (SD 10.30). For those with breast cancer the mean age was 53.8 (SD 
9.56) ranging from 32-83 years; those with blood cancer had a mean age of 59.1 (SD 
12.81) and ranged from 30-80 years.  Most of the participants were female n=117 (94%), 
white n=103 (82%), and married or living with a significant other n=67 (53%). See Table 
7.1 for a breakdown of each demographic characteristic.   
Table 7. 1 Demographics of Participants.  
Characteristic Mean (SD) Range 
Age 54.6 (10.3) 30-83 
    Frequency Percent 
Gender     
 
Female 117 93.6 
Male 8 6.4 
Missing 1 0.8 
Race/Ethnicity     
 
White 103 81.7 
Black 9 7.1 
Hispanic 6 4.8 
American Indian 3 2.8 
Missing 4 3.2 
Marital Status     
 
Married/Significant Other 67 53.2 
Separated/Divorced 34 27 
Single 13 10.3 
Widowed 4 3.8 
Missing 1 0.8 
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Education     
 
Graduate/Professional 39 31 
Bachelor's 33 26.2 
Some College/Technical 
School 36 28.6 
High School/GED 16 15.1 
Missing 2 1.9 
Occupation     
 
Professional/Technical 62 49.2 
Executive/Management 15 11.9 
Clerical/Sales/Service 23 18.3 
Agricultural 2 1.6 
Craft/Manufacturing 5 4 
Homemaker 15 11.9 
Missing 4 3.2 
Household Income     
 
Over $80,000 33 26.2 
60,001-80,000 19 15.1 
40,001-60,000 34 27.5 
25,001-40,000 21 19.8 
Less Than $25,000 13 10.3 
I don't know 3 2.4 
Missing 2 1.6 
 
Participants were asked if they experienced a job change due to their cancer 
experience (see Table 7.2 to view reported employment status prior to diagnosis and after 
treatment). A third of participants n=38 (30%) reported they experienced a change in 
status due to their cancer experience.  Over half of the participants n=66 (52%) reported 
to leave their job temporarily during their cancer treatment or recovery phase. A fourth 
n=27 (21%) reported to permanently leave their jobs due to their cancer experience.  
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Table 7. 2 Employment Status at Diagnosis and Current Status. 
At Diagnosis N % Current Job Status N % 
Full-time 87 69 Full-time 56 44.4 
Part-time 11 8.7 Part-time 15 11.9 
Retired 16 12.7 Retired 24 19 
Disabled 6 4.8 Disabled 17 13.5 
Unemployed 1 0.8 Unemployed 9 7.1 
Homemaker 5 4 Homemaker 5 4. 
 
The majority of participants n=93 (73%) received insurance from an employer-
based program prior to their cancer diagnosis. Just over a fourth of participants n=35 
(28%) reported a change in their insurance due to their cancer experience. See Table 7.3 
for participants’ current insurance status and insurance status when diagnosed.  
Table 7. 3 Insurance Status at Diagnosis and Current. 
Prior Insurance 
Status N % 
Current Insurance 
Status N % 
Employer Paid 93 73.8 Employer Paid 67 63.3 
Self-Paid 19 15.1 Self-Paid 16 15.1 
Veterans 1 0.8 Veterans 2 1.9 
Medicare 5 4 Medicare 12 11.3 
Medicaid 6 4.8 Medicaid 4 3.8 
No Insurance 2 1.6 No Insurance 4 3.8 
 
Cancer characteristics. The majority of participants reported to have had breast 
cancer (n=106, 84%). Over half of participants n=78 (62%) reported to have received 
treatment within the past year and “No Evidence” of cancer (n=67, 53%). (See Table 7.4 
for more detailed cancer specific characteristics.)  
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Table 7. 4 Description of Clinical Characteristics. 
Characteristic  Blood Cancer (n=20) 
Breast Cancer 
(n=106) 
Total 
 (n = 126) 
  Frequency % Frequency % Frequency % 
Cancer Type             
 Blood         20 15.9 
Breast         106 84.1 
Treatment             
 
Surgery 1 5 101 95.3 102 81 
Chemotherapy 16 80 79 74.5 95 75.4 
Radiation 4 20 71 67 75 59.5 
Stem Cell 7 35 1 0.9 8 6.3 
Immunotherapy 5 25 7 6.6 12 9.5 
Other 4 20 23 21.7 27 21.4 
Time Since Last Treatment           
 
Current – 1 
year 12 60 66 62.2 78 61.9 
1 year – 2 years 3 15 15 14.2 18 14.3 
2 year – 3 years   9 8.5 9 7.1 
3 year – 4 years 1 5 8 7.5 9 7.1 
4 year – 5 years 2 10 5 4.7 7 5.6 
Current Status             
 
Active 4 20 23 21.7 27 21.4 
Remission 9 45 23 21.7 32 25.4 
No Evidence 7 35 60 56.6 67 53.2 
 
Financial toxicity characteristics. Several One-way Analysis of Variance 
(ANOVA) were conducted to determine if certain characteristics were associated with 
financial burden and distress (financial toxicity). Financial toxicity and distress were 
assessed using the Comprehensive Score for Financial Toxicity (COST). Those who had 
undergone chemotherapy, had an active cancer status or were in remission, lower 
education, single, minority and had an income below $80,000 were significantly more 
likely to experience higher levels of financial toxicity. (See Table 7.5 for means, standard 
deviations and significance levels.)  Individuals who had a bachelor’s degree or higher, 
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had a household income over $80,000, and were married reported lower financial 
toxicity. Insurance status was not significantly related to financial toxicity. Individuals 
who were unemployed had a lower mean score which tended toward significance. (See 
Table 7.5 for means, standard deviations and significance levels.)   
Table 7. 5 Level of Financial Toxicity by Demographics. 
 
Variable Mean (SD) df F Sig. Partial Eta  Power 
Treatment       
 Chemotherapy 20.01 (8.54) 1, 124 4.08 .046 0.032 0.518 
No Chemotherapy 16.42 (8.74) 
     
Cancer Status  
     
 
Active 20.41 (7.35) 2, 123 3.07 .05 0.048 0.584 
Remission 21.66 (10.01) 
    
No Evidence 17.40 (8.24) 
     
Education  
     
 Less than Bachelors 20.21 (8.33) 1, 124 5.26 .041 0.034 0.535  
Bachelor or Higher 16.69 (9.08)      
Employment Status       
 Unemployed 24.22 (6.22) 1, 124 3.39 .068 0.027 0.448  
Other 18.73 (8.75) 
     
Income  
     
 Under 80,000 20.42 (8.61) 2, 121 3.6 .03 0.056 0.657 
Over 80,000 16.05 (8.33) 
     
Marital Status  
     
 Single 21.09 (8.79) 1, 124 4.4 .032 0.035 0.575 
Married/Other 17.74 (8.40) 
     
Race  
     
 White 18.38 (8.80) 1, 123 5.18 .025 0.04 0.617 
  Other 22.95 (7.25)           
 
Univariate analysis. All scales were calculated and assessed to determine if the 
data met assumptions for analyses (see Appendix K for details on database preparation.)  
A one-way Analysis of Variance (ANOVA) was conducted to determine if 
differences existed between cancer types for all scales. See Table 7.6 for descriptive 
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statistics. There were no differences between cancer types (blood or breast) for all scales 
except for Received Social Support. Respondents with blood cancer reported more 
received social supports than those who had breast cancer.  
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Table 7. 6 Descriptive Statistics by Type of Cancer. 
 
  Total Blood Cancer Breast Cancer     
Variable Mean (SD) Range Mean (SD) Range Mean (SD) Range F (1, 124) p 
COST 20.5 0-44 18.4 (11.9) 2-44 19.26 (8) 0-44 0.164 .686 
Emotional Support 51.82 (8.46) 29.9-62 53.62 (7.61) 40.5-62 51.48 (8.6) 29.9-62 1.077 .301 
Informational Support 52.14 (9.9) 25.6-65.6 54.69 (6.85) 39.8-65.6 51.67 (10.33) 25.6-65.6 1.576 .212 
Instrumental Support 51.04 (9.74) 29.3-63.3 53.53 (11.03) 29.3-63.3 50.57 (9.46) 29.3-63.3 1.565 .213 
Composite Support  51.67 (8.29) 32.6-63.6 53.95 (7.34) 41.8-63.6 51.24 (8.42) 32.6-63.6 1.808 .181 
Received Support 45.74 (14.67) 19-80 52.25 (16.66) 26-80 44.52 (45.74) 19-74 4.811 .030* 
Social Constraint 21.75 (16.59) 0-60 18.55 (19.03) 0-58 22.35 (16.11) 0-60 0.882 .35 
FACT-G 67.05 (19.75) 15-104 67.2 (18.66) 36-102 67.02 (20.02) 15-104 0.001 .097 
FACT-G Plus 111.38 (31.09)  32-168 113.65 (30.3) 59-162  110.95 (31.35) 32-168  0.136 .723 
COST Comprehensive Score for Financial Toxicity, FACT-G Functional Assessment of Cancer Therapy scale for QoL, FACT-G Plus with Socioeconomic 
Well-being scale. 
* A one-way Analysis of Variance determined differences between groups p < 0.05.    
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Bivariate Analysis. Several analyses were conducted to determine which 
variables could influence the outcome variable. A series of ANOVA analyses were 
conducted to determine if nominal and interval variables had a mean difference in QoL. 
Interval variables were transformed into dichotomous variables. See Table 7.7 for 
variables that showed a significant difference between groups with the Functional 
Assessment of Cancer Therapy scale (FACT-G), and Table 7.8 for Functional 
Assessment of Cancer Therapy with Socioeconomic Wellbeing (FACT-G Plus). 
Variables that showed a significant difference in mean QoL include: Chemotherapy, 
Education, Employment Status, Insurance Status, Marital Status. All analyses for 
homogeneity of variance (Levene’s Test) were non-significant. Time since last treatment, 
income, and gender were assessed and were not significant.  
Table 7. 7 Differences in Quality of Life (FACT-G) by Cancer Treatment and 
Demographics. 
 
Variable Mean (SD) df F Sig. 
Cancer Treatment     
 Other 74.65(21.28) 1, 124 6.37 0.013  Chemotherapy 64.57(18.67) 
  
Education   
  
 Less Than Bachelor 60.42(21.13) 1, 122 11.88 0.001  Bachelor or Higher 72.29(17.167) 
  
Employment Status   
  
 Not Working 62.22(20.01) 1, 124 6.08 0.015  Working 70.79(19.75) 
  
Insurance   
  
 No 45.5(22.52) 1, 123 5.015 0.027  Yes 67.69(19.41) 
  
Marital Status   
  
 Single 62.12(20.86) 1, 123 5.772 0.018 
  Married/Other 70.61(18.38)     
p = .05, FACT-G = Functional Assessment of Cancer Therapy scale  
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Table 7. 8 Group Differences in Quality of Life Plus SEW (FACT-G Plus). 
 
Variable Mean (SD) df F Sig. 
Cancer Treatment     
 Other 122.12(30.70) 1, 124 5.067 0.026  Chemotherapy 107.87(30.55)   
Education     
 Less Than Bachelors 99.00(31.59) 1, 122 17.364 0.001  Bachelor or Higher 121.12(31.05)   
Employment Status     
 Not Working 104.94(32.04) 1, 124 4.3 0.04  Working 116.37(29.60)   
Insurance     
 No 71.00(41.18) 1, 123 7.261 0.008  Yes 112.70(30.14)   
Marital Status     
 Single 102.71(31.21) 1, 123 7.072 0.009 
  Married/Other 117.46(29.95)     
p = .05                 
Further analyses were conducted to determine relationships between scales. In 
order for a mediator variable to be present the variables must show correlation. Pearson’s 
bivariate correlations were conducted (see Table 7.9 for correlation values and 
significance.) Received Social Support was not significantly correlated with the FACT-G, 
Comprehensive Score for Financial Toxicity (COST) or social constraint variables. This 
violates the assumptions for the mediator analysis.  
Pearson’s bivariate correlations were then used to determine the relationship 
between age and all the scales used for the moderator and mediator analyses.  Age 
showed a moderate negative correlation with social constraint r (124) = -.22, p < 0.013. 
Age was not correlated with the FACT-G, FACT-G Plus, COST or any of the social 
support scales. 
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Table 7. 9 Pearson's Bivariate Correlations (r) of Support, Quality of Life and Financial Toxicity Variables. 
 
  1 2 3 4 5 6 7 8 9 
1. FACT-G 1 .944*** -.591*** .528*** .510*** .477*** .570*** 0.174 -.629*** 
2. FACT-G Plus  1 -.696*** .5548*** .556*** .506*** .606*** .195* -.647*** 
3. COST   1 -.385*** -.430*** -.402*** -.460*** -0.013 .524*** 
4. Emotional Support    1 .777*** .622*** .893*** .377*** -.498*** 
5.Informational 
Support     
1 .629*** .909*** .405*** -.534*** 
6. Instrumental 
Support      
1 .854*** .337*** -.390*** 
7. Composite Support       1 .421*** -.535*** 
8. Received Support        1 -0.162 
9. Social Constraint                 1 
*p < 0.05, **p < 0.01, ***p < 0.001; COST Comprehensive Score for Financial Toxicity, FACT-G Functional Assessment of Cancer Therapy scale for QoL, 
FACT-G Plus Functional Assessment of Cancer Therapy with Socioeconomic Well-being scale. 
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Aim 1  
The first aim of this study was to determine if received and perceived social 
support moderates the relationship between cancer-related financial toxicity, and QoL. As 
presented in Chapter 6, the equation for multiple regression analysis is:  
Ypred=a+b1X1+b2X2+b3X1X2       (1)  
The moderator models from Chapter 3 are presented in Figure 7.1. These models 
represent social support as a moderator on the relations between financial toxicity and 
QoL. 
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Figure 7. 1 Social Support Moderation Pathways (Hayes, 2018).  
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The analyses were conducted using the Introduction to Mediation, Moderation, 
and Conditional Process Analysis (PROCESS) macro for SPSS. (See Chapter 6 for 
details on the PROCESS macro). Continuous variables included financial toxicity, 
perceived social support, received social support and QoL. The variable financial toxicity 
was assessed using the Comprehensive Score for Financial Toxicity (COST) scale. To 
assess perceived social support, analyses were conducted using each perceived support 
separately (emotion, informational, instrumental) and then with a composite variable 
made from perceived emotional, informational and instrumental scales. The received 
social support variable was created using the Inventory of Socially Supportive Behaviors 
(ISSB) short form. The variable QoL was assessed in two ways: 1) four domains of 
quality of life using the FACT-G (physical, emotional, social, and functional); 2) the 
FACT-G Plus which is composed of the four domains previously stated and the socio-
economic well-being scale. (Details on each scale can be reviewed in Chapter 6).  
Hypothesis 1.1: Received social support will moderate the relationship between 
COST and QoL (FACT-G).  
A simple moderation analysis was conducted in PROCESS using simultaneous 
multiple regression analysis to determine if received social support moderated the 
relationship between financial toxicity and QoL. Bootstrap (1,000 samples) technique 
was used to avoid violations of normal distribution and produce confidence intervals 
levels.  The total model fit accounted for a significant amount of the variance in QoL, R2 
= .38, F (3, 122) = 25.23, p = .001. Variables were centered on zero prior to creating the 
interaction variable (interaction between financial toxicity and received social support) to 
avoid the risk of multicollinearity which can occur between financial toxicity, received 
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social support and the interaction variable. Nevertheless, the interaction variable was not 
significant and did not account for variance in quality of life. Received social support did 
not moderate the relationship. This finding did not support the hypothesis. (Data tables 
reporting non-significant moderator analysis results can be viewed in Appendix Q Table 
Q.1). 
Analysis by cancer type. Since there was a difference in received social support 
between cancer types, additional analyses were conducted on each cancer type. For 
individuals with blood cancer, received social support did not moderate the relationship 
between financial toxicity and QoL (FACT-G). However, received social support was a 
moderator for participants with breast cancer. (The results of that analysis are presented 
below.) 
Breast Cancer Dataset. To test the hypothesis that received social support will 
moderate the relationship between financial toxicity and FACT-G, a simple moderation 
analysis was conducted in PROCESS (using simultaneous multiple regression analysis) 
using the breast cancer dataset. Received social support, financial toxicity and the 
interaction variable (toxicity*support) accounted for a significant amount of the variance 
in QoL, R2 = .39, F (3, 102) = 18.18, p = .001. Received social support and financial 
toxicity were centered prior to the creation of the interaction term to avoid 
multicollinearity which can occur between the received social support, financial toxicity 
the interaction variable. The interaction variable accounted for a significant proportion of 
variance in quality of life, DR2 = .03, F (1, 102) = 5.65, p = .019. Quality of life increases 
as financial toxicity decreased and received social supports increased. This moderation 
model explains 39% of the variance in FACT-G; although, the interaction 
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(toxicity*support) only accounts for 3% of the variance. Bootstrap technique at 1000 
samples provided confidence intervals (CL). (See Table 7.10 and Figure 7.2 for 
moderation analysis results.) 
Table 7. 10 Received Social Support and Financial Toxicity as Predictors of Quality of 
Life (FACT-G). 
 
Variable b SE  95% CL F (df) R2 D R2 
Predictor Variables   18.18 (3, 102) .38  
   Constant 67.08** 1.51 [64.09, 70.09]    
   Financial 
      Toxicity   
      (centered) 
-1.41** 0.22 [-1.83, -0.98]    
   Received      
      Support   
      (centered) 
0.32* 0.10 [0.11, 0.53]    
Interaction    5.65 (1, 102)  .03 
    Financial     
      Toxicity x  
      Received   
      Support 
0.03* 0.01 [0.01, 0.06]      
*p < .05, **p < .01, ***p < .001, CL= confidence intervals at 95%. FACT-G = Functional Assessment 
of Cancer Therapy scale . 
  
 Figure 7. 2 Moderation of Financial Toxicity and QoL (FACT-G). 
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In this model, receive social support was significant at low, medium and high 
levels of social support (see Table 7.11 for conditional effects). The Johnson- Neyman 
technique was conducted to further probe the analysis using the parameters of one 
standard deviation above and below the mean of received support. When social support 
scores are equal to or below 69.28 units on the received support scale, financial toxicity 
and QoL are significantly related t (102) = -1.98, p = .05, b = -.58. As financial toxicity 
increases and received social support decreases, QoL also decreases. 
Table 7. 11 Conditional Effects of Financial Toxicity at Levels of the Moderator. 
 
Received Support b SE t p LLCI - ULCI 
Low -1.88 0.36 -5.17 0.001 [-2.60, -1.16] 
Average -1.41 0.22 -6.55 0.001 [-1.84, -.98] 
High -0.94 0.2 -4.8 0.001 [-1.33, -.55] 
CL= confidence intervals at 95%. FACT-G = Functional Assessment of Cancer Therapy scale. 
Moderation analysis with control variables. A second moderation analysis was 
conducted adding control variables to the model. A simple moderation analysis was 
conducted in PROCESS (using simultaneous multiple regression analyses) to determine 
if received social supports moderated the relationship between financial toxicity and 
FACT-G controlling for cancer treatment, education, employment, and marital status. 
Dummy variables were created for all nominal variables. The total model fit accounted 
for a significant amount of the variance in FACT-G, R2 = .49, F = (8, 96) = 17.16, p = 
.001. All continuous scales were centered prior to analysis to avoid multicollinearity 
which can occur between received social support, financial toxicity and the interaction 
variable. The interaction variable accounted for a significant amount of the variance in 
FACT-G with the addition of the control variables DR2 = .03, F = (1, 96) = 8.10, p = .005. 
Received social support continues to moderate the relationship between financial toxicity 
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and quality of life after taking into consideration the potential effects of the control 
variables. As shown in Table 7.12 the entire model was significant, accounting for 49% 
of the variance in FACT-G; although, the interaction (toxicity*support) only accounted 
for 3% of the variance. A visual glance of the interaction is provided in Figure 7.3. 
Table 7. 12 Predictors of Quality of Life (FACT-G) with Control Variables. 
 
Variable b SE 95% CL F (df) R2 D R2 
Predictor Variables   17.16*** (8, 96) .49  
   Constant 37.06*** 6.92 [23.32, 50.80]    
   Financial 
      Toxicity   
      (centered) 
-1.18*** 0.20 [-1.58, -.78]    
   Received      
      Support   
      (centered) 
0.24** 0.09 [0.06, 0.43]    
Interaction    8.10** (1, 96)  .03 
   Financial     
      Toxicity x  
      Received   
      Support 
0.04** 0.01 [.01, 0.06]      
Control Variables      
    Education 6.72* 3.14 [.4867, 12.96]    
    Employment 8.43** 3.2 [2.07, 14.78]    
    Insurance 14.43* 7.2 [.14, 28.71]    
    Marital Status 6.23* 3.07 [.14, 12.32]    
    Treatment 5.22 3.5 [-1.71, 12.15]    
*p < .05, **p < .01, ***p < .001, CL= confidence intervals at 95%. FACT-G = Functional Assessment 
of Cancer Therapy scale. 
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As displayed in Table 7.13, the conditional effects of financial toxicity decrease, 
as received supports increases. The moderation interaction was further probed using a 
Johnson-Neyman technique. When social support scores are equal to or below 64.5 units 
on the received support scale, financial toxicity and QoL are significantly related, t (96) = 
-1.98, p = .05, b = -.44. As Financial toxicity increases and received social support 
decreases, QoL also decreases. 
Table 7. 13 Conditional Effects of Financial Toxicity at Levels of the Moderator with 
Control Variables. 
Received Support b SE t p LLCI - ULCI 
Low -1.70 0.34 -4.98 0.001 [-2.38, -1.02] 
Average -1.18 0.20 -5.81 0.001 [-1.58, -.78] 
High -0.66 0.10 -3.64 0.001 [-1.02, -.30] 
CL= confidence intervals at 95%. FACT-G = Functional Assessment of Cancer Therapy scale. 
 
Figure 7. 3 Moderation of Financial Toxicity and Quality of Life (FACT-G) in presence 
of control variables. 
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Three-way moderation analysis. A final analysis was conducted to determine if 
social constraint would have a moderation effect on the moderation between financial 
toxicity and received support. Social constraint is a continuous variable and was added to 
the model using a 3-way moderation or moderated moderation model (Hayes, 2018). 
View the model of a 3-way moderation in Figure 7. 1(b).  
A 3-way moderation analysis in PROCESS (using simultaneous multiple 
regression analysis) was conducted to determine if received social support was associated 
with the relationship between financial toxicity and FACT-G taking into consideration 
social constraints. The total model fit accounted for a significant amount of variance in 
QoL, F (7, 98) = 22.01, p = .001, R2 = .56.  The interaction term between received social 
supports, financial toxicity, and social constraint was significant and accounted for 
variation in QoL, F (1, 98) = 10.03, p = 0.02, DR2 = .04. This means that there is evidence 
of a three-way interaction between social supports, financial toxicity, and social 
constraint. The magnitude of the moderation of financial toxicity by social support is 
dependent on the effects of social constraint, though the moderation of the moderator 
(Received Support) explains only 4% of the variance in QoL. (See Table 7.14 and Figure 
7.4 for analysis details.) 
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Table 7. 14 Financial Toxicity, Received Social Support, and Social Constraint as 
Predictors of Quality of Life (FACT-G). 
 
Variable b SE  95% CL F (df) R2 D R2 
Predictor Variables  22.01*** (7. 98) .56  
   Constant 65.38*** 1.61 [62.18, 68.58]    
   Financial 
      Toxicity   
      (centered) 
-.89*** 0.20 [-1.28, -0.49]    
   Received      
      Support   
      (centered) 
0.40*** 0.10 [0.19, 0.60]    
   Social 
Constraint -0.58*** 0.11 [-.79, -.37]    
Interaction    10.03 (1, 98)  .04 
    Financial     
      Toxicity x  
      Received   
      Support x  
Social  
Constraint 
-0.003* 0.00 [-0.005, -0.001]      
*p < .05, **p < .01, ***p < .001, CL= confidence intervals at 95%. FACT-G = Functional Assessment 
of Cancer Therapy scale. 
  
 
Figure 7. 4 Three-way moderation predicts Quality of Life (FACT-G). 
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The conditional effects of financial toxicity decrease as received supports 
increase; however, the effects with social constraint vary (see Table 7.15 For details). The 
Johnson-Neyman technique was used to further probe the conditional toxicity*support 
interaction according to the values of social constraint. When social constraint scores are 
low (equal to or below 13.63) and  high (equal to or above 46) units on the social 
constraint scale, financial toxicity and received social support are significantly related, 
low t (99) = 1.98, p = .05, b = .025 and high t (99) = -1.95, p = .05, b = -.065. As 
financial toxicity increases and received social support decreases, social constraint 
increases. These analyses support the hypothesis stating that received support moderates 
the relationship between financial toxicity and quality of life. This moderation remained 
true when control variables and social constraint were added to the model.  
Table 7. 15 Three-way Moderation Conditional Effects of Financial Toxicity. 
 
Received Support 
Social 
Constraint b SE t p LLCI - ULCI 
Low Low -1.77 0.35 -5.1 0.001 [-2.46, -1.08] 
Low Average -0.89 0.35 -2.52 0.01 [-1.59, -.19] 
Low High -0.01 0.56 -0.02 0.99 [-1.12, 1.1] 
Average Low -1.13 0.21 -5.3 0.001 [-1.55, -.71] 
Average Average -0.89 0.2 -4.47 0.001 [-1.29, -.50] 
Average High -0.67 0.33 -2.02 0.05 [-1.30, -.01] 
High Low -0.48 0.19 -2.57 0.01 [-.85, -.11] 
High Average -0.89 0.24 -3.73 0.001 [-1.37, -.42] 
High High -1.3 0.45 -2.89 0.005 [-2.20, -.41] 
CL= confidence intervals at 95%. FACT-G = Functional Assessment of Cancer Therapy scale.  
 
Hypothesis 1.2: Perceived social support will moderate the relationship between 
financial toxicity and QoL (FACT-G). 
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To determine if perceived social support moderates the relationship between 
financial toxicity and QoL, a simple moderation analysis was conducted in PROCESS 
(using simultaneous multiple regression analysis). The analysis was run individually with 
each variable of perceived social support (emotional, informational, instrumental, and 
composite perceived social support). Each variable of perceived social support and 
financial toxicity accounted for a significant amount of the variance in QoL. The 
interaction variable did not account for any variance in the perceived emotional, 
informational or composite (emotional, informational, and instrumental) support models. 
However, in the instrumental support model, the interaction variable reported 
significance. The confidence levels crossed zero which is in violation of accepted 
parameters; therefore, there is no significant interaction effect. The hypothesis that 
perceived support moderates the relationship between financial toxicity and QoL was not 
supported in this sample. (See Appendix Q Tables Q.2 -Q.5 for non-significant moderator 
analysis results.) 
Hypothesis 1.3: Received social support will moderate the relationship between 
financial burden and QoL (FACT-G Plus).  
To test this hypothesis a simple moderation analysis in PROCESS (using 
simultaneous multiple regression). The total model accounted for a significant amount of 
the variance in FACT-G Plus, F (3, 122) = 42.11, p = .001, R2 = .53. Although, the 
interaction variable did not significantly account for the variance in FACT-G Plus. 
Received social support did not moderate the relationship.  See Appendix Q Table Q.6 
for non-significant moderator analysis results for hypothesis 1.3. 
  150 
Analysis by cancer type. Due to the difference in received support by cancer type, 
these same variables were then run by each type of cancer. For participants with blood 
cancer, received support did not moderate the relationship between financial toxicity and 
quality of life. On the other hand, received support did moderate the relationship for 
participants with breast cancer.  
Breast cancer dataset. To test the hypothesis that received social support will 
moderate the relationship between financial toxicity and QoL (FACT-G Plus) a simple 
moderation analysis in PROCESS (simultaneous multiple regression analysis) was 
conducted. The total model accounted for a significant amount of the variance in QoL, R2 
= .52, F (3, 102) = 26.84, p = .001. Scales were centered prior to the creation of the 
interaction term to avoid multicollinearity. Next, the interaction term was added to the 
model and accounted for a significant proportion of variance in quality of life, DR2 = .03, 
F (1, 102) = 7.09, p = .009. Financial toxicity decreased as received social supports and 
quality of life increased. This moderation model explains 52% of the variance in QoL 
with 3% of that amount explained by the interaction (toxicity*support). Bootstrap 
technique at 1000 samples provided confidence intervals (CL). (Table 7.16 and Figure 
7.5 display analysis results.) 
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Table 7. 16 Predictors of Quality of Life (FACT-G Plus). 
 
Variable b SE  95% CL F (df) R2 D R2 
Predictor Variables           26.85** (2, 102) .52  
   Constant 111.06** 2.09 [106.02, 115.20]    
   Financial 
      Toxicity   
     (centered) 
-2.67** 0.31 [-3.29, -2.04]    
   Received      
      Support   
     (centered) 
0.46** 0.14 [0.18, 0.73]    
Interaction        7.09* (1, 102)  .03 
    Financial     
      Toxicity x 
Received   
      Support 
0.06* 0.02 [.01, 0.10]      
*p < .01, **p < .001, CL= confidence intervals at 95%. FACT-G Plus = Functional Assessment of 
Cancer Therapy scale plus Socio-economic Well-being scale.   
 
In this model received social support was significant at low, medium and high 
levels of social support. (See Table 7.17.) Then the Johnson- Neyman technique was 
conducted to further probe the analysis using the parameters of one standard deviation 
Figure 7. 5 Moderates of Financial Toxicity and QoL (FACT-G Plus).  
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above and below the mean of received support. When social support scores are equal to 
or below 73.09 units on the received support scale, financial toxicity and QoL are 
significantly related t (102) = -1.98, p = .05, b = -1.07. As financial toxicity increases and 
received social support decreases, QoL also decreases. 
Table 7. 17 Conditional Effects of Financial Toxicity at Levels of the Moderator. 
 
Received Support b SE t p LLCI - ULCI 
Low -3.44 0.52 -6.69 0.001 [-4.46, -2.43] 
Average -2.66 0.31 -8.48 0.001 [-3.29, -2.04] 
High -1.88 0.32 -5.83 0.001 [-2.52, -1.24] 
CL= confidence intervals at 95%. FACT-G Plus = Functional Assessment of Cancer Therapy scale plus 
Socio-economic Well-being scale.  
 
Moderation analysis with control variables. A second analysis was conducted to 
test for moderation analysis controlling for the effects of cancer treatment, education, 
employment, insurance status, and marital status. A simple moderation analysis in 
PROCESS (using simultaneous multiple regression analysis) was conducted to determine 
if received social supports moderated the relationship between financial toxicity and 
QoL. The total model accounted for a significant amount of the variance in QoL, R2 = 
.63, F (8, 96) = 25.04, p = .001. All continuous predictor variables were centered prior to 
analysis to avoid multicollinearity. In the analysis, the interaction term accounted for a 
significant amount of the variance in QoL even in the presence of the addition of the 
control variables, DR2 = .04, F (1, 96) = 12.38, p = .0007. Received social support 
continues to moderate the relationship between financial toxicity and QoL. This 
moderation model accounts for 61% of the variance in QoL with the interaction variable 
(toxicity*support) accounting for 4% of the variance. (Table 7.18 and Figure 7.6 provide 
details of this analysis.) 
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Table 7. 18 Predictors of Quality of Life (FACT-G Plus) with Control Variables. 
 
Variable b SE 95% CL F (df) R2 D R2 
Predictor Variables   25.04*** (8, 96) .63  
   Constant 63.9*** 12.66 [38.77, 89.03]    
   Financial 
      Toxicity   
      (centered) 
-2.4*** 0.29 [-2.96, -1.83]    
   Received      
      Support   
      (centered) 
0.27* 0.12 [0.04, 0.51]    
Interaction    12.38** (1, 96)  .007 
   Financial     
      Toxicity x  
      Received   
      Support 
0.07** 0.02 [.03, 0.10]      
Control Variables      
    Education 13.02** 4.16 [4.77, 21.28]    
    
Employment 5.41 5.24 [-4.99, 15.80]    
    Insurance 30.57* 13.4 [3.96, 57.18]    
    Marital Status 8.93* 41.2 [.74, 17.12]    
    Treatment 3.00 4.32 [-5.58, 11.57]    
*p < .05, **p < .01, ***p < .001, CL= confidence intervals at 95%. FACT-G Plus = Functional 
Assessment of Cancer Therapy scale plus Socio-economic Well-being scale.  
 
 
Figure 7. 6 Moderates of Financial Toxicity and QoL (FACT-G Plus) with Control 
Variables. 
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Received social support was significant at low, medium and high levels of social 
support. (See Table 7.19.) In order to probe the analysis for an understanding of what was 
going on in the analysis, the Johnson- Neyman technique was conducted (using 
parameters of one standard deviation above and below the mean of received support). For 
social support scores that are equal to or below 68.78 units on the received support scale, 
financial toxicity and QoL are significantly related t (96) = -1.99, p = .05, b = -.80. As 
financial toxicity increases and received social support decreases; QoL also decreases. 
Table 7. 19Conditional Effects of Financial Toxicity at Levels of the Moderator with 
Control Variables.  
 
Received Support b SE t p LLCI - ULCI 
Low -3.32 0.52 -7.04 0.001 [-4.26, -2.39] 
Average -2.40 0.31 -8.41 0.001 [-2.96, -1.83] 
High -1.47 0.32 -5.26 0.001 [-2.03, -.92] 
CL= confidence intervals at 95%. FACT-G Plus = Functional Assessment of Cancer Therapy scale plus 
Socio-economic Well-being scale.  
 
Three-way moderation analysis. In the final step, social constraint was added 
using a three-way moderation or moderated moderation model (Hayes, 2018). A 
moderated moderation analysis in PROCESS (simultaneous multiple regression analysis) 
was conducted to determine if received social support impacted the relationship between 
financial toxicity and QoL taking into consideration social constraints. This model 
accounted for a significant amount of variance in QoL, R2 = .80, F (7, 98) = 26.88, p = 
.001.  The interaction term between received social supports, financial toxicity, and social 
constraint was significant, DR2 = .02, F (1, 98) = 4.82, p = .03). This suggests that the 
three-way interaction between social supports, financial toxicity, and social constraint 
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significantly explains 2% of the variance.  (See Table 7.20 and Figure 7.7 for outcomes 
of analysis.) 
Table 7. 20 Three-way Moderation of Quality of Life (FACT-G). 
 
Variable b SE  95% CL F (df) R2 D R2 
Predictor Variables   26.89*** (7. 98) .80  
   Constant 109.20*** 2.28 [104.68, 113.71]    
   Financial 
      Toxicity   
      (centered) 
-1.94*** 0.32 [-2.58, -1.31]    
   Received      
      Support   
      (centered) 
0.52*** 0.14 [0.24, 0.81]    
   Social 
Constraint -0.72*** 0.16 [-1.04, -.41]    
Interaction    4.82* (1, 98)  .02 
    Financial     
      Toxicity x  
      Received   
      Support x  
Social  
Constraint 
-0.003* 0.00 [-0.006, -0.003]      
*p < .05, **p < .01, ***p < .001, CL= confidence intervals at 95%. FACT-G = Functional Assessment 
of Cancer Therapy scale. 
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The conditional effects of financial toxicity decrease as received supports 
increase; however, the effects with social constraint vary (see Table 7.21 for details). The 
Johnson-Neyman technique was used to further probe the conditional toxicity*support 
interaction according to the values of social constraint. When social constraint scores are 
low (equal to or below 12.01) financial toxicity and received social support are 
significantly related, low t (98) = 1.98, p = .05, b = .04 and high t (99) = -1.95, p = .05, b 
= -.065. As financial toxicity increases and received social support decreases, social 
constraint increases. 
 
 
 
 
Figure 7. 7 Three-way Moderation of QoL (FACT-G Plus).  
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Table 7. 21 Three-way Moderation Conditional Effects of Financial Toxicity. 
 
Received Support 
Social 
Constraint b SE t p LLCI - ULCI 
Low Low -3.09 0.52 -5.98 0.001 [-4.11, -2.06] 
Low Average -2.04 0.55 -3.71 0.001 [-3.13, -.95] 
Low High -0.99 0.89 -1.12 0.27 [-2.75, 0.77] 
Average Low -2.28 0.32 -7.08 0.001 [-2.92, -1.64] 
Average Average -1.94 0.32 -6.06 0.001 [-2.58, -1.31] 
Average High -1.61 0.49 -3.28 0.001 [-2.58, -0.64] 
High Low -1.85 0.44 -4.20 0.001 [-2.08, -0.85] 
High Average -2.23 0.74 -3.01 0.003 [-2,73, -0.98] 
High High -2.23 0.74 -3.01 0.003 [-3.70, -0.76] 
CL= confidence intervals at 95%. FACT-G Plus = Functional Assessment of Cancer Therapy scale with 
Socio-economic Well-being Scale.   
 
Hypothesis 1.4: Perceived social support will moderate the relationship between 
financial burden and QoL (FACT-G Plus).  
Hierarchical multiple regression analyses were conducted using PROCESS macro 
for SPSS to determine if perceived social support moderates the relationship between 
financial toxicity and FACT-G Plus. Variables were added to the model in a stepwise 
approach. Individual analyses were conducted with each variable of perceived social 
support (emotional, informational, instrumental, and composite perceived support – 
emotional, informational and instrumental combined). A significant amount of the 
variance in FACT-G Plus was accounted for by perceived social support (each variation) 
and financial toxicity directly; however, the interaction variable for perceived emotional, 
informational and composite social support models did not account for any variance in 
FACT-G Plus. See Appendix Tables Q.7 – Q. 9 for reported moderator analysis for each 
variable of perceived social support and financial toxicity. The instrumental support 
model showed a significant interaction effect, but the confidence intervals contained zero 
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(CL-0.101, 0.003). This indicates non-significant interaction effect can be assumed. 
Perceived social support did not moderate the relationship between financial toxicity and 
FACT-G Plus. (See Appendix Tables Q.10 for perceived instrumental support and 
financial toxicity interaction results.) 
Specific Aim 2 
Aim 2 sought to determine if received and perceived social support mediates the 
relationship between financial toxicity and QoL. As previously stated, QoL is assessed 
using two versions of the FACT-G scale: 1) the FACT-G and 2) FACT-G Plus (with 
socio-economic well-being). Perceived social support was analyzed using the composite 
(emotion, informational, and instrumental) variable. In order to test for a mediator 
variable, a simple mediation model using ordinary least squares (OLS) regression-based 
path analysis was conducted using the PROCESS tool in SPSS. This model uses the 
statistical equation for a simple mediation model (Hayes, 2017): 
M = iM + aX + eM       (2) 
Y = iY + c’X + bM +eY  
The mediations models informing these analyses can be viewed in Figure 7.8. 
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Hypothesis 2.1: Received social support mediates between financial toxicity and 
QoL (FACT-G).  
The data did not meet assumptions for mediation analyses. Received social 
support was not correlated with the FACT-G, COST, or social constraint (see Table 7.8 
Figure 7. 8 Social Support in Mediation Pathways 
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for correlation values.) The mediation analyses were not conducted. The hypothesis was 
not supported.  
Hypothesis 2.2: Perceived social support mediates between financial toxicity and 
QoL (FACT-G). 
  To test whether perceived social support mediates between financial toxicity and 
QoL (FACT-G) the PROCESS macro for SPSS was used. The PROCESS macro is a path 
analysis-based tool using ordinary least squares linear regression analyses to determine a 
mediator effect. Financial toxicity significantly predicted FACT-G when the mediator 
variable is not in the model, b = -1.342, t (124) = -31.20, F (1, 124) = 72.29, p = .001, R2 
= .35. The R2 value indicated that 35% of the variance in FACT-G can be explained by 
financial toxicity. Beta (b) value is negative which means that the higher financial 
toxicity the lower FACT-G. Next, financial toxicity significantly predicted perceived 
social support, b = -0.44, t (124) = -5.85, F (1, 124) = 34.16, p = .001, R2 = .21 (see 
Figure 7.8 for Path a). As financial burden increases perceived social support decreases. 
The R2 value for Path a indicates that financial burden explains 21% of the variance in 
the composite perceived social support variable. Then the outcome of FACT-G was 
predicted by financial toxicity and perceived social support. Perceived social support 
significantly predicts QoL in the model, b = 0.90, t (124) = 3.5, p = .001 (Path b); 
financial burden also significantly predicts QoL, b = -0.95, t (124) = -5.69, p = .001 (Path 
c). The total effect model is significant, F (2, 123) = 48.33, p = .001, R2 = .46 (Path c’). 
The R2 value indicates the model accounts for 46% of the variance in FACT-G. The final 
step indicates there is a significant indirect effect of financial toxicity on FACT-G 
through perceived social support, b = -0.39. The true b-value for the indirect effect falls 
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between the confidence intervals [-0.64, -0.20] which does not cross zero indicating 
likelihood of significance indirect effect at a 95% confidence interval. (See Table 7.22 for 
correlations among variables and Figure 7.9 for model with analysis results). 
Table 7. 22 Correlations Among Mediation Variables. 
Variables 1 2 3 
1. Financial Toxicity 1 -0.5* -0.55* 
2. Perceived Support  1 0.6* 
3. Quality of Life (FACT-G)   1 
*p < .01  
 
  
 
 
 
 
  
 
 
 
 
 
 
Further analysis was conducted to determine if perceived social support mediates 
between financial burden and QoL controlling for cancer treatment, education, 
employment, and marital status. (Insurance status was removed due to creating an error in 
the analysis.) There was a significant indirect effect of financial burden on QoL through 
Path a 
(b = -0.44, p = 
.001) 
Financial 
Toxicity 
 
Social Support 
-Perceived  
 
 QoL 
Path b 
(b = 0.90, p = .001) 
Path c’ 
Indirect effect, b = -0.39, 95% CI [-0.64, -
0.20] 
Financial 
Toxicity 
 
 QoL 
Path c 
(Direct effect, b = -0.95, p = 
.001 
Figure 7. 9 Perceived Social Support Mediates Financial Burden as a Predictor of Quality 
of Life (QoL). 
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perceived social support, b = -0.54 CI [-0.81, -0.31]. This model indicates a likely 
indirect effect of financial burden through perceived social support at a 95% confidence 
interval. (See Table 7.23 for summary of analysis results.) 
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Table 7. 23 Summarized Mediation Regression Analysis for Financial Toxicity, Perceived Social Support and Quality of Life. 
 
Path Variable b t R2 F df p LLCL, ULCL  
Control Variables       
 
 Education 5.73 2.82    .04* [0.14, 11.32] 
 Employment 7.29 4.55    .11 [-1.72, 16.31] 
 Marital Status 5.53 3.01    .068 [-0.43, 11.50] 
 Treatment 6.35 1.71    .89 [-0.99, 13.69] 
  
  
    
 
Path a COST -> Support -0.41 -4.80 .27 11.23 5, 120 .01** [-0.57, -0.24] 
         
Path b    .52 21.87 6, 119 .001**  
 Support -> QoL 0.92 0.17    .001* [0.58, 1.26] 
 COST -> QoL -0.76 -4.35    .001* [-1.11, -0.41] 
  
     
 
 
Path c COST -> QoL -1.13 -7.06 .41 17.58 5. 120 .001* [-1.45, -0.82] 
         
Total Model Direct Effect -0.76 -4.33    .001* [-1.26, -0.42] 
  Indirect Effect -0.54           [-0.81, -0.31] 
*p < 0.05   COST Comprehensive Score for Financial Toxicity, QOL Quality of Life FACT-G Scale. Bootstrap sample size = 5000 
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Social constraint may have an impact on social support and quality of life. A final 
analysis was conducted to determine if social constraint impacted the relationship 
between financial toxicity, social support and quality of life. To determine if social 
constraint had an effect on the mediation model, a moderated mediator analysis (Hayes, 
2018) was conducted (see Figure 7.8 b). In this model, social constraint is thought to 
moderate between social support and quality of life. Social constraint did not moderate 
the mediation [b = -0.01, CI [-.03, .01]; therefore, did not have an effect on the 
relationship between financial toxicity, social support and quality of life. (See Table 7.24 
for analysis findings.) The hypothesis stating that perceived support mediates the 
relationship of financial toxicity and QoL was supported by these analyses and findings. 
Table 7. 24 Perceived Support Mediation on Financial Toxicity and Quality of Life 
without Moderation of Social Constraint. 
 
Path Variable b SE t CL R2 F df 
Path a 
    
0.21 34.16
* 
1, 124 
a Financial 
Toxicity 
-0.44* 0.08 -5.85 [-0.59, -0.29] 
  
 
Constant 8.38* 1.38 6.06 [5.64, 11.12] 
  
Path b & c' 
    
0.54 39.18
* 
4, 121 
b Perceived 
Support 
0.62* 0.161 3.84 [0.30, .94] 
   
c' Financial 
Toxicity 
-0.61* 0.17 -3.6 [-.95, -
0.28] 
   
z Social Constraint -0.46* 0.09 -4.88 [-.64, -.27] 
   
 
Interaction 1 -0.01 0.01 -1.14 [-.03, .01] 0.01 1.3 1, 121  
Constant 77.92
* 
3.56 21.87 [70.87, 84.97] 
  
Path c 
    
0.41 17.58 5. 120 
c Financial 
Toxicity 
-0.61* 0.17 -3.6 [-9.5, -
0.28] 
   
*p < 0.001 QOL Quality of Life FACT-G Scale. Interaction 1 = Perceived Support *Social Constraint 
does not Moderate the Relationship. 
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Hypothesis 2.3: Received social support mediates between financial toxicity and 
QoL with socio-economic well-being (FACT-G Plus). 
 The data did not meet the assumptions for mediator analyses. Received social 
support was not correlated with financial toxicity or social constraint. The mediation 
analysis was not conducted. Hypothesis 2.3 was not supported.  
Hypothesis 2.4: Perceived social support mediates between financial toxicity and 
QoL (FACT-G Plus).  
Financial toxicity significantly predicted FACT-G Plus when the mediator 
variable was not in the model, b = -2.49, t (124) = -10.47, F (1, 124) = 109.64, p = .001, 
R2 = .49. The R2 value indicated that 49% of the variance in FACT-G Plus can be 
explained by financial toxicity. The relationship is negative so as financial toxicity 
increases, quality of life decreases. Next, financial toxicity significantly predicted 
perceived social support, b = -0.43, t (124) = -5.85, F (1, 124) = 34.16, p = .001, R2 = .21 
(path a); as financial toxicity increased, perceived social support decreased. Financial 
toxicity accounted for 21% of the variance in social support. Then FACT-G Plus was 
predicted by financial toxicity and perceived social support. This was a significant effect, 
F (2, 123) = 78.73, p = .001, R2 = .59.  Social support significantly predicted FACT-G 
Plus, b = 1.36, t (123) = 5.47, p = .001 (path b); financial toxicity also significantly 
predicted FACT-G Plus, b = -1.90, t (123) = -7.70, p = .001 (path c). This model accounts 
for 59% of the variance in FACT-G Plus. Lastly, there is a significant indirect effect of 
financial toxicity on FACT-G Plus through perceived social support, b = -0.60, CL [-
0.98, -0.32] (path c’). The confidence intervals do not cross zero indicating a likely 
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significance indirect effect at a 95% confidence interval. (See Figure 7.10 for model 
depiction.)  
 
 
 
 
 
 
 
 
 
 
 
 
Similar to Hypothesis 2.2, further analysis was conducted controlling for cancer 
treatment, education, employment, and marital status. As stated before, insurance status 
was removed due to creating an error in the analysis. Similar to the first analysis, this 
model continued to show a likelihood of a significant indirect effect of financial toxicity 
on FACT-G Plus through perceived social support. See Table 7.25 for a summary of 
analysis results. 
Path a 
(b = -0.43, p = .001) 
Financial 
Toxicity 
 
Social Support 
-Perceived  
 
 QoL 
Path b 
(b = 1.36, p = .001) 
Path c’ 
Indirect effect, b = -0.60 95% CI [-0.98, -
0.32] 
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Toxicity 
 
 QoL 
Path c 
(Direct effect, b = -1.90, p = 
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Figure 7. 10 Mediation of financial toxicity when quality of life (QoL) is assessed by 
Functional Assessment of Cancer Therapy plus Socioeconomic Wellbeing. 
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Table 7. 25 Mediation by Perceived Social Support with Control Variables. 
 
Path Variable b t R2 F df p LLCL, ULCL 
  Control Variables        
Education 14.28 4.23    .001* [0.7.69, 20.97] 
Employment 10.13 1.71    .09 [-1.61, 21.88] 
Marital Status 3.02 0.85    .39 [-4.05, 10.10] 
Treatment 3.88 3.7    .29 [-3.44, 11.21] 
         
Path a COST -> Support -0.41 -4.80 .27 11.23 5, 120 .001* [-0.57, -0.24] 
         
Path b    .65 42.14 6, 119 .001*  
 Support -> QoL 1.41 6.06    .001* [0.95, 1.87] 
 COST -> QoL -1.61 -6.5    .001* [-2.10, -1.12] 
         
Path c COST -> QoL -2.19 -9.34 .54 30.96 5, 120 .001* [-2.65, -1.72] 
         
Total Model Direct Effect -1.61 -6.5    .001* [-2.10, -1.12] 
  Indirect Effect -0.57       [-0.94, -0.30] 
*p < 0.001 COST Comprehensive Score for Financial Toxicity, QOL= Quality of Life assessed by Functional Assessment of Cancer Therapy plus Socio-
Economic Well-being Scale (FACT-G Plus). Bootstrap sample size = 1000. 
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A third analysis was conducted to see if social constraint impacted the 
relationship between financial toxicity, social support and quality of life. Social 
constraint was added to the mediator model as a moderator on the relationship between 
perceived social support and quality of life. As shown in Table 7.26 social constraint did 
not moderate the mediation [b = .03, CI [-.03, .02]. Hypothesis 2.4 is supported, and 
perceived support mediates the relationship with financial toxicity and QoL.  
Table 7. 26 Mediation without Moderation of Social Constraint 
 
Path Variable b SE t CL R2 F df 
Path a 
    
0.21 34.16* 1, 124 
a Financial 
Toxicity 
-0.44* 0.08 -5.85 [-0.59, -0.29] 
  
 
Constant 8.38* 1.38 6.06 [5.64, 11.12] 
  
Path b & c' 
    
0.64 54.25* 4, 121 
b Perceived 
Support 
0.97* 0.22
3 
4.33 [0.52, 1.41] 
   
c' Financial 
Toxicity 
-1.52* 0.23 -6.50 [-1.99, -1.06] 
   
z Social 
Constraint 
-0.54* 0.13 -4.05 [-.81, -.28] 
   
 
Interaction 1 -0.00 0.02 -.16 [-.03, .02] 0.00 .03 1, 121  
Constant 140.39
* 
4.87 28.8
5 
[130.76, 150.02] 
  
Path c 
       
c Financial 
Toxicity 
-1.52* 0.23 -6.50 [-1.99, -1.06] 
   
*p < 0.001 QOL Quality of Life = Functional Assessment of Cancer Therapy plus Socioeconomic 
Wellbeing (FACT-G Plus) scale. Interaction 1 = Perceived Support *Social Constraint does not Moderate 
the Relationship between support and quality of life.  
 
Summary of analyses. Several analyses were conducted to determine if social 
support moderated or mediate the relationship between financial toxicity and quality of 
life. Received support moderated and perceived support mediated the relationship 
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between financial toxicity and quality of life. See Table 7.27 for the summary of 
analyses. 
Table 7. 27 Analyses Outcome by Hypothesis. 
Hypothesis Analysis Outcome 
1.1 Received social support will moderate 
the relationship between financial 
toxicity and QoL. 
Supported 
1.2 Perceived social support will moderate 
the relationship between financial 
toxicity and QoL. 
Not Supported 
1.3 Received social support will moderate 
the relationship between financial 
toxicity and QoL including Plus SEW. 
Supported 
1.4 Perceived social support will moderate 
the relationship between financial 
toxicity and QoL Plus SEW. 
Not Supported 
2.1 Received social support mediates 
between financial toxicity and QoL. 
Not Supported 
2.2 Perceived social support mediates 
between financial toxicity and QoL.  
Supported 
2.3 Received social support mediates 
between financial toxicity and QoL 
Plus SEW 
Not Supported 
2.4 Perceived social support mediates 
between financial toxicity and QoL 
Plus SEW. 
Supported 
 
Summary 
The purpose for the present study was to examine the experience of financial 
toxicity (objective burden and subjective distress) with blood cancer and breast cancer 
survivors. Specifically, I sought to examine the relations among financial toxicity, social 
support and quality of life. Social support was conceptualized as perceived (emotional, 
informational, and instrumental) social support and received (informational and 
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instrumental) social support.  Previous research has demonstrated that social supports can 
have a positive impact on the cancer experience (see Chapter 2 literature review). The 
current study extends this research by examining the role (moderator and mediator) of 
social supports in the context of financial toxicity. These analyses indicate that both 
received and perceived social supports play a significant role in the relationship between 
financial toxicity and quality of life. However, these roles were very different.  
Received social support for the total sample (blood and breast cancers) only had a 
direct correlation with quality of life (FACT-G and FACT-G Plus). It did not have a 
moderator or mediator effect on the relationship between financial toxicity and quality of 
life. However, when the analyses were conducted on just the breast cancer respondents, 
received social support moderated the relationship between financial toxicity and quality 
of life.  
In contrast, perceived social support was significantly related to quality of life and 
financial toxicity in the expected directions, and functioned as a mediator of the 
relationship between financial toxicity and quality of life.  Indirectly, financial toxicity 
still had a negative effect through perceived social support; however, as expected, this 
effect was must smaller. These results show that having a perception of available support 
may ease the negative impact of financial toxicity.  
This chapter presented the results for study 2 which examined social support as 
either a moderator or mediator variable. The next chapter, 8, includes a final discussion 
and concluding thoughts on the findings from this multiple method design project as well 
as present implications for practice and future ideas for research.   
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CHAPTER 8: DISCUSSION & CONCLUSIONS 
  
“It hit me like a train and I’m barely recovering. I lost insurance coverage several 
months ago right when new lymph nodes became suspicious. They have since grown and 
become so painful. The same side the previous cancer was. I know I need to get help and 
get checked out, but the very thought of this financial burden has left me in a solitary 
confinement of madness in my head and just being okay with letting cancer get me (if it 
is) than put my family through the financial burden again. Absolute hopelessness.” 
 -Study 2 #37 (32-year-old female, Breast Cancer) 
 
“I was forced out of my job, after many years with good reviews, during my cancer 
treatment. I had no income for almost a year. Used savings up, maxed out credit cards, 
took loan against life insurance, withdrew money from retirement savings. Was 
DESPERATE and destitute. All recommended sources of help turned me down. Filed for 
disability retirement – finally approved. Have not recovered financially, socially, 
emotionally. Many “friends” dropped me after the cancer diagnosis…Need help with 
housework but don’t know how to get this help with limited money. Still drive 1990 
Toyota car, hope it holds up. Refinanced mortgage to lower interest rate. That helped. If 
my cancer recurs, based on my initial experience: I would likely not seek treatment; can’t 
afford it.” 
- Study 2 #41 (62-year-old female, Breast Cancer) 
 
There are no easy fixes to addressing cancer-related financial toxicity (objective 
burden and subjective distress), and to date there are no evidence-based practices to help 
patients resolve this problem. As is evident, financial toxicity is a complex issue that can 
leave patients financially and emotionally devastated. The purpose of this project was to 
gain a different perspective on cancer-related financial toxicity than what is already 
identified in the current literature.  Specifically, I examined the role of social support 
within this context, determining if social support is associated with the relationships 
between financial toxicity and quality of life (QoL) as well as determining what types of 
supports were available, used or needed. 
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Using a multiple methods approach, two studies were conducted to answer the 
overarching question: What role does social support play in the experience of cancer-
related financial toxicity? The first study used qualitative data (see Chapter 4 methods 
and Chapter 5 results), and the second study used quantitative data (see Chapter 6 
methods and Chapter 7 results). This final chapter presents a discussion of this project 
bringing together the results from both studies. It discusses at length the implications for 
practice and further research ideas to improve patient-centered care.   
Discussion 
Study 1. Differing from much of the literature on financial toxicity, this study 
takes a unique view of this complex issue. Using qualitative methods, Study 1 answered 
the question: For individuals who have had cancer, what is their experience with social 
support in the context of cancer-related financial toxicity? Social support theories were 
used as a sensitizing lens to explore the supportive resources available and used by 26 
cancer survivors who self-reported experiencing financial hardship due to their cancer. 
The broad categories that were identified from this analysis were the following: Helpful 
Support, Non-helpful Support, and Gaps in Support. First, this process allowed for the 
distinction of received and perceived supports to be witnessed in the data and brought to 
light that the data lacked the presence of perceived supports. More noticeably, it validated 
the presence of received social support (emotional, informational, and instrumental). In 
turn it gave insight into areas where support is needed (i.e., missing supports or barriers 
to accessing it). 
 It is clear that aspects of social support theories can be supported by the Helpful 
Support and Non-helpful Support categories. In support of Cohen and Wills (1985), 
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participants spoke about receiving helpful supports such as emotional, informational, and 
instrumental support. Received emotional and informational support had a weaker 
presence in this data, and perceived support only had one excerpt; however, instrumental 
support was discussed by all of the participants. This is understandable as the overall 
topic was financial hardship, thus the logical solution is monetarily related. Participants 
reported receiving supports such as food, money, childcare, and transportation assistance 
from family and friends. Some received grants, medication and medical bill assistance 
from more formal social networks (medical professionals and organizations). 
Instrumental supports also included services such as advocacy efforts, managing 
finances, and resolving issues with complex healthcare systems. In spite of the 
participants’ comments on receiving some form of instrumental support, the support 
received was not enough to offset their perception of financial burden. 
It is well supported in the literature that emotional and informational supports also 
play important roles (Cohen & Syme, 1985; and Sarason et al., 1990 and Cohen, 2013). 
Emotional support is suggested to have the greatest effect on individuals who are 
experiencing stressful events. This is likely due to help-seeking behaviors which can lead 
to corresponding supportive responses from others (Cohen & Wills, 1985). Although 
emotional support was depicted in these interviews, not all interviewees spoke about 
receiving emotional support. Moreover, several stated they did not have anyone to talk to 
about their financial struggles. One interviewee went as far as saying she did not talk to 
others about her financial concerns because she was embarrassed. On a similar note, 
informational supports can act as a buffer (Cohen & Wills, 1985). Having information 
about what is expected can allow patients to prepare emotionally or find other ways to 
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cope financially. Interviewees talked about receiving advice on finances, navigating 
complex systems, and receiving direction on when to seek assistance from government 
programs. Receiving information can allow patients to make educated decisions or 
emotionally prepare for an expected outcome of their medical decisions.  
As a further support to this theory, the present study provides an example of 
social constraint in the experiences of cancer patents. Adding to the works of Lepore 
(2002), social constraint is observed in the context of cancer-related financial toxicity. 
Some participants shared experiences of receiving non-helpful supports (social 
constraints). Participants gave examples about behaviors from others that were likely 
meant to be helpful but were not interpreted as such or ended in outcomes that may have 
further jeopardized the support receiver’s financial situation. As evidenced in the 
literature, stressful life events may elicit avoidant or minimizing behaviors from others 
(Veiel et al., 2013). This was true for some participants in this study. Here we saw 
instances where social network members said or did things that were interpreted by the 
participant as inappropriate, critical, or insensitive. Hypothetically, these aspects of social 
constraint could play a role in preventing patients from engaging in help-seeking 
behaviors. 
As a result of using social support as a theoretical sensitizing lens and the iterative 
processes of the analysis, Gaps in Support became apparent. This category was formed 
by two subcategories: missing support and barriers to accessing support. Several 
interviewees commented on not receiving information that consequently could have 
directed them to take steps to overt financial catastrophes or emotionally prepare for the 
financial outcomes. Receiving timely information about resources through the medical 
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system, pharmaceutical assistance, government assistance, or employer-based benefits, 
could potentially lead to alleviating some financial demands on patients. Unfortunately, 
this was not the only missing information, as most of the participants talked about lacking 
information on what the costs of their care would be. Some attempted to request this 
information but were told to not worry about it or to not talk about it. One participant was 
told by the hospital staff that she should know what her insurance deductible was and 
proceeded to not provide the participant with that information. Additionally, participants 
talked about receiving resources that were not helpful or did not meet their financial 
needs. In order for support to be interpreted as helpful, it must address a patient’s need or 
request (Cutrona & Russell, 1990). Participants shared examples of being offered support 
that did not match their need for financial assistance. In these examples, participants were 
seeking information on financial assistance; instead, they were provided information 
about other services such as a free monthly massage or art therapy. “But at the end of the 
day it wasn’t what was needed most” (#21, 36-year-old male, Lymphoma).  
In addition, interviewees talked about diminishing help and missed opportunities 
for getting support. When patients are unable to maintain social relationships due to 
cutting back on entertainment, they may miss out on opportunities to connect with others 
and receive or request support. Having close relationship bonds may instill in others a 
strong desire to help and may also serve as a reminder that help is needed. These types of 
relationships take time to develop, however, and need to be nurtured. Creating further 
barriers to accessing support are feelings of embarrassment, pride and guilt - all issues 
that may get in the way of people reaching out to others and sharing their financial 
concerns. We live in a society with the ingrained idea that you should pick yourselves up 
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by the bootstraps. Social messages falsely blame financial struggles on the person as a 
result of not working hard enough or not spending money wisely. On the contrary, 
financial struggles are a devastating consequence of the costs of cancer care. Not only are 
the costs of care astronomical, but patients also struggle to find helpful resources and 
acquire information.  
In summary, we see the presence of social support in the context of financial 
toxicity. This in turn brings our awareness to the gaps in support that patients may 
experience. To an extent, these gaps may be targeted for solutions to addressing the 
financial devastation caused by cancer. Implications from this study will be discussed in 
culmination with the results from Study 2 at the end of this chapter.  
 Study 2. Deriving from the overarching question and aspects informed by Study 
1, Study 2 sought to statistically verify the importance of social support in the context of 
financial toxicity due to the costs of cancer care. It attempted to answer the question: 
How does social support influence cancer-related financial burden and patients’ quality 
of life?  Specifically, Study 2 investigated the influence of social support on the 
relationship between financial toxicity and QoL. Conceptualizing social support through 
the use of theory, Study 2 investigated the moderating or mediating potential of received 
(informational and instrumental) and perceived (emotional, informational, and 
instrumental) support.  
Received social support (informational and instrumental) acts as a moderator 
between financial burden and quality of life. Moderation implies that received social 
support changes the direction or magnitude of the relationship between financial burden 
and quality of life.  Received social support acts as a buffer where increasing received 
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social supports may decrease the effect of financial burden on quality of life. This result 
adds to the body of research demonstrating that received support acts as a moderator. In a 
study with gynecologic cancer survivors, received social support was found to moderate 
the relationship between physical functioning and traumatic stress (Carpenter et al., 
2010). Another study conducted on the general population found that received social 
support buffered the relationship between financial stress and psychological well-being as 
well as between financial stress and psychosomatic symptoms (Aslund et al., 2014). 
Instrumental support was suggested to be greatest in the presence of higher financial 
stress and decreased the likelihood of experiencing low psychosomatic symptoms. 
Consistent with buffering hypotheses, the interactions between financial toxicity 
and received instrumental support were significant. The interaction variable accounted 
for only a small amount of the variance in QoL. These findings suggest that received 
instrumental support does have a buffering effect on the relationship between financial 
toxicity and QoL.   
To further examine the relationship, social constraint was added to the model. In 
essence, social constraint is negative support (i.e., when the support provided is 
interpreted by the support receiver as negative or not helpful). This study is unique in that 
it examines social constraint in a three-way moderation (moderated moderator) analysis. 
Interestingly, social constraint was observed to moderate the relationship of received 
social support and financial toxicity on their relationship with QoL. Prior research and 
theory suggest social constraint is associated with cancer-specific distress and 
psychological adjustment to stressful events (Adams, Winger, & Mosher, 2014). In terms 
of psychological outcomes, negative interactions are thought to be more salient than 
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positive ones (Baumeister et al., 2001). Cancer patients may be more vulnerable to the 
effects of social constraint as they would generally be expecting to receive support and 
empathy from others.  
In contrast, perceived social support did not interact as a moderator variable. 
Instead, perceived social support played the role of a mediator in the relationship between 
financial toxicity and QoL. This implies that the potential effect of financial toxicity on 
QoL can also be explained by way of perceived social support. In this interaction, 
financial toxicity may lead to the perception of social support which in turn changes or 
alters this association with QoL. While perceived social support mediates financial 
toxicity indirectly, it also has a direct association with QoL. As a person’s awareness of 
perceived social support increases, the indirect influence of financial toxicity and QoL 
decreases. This study adds to the literature on perceived support as a mediator variable. 
Hodges et. al. (2012) showed that perceived social supports mediated the relationship of 
optimism and positive affect in cancer survivors. From a moderator perspective, Lewis et 
al. (2001) revealed that perceived social support moderated the impact of intrusive 
thoughts on QoL in long-term breast cancer survivors. 
The results for Study 2 provide an interesting view of the influence of social 
support on the relationship between financial toxicity and QoL. They add to the literature 
supporting the importance of social support as a buffer to the long-term negative impact 
of cancer. Moreover, these findings are distinctive in that few studies on financial toxicity 
have examined variables that may influence (moderate or mediate) the impact financial 
toxicity can have on cancer patients and survivors. They provide insight into the complex 
variable of social support (received and perceived emotional, informational, and 
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instrumental) and provide support to the idea that having access to support can play a 
valuable role in easing the financial hardship faced by many patients with cancer.  
Bringing it all together. Taking a pragmatic approach to investigate this 
phenomenon, we are able to create an understanding of the reality faced by some cancer 
patients. Using an overall inductive approach, the results of these two studies are brought 
together to confirm the existence and significance of social support in the cancer-related 
financial experience. Research has shown that social support is important in the cancer 
experience. This research project broadens the existing literature further by exposing the 
importance of support in addressing the financial component of cancer. 
 In Study 2, received support moderates the relationship between financial toxicity 
and QoL. This is understandable since receiving supports such as those identified in 
Study 1 (food, monetary assistance, groceries, gas, childcare, advice, etc.) can provide 
some financial relief. Several participants in Study 1 commented on how helpful these 
supports were. No matter how small or large the support (emotional, informational, 
instrumental) was, it made a difference. 
Further investigating this moderator model in Study 2, social constraint (non-
helpful support) was observed to moderate the relationship between financial toxicity and 
received support. In this respect, as financial toxicity and social constraint increase, 
received support and quality of life decrease. Participants in Study 1 talked about 
receiving support that was not helpful or came at a cost, adding to their financial 
hardship. In contrast, individuals with low social constraint and high received support 
reported higher quality of life. These individuals were able to access the supports they 
needed without the constraint or non-supportive behavior of others. The presence of 
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social constraint adds to the complexity of the situation and points to the importance of 
surrounding yourself with people who are supportive and understand that cancer has 
financial implications as well. This claim is supported by responses from participants in 
Study 1 who found the support and understanding they need through support groups such 
as Gilda’s Club in Louisville, KY.  
Equally important, in Study 2 perceived support mediated the relationship 
between financial toxicity and quality of life instead of moderating it. Perceiving 
something exists is a cognitive activity. The perception of support means to be conscious 
of its existence and to have the belief that it is realistically available if needed. In essence, 
this way of thinking is a means of coping with the financial experience. Believing the 
support exists could ease feelings of anxiousness or hopelessness. In spite of its statistical 
importance in Study 2, perceived support was only mentioned once in Study 1. One 
reason for this absence could be that participants did not believe they had someone who 
could help them with their financial hardship. Participants may have exhausted the 
resources they had access to and felt they could not ask for more help as was stated by 
one participant. With respect to this, it was unexpected that social constraint did not 
moderate the mediation model in Study 2. It may be that social constraint plays into the 
scenario in another capacity, which could be further explored. 
If one revisits the theoretical models presented in Chapter 3, both Study 1 and 
Study 2 can provide further understanding. Figure 8.1 presents social support in a model 
adapted from the Stress-buffering Hypothesis (Cohn & Wills, 1985) and Transactional 
Model of Stress and Coping Theory (Lazarus & Folkman, 1984). In Figure 8.1 we see 
that social support is part of the appraisal process and coping responses. As stated in 
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Chapter 3, social support is thought to buffer the experienced burden during the appraisal 
process. An individual may not perceive the threat to be as much of a threat as it would 
be if social support was not present. Similarly, during the coping response, social support 
directly alters or eliminates the stress response (Cohn & Wills, 1985).  Findings from 
Study 1 and Study 2 provided empirical support for the Stress-buffering Hypothesis in 
the appraisal and coping processes.  As interpreted from the findings of Study 2, in 
perceived social support interacts as a mediator and received social support as a 
moderator (Figure 8.2). Both of these forms of support in turn influence the outcome 
(quality of life). Furthermore, social constraint (Unhelpful Supports) interacts with 
received social support (Helpful Support). Social Constraint regulates the buffering 
abilities of received support to impact the outcome. Although not presented in the model, 
the Gaps in Support (missing and barriers to support identified in Study 1) further detract 
from the coping response. When emotional, informational, and instrumental supports are 
unavailable or blocked due to barriers, social supports are unable to function to their 
capacity.  
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Similarly, the Financial Toxicity Framework proposed by Carrera & Zafar (2018) 
allows an additional perspective in viewing the study findings. Received social support 
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Figure 8. 1 Depiction of social support informed by the Stress and Copying Theory and 
the Stress-buffering Hypothesis (Cohn & Wills, 1985). 
 
Figure 8. 2 Social support moderating and mediating the relationship between 
financial toxicity and quality of life. 
  183 
interacts along the pathway from financial toxicity to quality of life (see Figure 8.3). In 
considering the forms of support, we can conceivably say that received support impacts 
the objective burden experience. Receiving helpful information can lead to financial 
assistance or smarter ways to organize and pay medical bills as well as lead to food, 
monetary, or other tangible assistance. This, in turn, can relieve the objective financial 
burden, which subsequently impacts the subjective financial distress. Furthermore, 
perceived supports can influence the subjective distress component of financial toxicity. 
Having the perception that financial assistance is available and accessible if needed can 
alleviate the anxiety and fear of not being able to afford medical treatment or daily living 
expenses.  
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Figure 8. 3 Moderator and mediator interactions of social support using the Financial 
Toxicity Framework (Caerrera & Zafar, 2018). 
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Finally, the results from this multiple method approach aided the development of 
a ‘Things to Do’ checklist for oncology social workers. Largely influenced by Study 1, 
this checklist can guide oncology social workers or other healthcare professionals in 
engaging in important financial conversations and identifying supports. (See Table 8.1 to 
view the checklist). Oncology social workers are well trained to address these financial 
concerns with patients. Not all patients want to know what their costs are, but someone in 
the person’s support network should be aware. Furthermore, it is important to offer the 
information and provide it. Several participants in Study 1 commented that they were 
never told the costs of their care, and those who directly asked were not told. Purposely 
engaging in financial discussions with patients opens up that line of communication 
essentially giving them permission to ask for help. Furthermore, giving patients the 
information, they need to make informed choices about their care and related financial 
costs gives patients control over their situation. Moreover, it is important to recognize 
that these questions should be asked again at other times throughout the cancer 
experience as situations may change.   
Table 8. 1 Checklist for Engaging Patients in Financial Toxicity Conversations 
Things to do: 
Communicate openly with patients about financial issues. 
Normalize the experience of financial concerns and hardship. 
Address the issue in a non-judgmental or non-shaming way. 
Provide current and updated resources. 
 
Questions to ask: 
What is the patient’s diagnosis, treatment and prognosis? 
 
Do they have insurance?  
• What is their deductible? 
• What will their costs be after insurance? 
• Do they qualify for Medicaid/Medicare? 
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Does the patient want to know what their healthcare costs will be?  
• If not, do they have a support person who can assist? 
 
Are they satisfied with their financial situation?  
 
Do they need help understanding their medical bills and insurance forms? 
 
Does the patient have an advocate or support person to help them organize their 
medical bills and insurance forms?  
• Someone to assist with appeals to the insurance agency if needed or apply for 
other financial assistance programs?   
 
Does the diagnosis and treatment meet Medicare and/or Social Security Benefit 
qualifications? 
 
Does the patient work?  Do they have a spouse/partner who works? 
• What benefits do they have through their employer? (Sick leave assistance 
programs, part-time disability, Family Medical Leave, etc.)  
• Do they feel comfortable disclosing their cancer diagnosis to their employer?  
 
Do they have student loans that can be deferred for medical reasons?  
 
What barriers to accessing treatment might the patient be facing?  
• Does the patient need help completing paperwork?  
• Do they need guidance on how to talk to others about their financial concerns?  
• How to approach their employer? 
• What specific support or information is it that they need?  
• Does the service provided to patients match their needs? 
 
 
Further considerations should be made to ensuring an environment is created that 
will encourage patients to discuss their financial concerns with their medical provides. As 
noted in Chapter 3, certain conditions of support need to meet for social support to be 
requested or provided. First, the request for assistance cannot be a request that will 
potentially harm the relationship (Cohen, 2013). This requires a certain amount of trust 
and comfort within the relationship for requests to be made. Second, the stress-causing 
issue must be socially acceptable (Cohen, 2013). Given the fact that financial discussions 
are generally considered taboo in our society, requesting financial assistance from others 
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or sharing financial concerns with others can be difficult for some people. Some 
participants in Study 1 commented on not talking to others about their financial situation. 
In order to breakdown these social barriers, financial concerns should be normalized for 
cancer patients. There should be a level of trust, non-judgment and empathy conveyed 
from the healthcare professionals (financial counselor, social work, physician, etc.) to the 
patient.  Third, overreacting to the request for assistance could lead the individual into 
feeling ashamed or embarrassed (Cohen, 2013), which could have further help-seeking 
implications. One participant in Study 1 shared her story of attempting to get information 
and resources. The response and lack of help she received left her feeling as though it 
was a racial issue, and she was angry for being treated so poorly. Fourth, the support 
provider needs to be capable of providing the support needed (Cohen, 2013) and needs to 
have access to available resources. This requires a skilled individual who is not only 
aware of the impact of cancer on a patient’s life but is also familiar with working in 
social systems (healthcare, insurance, disability). Lastly, the resources must match the 
needs of the patient (Cutrona & Russell, 1990).  Although many of the supports provided 
to cancer patients (resource centers, art therapy, monthly massages) provide a sense of 
well-being for patients, they do not directly impact the issue of financial toxicity. Several 
participants in Study 1 sought information and were sent to the hospital’s resource center 
but were unable to obtain helpful advice. Others were provided resources that did not 
provide assistance. Consequently, there were multiple examples of those resources not 
meeting the needs of the participant.  
In summary, the present study contributes to the knowledge and understanding of 
the financial experience of cancer survivors. This study highlights the importance of 
  187 
social support broadening its benefits within the cancer experience and highlighting its 
role in financial toxicity. It has also examined the different pathways by which each form 
of support (perceived and received) influences the situation. Cancer patients with fewer 
social supports are at greater risk of experiencing financial toxicity. This can be further 
complicated by issues of social constraint. From this investigation emerges the need for 
better communication with patients about their costs, the needs for adequate resources 
and information to help improve their circumstance, as well as the need to break down 
barriers that prevent patients from accessing financial assistance.  It therefore follows that 
oncology social workers and healthcare professionals have an essential role to fulfill in 
assisting patients in averting financial hardship.  
Implications for Practice 
 Findings from the present study suggest the benefits associated with social 
supports in the context of financial toxicity. The results from this research study should 
be used to inform practice of the need to ensure information and guidance is provided to 
patients. Social support (emotional, information, and instrumental) as it relates to 
financial toxicity can have a significant impact on patient outcomes. Yet, as evident by 
the findings of Study 1, participants lacked information that could have assisted them and 
potentially improved their financial outcomes. To that end, it is imperative that social 
workers and medical professionals address financial toxicity before it is a problem.  
 Proactive discussions with patients regarding the costs of cancer care should 
occur at the beginning of the cancer experience before treatment starts. Waiting until a 
patient is experiencing financial toxicity, which could be several months later, limits the 
availability of receiving support and assistance. Instead, all patients should be approached 
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immediately upon their diagnosis, provided financial assistance information and 
encouraged to look into specific work-related benefits or other supports. As was seen in 
Study 1, patients were taken off-guard by the costs of their care. Many of them were 
unaware of the expenses until receiving an overwhelming amount of bills several months 
later.  By not engaging in these important conversations, patients are caught off-guard 
and may have no idea who to approach for assistance. Oncology social workers are well 
positioned for engaging in these proactive conversations. They are skilled and proficient 
in quickly developing a trusting rapport with patients. They understand the importance of 
engaging in active listening and taking time to fully understanding what patients are 
experiencing. They are skilled in ways to put others at ease creating a comfortable safe 
environment for patients to share their concerns. 
Justifiably, discussing finances is said to be one of the most difficult 
conversations for people to have. This was an issue for several participants in both 
studies. Financial struggles can lead to feelings of inadequacy, guilt, and embarrassment 
making it difficult for people to confide in others. Yet much of the information available 
for patients, encourages them to bring up the conversation and tells them to talk to their 
medical providers about their financial concerns. This could be very difficult for some 
patients, especially those who are embarrassed about their financial situation. Therefore, 
individuals who fulfill those roles should be well training and equipped to handle these 
difficult conversations.  
Oncology social workers have the clinical skills required to engage in difficult 
conversation in a sensitive, empathetic and respectful manner. They seek to identify and 
deal with the significant stressors created by burden. They are skilled at building trusting 
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relationships which allows them to approach difficult conversations such as finances. 
With respect to this, engaging in important and difficult, even taboo, conversations are a 
common occurrence for oncology social workers.  
To the contrary, the majority of people who provide financial counseling to 
patients in the healthcare setting have a high school level education (Advisory Board, 
2014). They lack the necessary medical understanding of diagnosis and treatment as well 
as how those can impact a patient’s life and ability to continue working. Furthermore, 
they lack the necessary training to engage in difficult, taboo conversations that require 
sensitivity and empathy. In spite of this, there are no policies or regulations requiring 
these positions receive training or certification. Consequently, many patients do not 
receive the information, resources or help they need.     
Furthermore, there is a lack of resource availability and what is available 
(Medicare, financial and pharmaceutical assistance programs, charity) may not be enough 
to help patients once they are experiencing financial toxicity. A study by Smith, Nicolla, 
and Zafar (2014) and another by Spencer et. al. (2018), found that many oncology social 
workers and financial navigators do not have the resources needed to help patients. This 
can lead to avoidant behaviors or non-helpful responses from medical professionals as 
was seen in Study 1. Arguably, this is because issues of financial toxicity are not dealt 
with until it is a problem instead of addressing them from the initial diagnosis. With 
respect to this, a program created by Dan Sherman and the NaVectis Group (2016) 
addresses the needs of patients and their families early in the cancer experience. Through 
optimizing health insurance coverage (Medicare, Medicare, and the insurance exchange), 
they are able to ensure patients have the best and most affordable insurance to meet their 
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needs. Further, they provide patients with all the available information on patient 
assistance, programs. Although this program has not been proven in terms of evidence-
based research, it is considered to be practice informed and best practices.  
To date there are no evidence-based practices to address financial toxicity, but 
there has been some progress. A pilot study by Shankaran et al. (2017) implemented a 
patient navigation program offering counseling and case management assistance. The 
program provided patients with access to counselors and case managers who assist with 
budgeting, answering medical billing questions, and applying for assistance programs. 
Although this study did not find a difference in financial burden, some patients did 
experience a decrease in anxiety over their medical costs (Shankaran et al., 2017). A 
second intervention, Care Payment program, provided patients with 0% APR lines of 
credit up to $25,000. Patients were put on repayment plans of 4% or as little as $25 per 
month. Patients were less likely to report barriers to care and bad credit issues as a result 
of the medical costs (Lessard & Solomon, 2017). Although both of these programs 
provided patients with assistance and some relief, patients still faced huge amounts of 
debt accumulation due to their treatment. This could be were the NaVectis program may 
be superior as it addresses financial issues through intervening by means of healthcare 
insurance before financial toxicity becomes a problem.  
Lastly, patients can take control over their cancer-related financial experiences by 
seeking the support and help they need. They should be empowered to advocate for 
themselves or seek the assistance of someone who can advocate for them. Staying 
organized and on top of their medical bills and insurance forms could be a way to catch 
billing errors which can lead to unnecessary insurance denials. If medical expenses are 
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denied, patients should be encouraged and assisted in finding out why. Equally important, 
patients should be encouraged to talk to others and openly communicate with their 
medical professional about their financial concerns. This could open the door to financial 
advice (what to pay, when to pay) or lead to other resources that may be beneficial. 
Support groups through organizations such as Gilda’s Club offer supportive 
programming in a safe and encouraging environment.   
Implications for Policy 
In order to truly enact change and improve conditions for patients, a larger 
systemic change is needed. Healthcare was one of the top issues in the 2018 elections and 
it will continue to remain a concern as costs of care continue to rise. Policy changes at 
both the healthcare level and larger government level can improve conditions for patients 
and possibly help patients avoid financial toxicity.  
From a public policy perspective, it is of utmost importance that cancer patients 
and survivors have “affordable, adequate, and accessible healthcare” (ACS-CAN, 2017). 
The Patient Protection and Affordable Care Act (ACA) ensured patients would have 
access to healthcare plans that covered a basic degree of cancer care, prevented denials 
for pre-existing conditions, and were affordable. Yet, these efforts were not enough; 
although, many American were able to purchase affordable insurance, patients still 
experienced financial toxicity. Furthermore, the current Presidential Administration and 
Republican-based Congress have made efforts to overturn parts and all of the ACA, 
which could jeopardize the financial security of many cancer patients and survivors.  
Accordingly, efforts should be made to craft legislation that covers all Americans 
in the event of a cancer diagnosis. A universal healthcare program would provide equal 
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health coverage to all Americans. According to Sen (2015), the United States could 
effectively provide a high level of universal healthcare. There is a considerable amount of 
evidence showing the benefits of such programing. It is well known that Canada and 
several countries in Europe have versions of universal healthcare, and all show better 
quality of health and quality of life than the United States. It is less known that poorer 
countries, such as Thailand, Rwanda, and some states in India (Himachal Pradesh and 
Tamil Nadu) are implementing universal healthcare policies and are seeing improvements 
in premature and infant mortality rates (Sen, 2015).  
With respect to the idea of universal healthcare, Medicare-for-All appears to be 
promising. There are currently several proposed bills that provide versions of access to 
insurance options that are Medicare or Medicaid based. One bill proposed by Senator 
Sanders (S. 1804) and Representative Ellison (H.R. 676) is a single national health 
insurance program that would cover all Americans. Alternatively, three other bills 
provide versions of a new plan option that could be available through the ACA 
marketplace: Choice Act (S. 194, H.R. 194), Medicare-S Choice Act (S. 1970, H.R. 
4094), and Choose Medicare Act (S. 2708, H.R. 6117). These would offer programs 
similar to Medicare to individuals and possibly employers. A fourth version provides a 
Medicare buy-in option for individuals who are nearing the eligible age for Medicare 
programs: Medicare at 55 Act (S. 1742), and Medicare Buy-in and Health Care 
Stabilization Act (H.R. 3748). These would be greatly beneficial to those nearing the age 
of retirement and also at a higher risk of receiving a cancer diagnosis. A final version of 
Medicare-for-All provides states with the authority to allow individuals a Medicaid buy-
in option through the ACA marketplace: State Public Option Act (S. 2001) and (H.R. 
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4129) (Kaiser Family Foundation, 2019). Through legislation such as these acts a greater 
number of Americans will have affordable access to insurance coverage.  
Unfortunately, achieving change at the governmental level can be an onerous task 
that could take a long time to achieve and patients need help now. Financial health 
literacy in the United States is considerably low (Lin, Lusardi, and Mottola, 2016). A 
survey in 2015 found that 63% of adults (N = 25,000) could not answer 4 out of 5 
financial literacy questions correctly. Likewise, many Americans lack the financial 
capability to make ends meet and deal with everyday financial matters. In this same 
survey, 34% felt they could not come up with $2000 in a month for an unexpected 
emergency without borrowing and 50% did not have enough funds set aside to cover a 3 
month laps in income (Lin, et. al., 2016). This is indicative of a substantial number of 
Americans being at risk of financial devastation in the event of a cancer diagnosis or 
economic downfall. 
To that end, it is imperative that the health care industry assist patients. The 
findings from this research suggest that patients need information and guidance in 
understanding their medical bills and health insurance forms. This information should be 
understandable at a basic-educational level. Agencies (medical and insurance companies) 
could simplify their forms to make them easier for patients to interpret and understand. 
One participant in Study 1 shared her confusion over her medical bills and consequently 
paid bills that her insurance eventually paid as well. When she attempted to get the 
money back from the medical provider, she was unsuccessful about doing so in a timely 
manner. Had she understood her medical bills, she would not have paid them at that time 
and possibly could have prevented some discord as a result.  
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Moreover, several participants in Study 1 struggled with the overwhelming 
amount of medical bills and insurance forms arriving through the mail. By providing a 
centralized billing system where patients can access their medical bills and insurance 
information all in one spot could help to eliminate redundancy in the system and could 
relieve patients from having to manage these documents. This would make the process 
more patient friendly relieving the burden of receiving excessive amounts of forms and 
documents through the mail.   
In addition, these agencies (medical and insurance) could provide trained and 
skilled individuals to help patients in a sensitive and empathic way. This service could 
assist patients in understanding what bills they need to pay and what their insurance will 
cover. Furthermore, just having someone to help complete paperwork could make a 
difference in whether or not patients complete paperwork requesting financial assistance. 
Likewise, assistance should be offered to caregivers as they may be responsible for 
managing the financial aspects of the experience.  
In summary, there are several ways the American healthcare system can be 
improved to ease the financial burden and distress experienced by patients. The 
healthcare industry can take steps to improve the exchange of information and provide 
services from trained, skilled workers who are aware of the circumstances resulting from 
cancer.  
Future Research  
As evidence accumulates on the devastating effects of cancer-related financial 
toxicity, there is an urgent need to develop and implement interventions to alleviate the 
burden and distress experienced by patients and their families. Further research should be 
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conducted on the NaVectis Group method of addressing financial toxicity to determine its 
overall effectiveness. It is imperative that research identify interventions and best 
practices to assure that patients can afford their cancer care and do not end up financially 
devastated attempting to do so.  
Further research could explore patients’ preferences for information and, equally 
important, who they would like to receive this information from. It may be important for 
every member of the medical team to be knowledgeable and sensitive about financial 
concerns. Providing patients with some guidance or at least direction as to who to get 
information from encourages them to continue to try to find relief.  Future research could 
develop and assess the effectiveness of a training program for medical professionals on 
engaging in these difficult financial discussions in a caring and respectful way.  
Another piece to the puzzle may be understanding help-seeking behaviors as they 
relate to financial aspects. Socially taboo issues have long constrained people from 
talking about such issue as politics, religion, sex, and money. This was supported in 
Study 2, which showed that social constraint was indeed a factor. Research could further 
explore ways to break down these barriers.  
Limitations 
The benefits of social support have long been established in the cancer 
experience. This study extends this knowledge into the experience of cancer-related 
financial toxicity.  A strength of this project was the use of multiple studies. Using this 
pragmatic approach allowed for this topic to be explored through qualitative and 
quantitative measures providing different perspectives and information. Another 
strengths was the variety of theoretical frameworks, which informed the development of 
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the study procedures and data analyses. Furthermore, each study provided a different 
perspective on the availability, use, and need for social support during the cancer 
experience.  
Despite the use of multiple methodologies, weaknesses were identified for each 
study. Study 1 had an almost non-existent presence of perceived support. This lack of 
perceived support as well as a weak existence of received information and emotional 
supports could be due to the way the interview questions were designed. This was a 
secondary analysis and the interview questions sought to understand the overall 
experience of cancer-related financial hardship not specific to social support. To the 
contrary, there was a strong presence of received instrumental support discussed by all 
participants. To that end, Study 1 provided insight into the types of social support 
(emotional, informational, and instrumental); nevertheless, it does not indicate which is 
more important. The aim of this study was not to determine the level of importance but 
rather to identify the existence of support, its use, and need for more. What we can 
surmise is that received instrumental support was more talked about than any other type 
of support.  
A strength of Study 2 was that the models accounted for a portion of the variance 
in QoL. However, the observed moderation variable (received social support) did not 
account for a large amount of the variance in QoL. According to Cohn & Willis (1985), 
the ability to detect a buffering effect could be dependent on the measures used. This 
requires having measures that directly get at the type of social support which can best 
respond to the stressor. In this respect, results may have shown more variance in QoL had 
the larger version of the scale (Inventory of Socially Supportive Behaviors short version) 
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or a different scale been used. Another weakness was that other variables could have 
been included, such as are the length of treatment and number of other chronic illnesses. 
These variables may have explained some of the variance in QoL. Furthermore, the study 
design did not allow for the establishment of causality.  
Study 1 and Study 2 cross-sectional designs were used, which does not allow for 
causal or directional inferences. In addition, a cross-sectional design prevents the 
evaluation of long-term financial impact. Furthermore, both studies were limited by a 
lack of racial diversity; most participants were white and female. Individuals from 
minority populations tend to have less access to financial reserves. According to the 
American Cancer Society (2018), Hispanics (16%) and blacks (11%) are more likely to 
be uninsured then Caucasians (6%). Minority populations are also more likely to be 
diagnosed with cancer at a later stage. It is therefore conceivable to propose these 
populations may experience higher toxicity and be in need of more intervention services. 
Future research could focus on identifying the effects of financial toxicity on minority 
populations and determining if racial differences exist in regard to the availability of 
social support.  
Conclusion 
It is evident that a significant number of people are impacted by the costs of 
cancer care and as costs continue to rise, more will experience financially toxic 
situations. Although financial toxicity continues to be extensively studied, answers to 
alleviating patients’ financial distress and burden are lacking. To my knowledge these are 
the first studies conducted to focus on specifically how social support can impact the 
cancer-related financial experience. These findings confirm the existence, use, and 
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importance of social support in this context. Furthermore, they provide empirical 
evidence for attending to the supportive financial needs of cancer patients.  
From this investigation emerges the need for purposeful conversations 
surrounding financial issues at the beginning of a cancer diagnosis. Patients should be 
provided information about their costs of care and the amount they are responsible for 
instead of being surprised by the bills several months later. Exactly who is at risk is 
debatable; therefore, the assumption should be made that anyone with cancer is at risk of 
experiencing financial toxicity. All patients should be provided financial assistance and 
resources before they experience financial toxicity (i.e., at the beginning of their cancer 
experience). Furthermore, all members of the healthcare team should receive training on 
engaging patients in a sensitive and empathic way when handling financial discussions.  
On a theoretical level, the study findings provided empirical evidence in support 
of the Stress-buffering Hypothesis (Cohn & Wills, 1985) and conceptually adds to the 
Financial Toxicity Framework proposed by Carrera & Zafar (2018). This has important 
implications for practice. Practitioners should understand the complexity of financial 
toxicity and how these supports can buffer patients’ experiences.   
Furthermore, the costs of care should not weigh into the decision of whether or 
not a person obtains cancer care. It is of the utmost importance that policies at the federal, 
state, and agency level address the astronomical costs of health care. Whether by cost 
regulation or universal health plans, systemic change needs to occur in order to 
effectively prevent patients from the experience of financial toxicity. 
Future studies should continue to investigate evidence-based interventions for 
addressing financial toxicity. Equally important is examining patient preferences for 
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information and with whom they prefer engaging in purposeful financial conversations. 
Other studies should explore the development of training for medical professional in 
engaging in sensitive financial conversations.  
In considering the findings from this research, it appears that the answer to the 
overarching question to what role does social support play, we can unequivocally answer: 
an important one. Social support is a critical element in helping protect patients from 
cancer-related financial toxicity.  
“I wish there would have been somebody, just to say, this is going to start costing you 
money, because all you’re thinking about is, ‘I want to save my life.’” 
-Study 1 # (53-year-old woman, Pancreatic Cancer) 
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APPENDIX A: STUDY 1 CONSENT PREAMBLE 
Living with the Financial Consequences of Cancer: The Stories of Survivors Support Person 
Consent 
You are being invited to participate in a research study by participating in a one-time interview 
conducted by a member of the research team. This interview can occur in your home or at our 
research office. The interview will ask about your experiences related to the financial and 
personal distress caused by a cancer diagnosis and related treatment. Completing the interview 
will take approximately 1 hour. Your interview will be audiotaped and then transcribed (typed 
out).  
The purpose of the study is to learn how a cancer diagnosis impacts financial well-being, how 
cancer patients manage financial hardship and how financial distress affects overall quality of 
life. The ultimate goal is to develop sustainable and effective interventions to assist cancer 
patients in preventing financial hardship.  
There are no foreseeable risks associated with this study besides the discomfort you might 
experience answering interview questions. There may be unforeseen risks. The study data 
collected may not benefit you directly, but it will be used to identify and address financial barriers 
to cancer care which could positively impact the future lives of survivors and their families.  
Your completed interview will be stored in a locked file cabinet at the Kent School of Social 
Work. Your responses to the questions will be maintained on a password protected computer. 
Identifying information such as your name will not be connected to the database or your 
transcribed interview, nor will any of your identifying data be published in articles written about 
the study.  
Individuals from the Department of University of Louisville Department of Medicine and the 
Kent School of Social Work, the Institutional Review Board (IRB), the Human Subjects 
Protection Program Office (HSPPO), and other regulatory agencies may inspect these records. In 
all other respects, however, the data will be held in confidence to the extent permitted by law. 
Should the data be published, your identity will not be disclosed.  
Taking part in this study is voluntary. By completing the interview you agree to take part in this 
research study. You do not have to answer any questions that make you uncomfortable. You may 
choose not to take part at all. If you decide to be in this study you may stop taking part at any 
time. If you decide not to be in this study or if you stop taking part at any time, you will not lose 
any benefits for which you may qualify.  
If you have any questions, concerns, or complaints about the research study, please contact the: 
principal investigator at 502-852-1946.  
  221 
If you have any questions about your rights as a research subject, you may call the Human 
Subjects Protection Program Office at (502) 852-5188. You can discuss any questions about your 
rights as a research subject, in private, with a member of the Institutional Review Board (IRB). 
You may also call this number if you have other questions about the research, and you cannot 
reach the research staff, or want to talk to someone else. The IRB is an independent  
UofL Institutional Review Boards 
IRB NUMBER: 15.0407 
IRB APPROVAL DATE: 06/04/2015 IRB EXPIRATION DATE: 05/13/2016  
committee made up of people from the University community, staff of the institutions, as well as 
people from the community not connected with these institutions. The IRB has reviewed this 
research study.  
If you have concerns or complaints about the research or research staff and you do not wish to 
give your name, you may call 1-877-852-1167. This is a 24 hour hot line answered by people 
who do not work at the University of Louisville.  
Sincerely,  
Karen Kayser PhD. Barbara Head PhD.  
DATE: 06/02/2015  
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APPENDIX B: STUDY 1 INTERVIEW GUIDE 
 
The Experience of Financial Toxicity during the Cancer Trajectory 
 
I would like to have a conversation with you about your experience with cancer. 
Specifically, I would like you to tell me in your own words the story of how your illness 
caused financial hardship in your life. 
 
Point of Most Financial Distress  
• When did you first start to experience financial stress related to your cancer? 
(Probe: Can you tell me more about that?) 
• When did you reach your highest point of financial stress and what was that like 
for you? 
 
 
Financial Situation & Health Insurance at the Time of Diagnosis 
• Tell me about your financial situation during the time of your diagnosis. 
• Were you employed at that time? Were you able to maintain your employment 
throughout your treatment? If so, tell me about the work you were doing?  
• Did you have health insurance coverage? If so, what type? (Probe: private, 
employer, self-paid) 
 
Understanding Assistance with Insurance, Medical Costs, and Coverage. 
• What did you understand about the costs of cancer care and your insurance 
coverage at the time of your diagnosis? 
• What assistance was given to you from the Cancer Center or any of your medical 
providers to guide you through the cost s and insurance coverage period during 
your cancer experience? (Probe: Financial counselor.) 
• Did you encounter any out of pocket expenses that you did not expect? If so, what 
were they? 
 
Managing the Financial Stress 
• What strategies did you use to manage the financial burden during your cancer 
experience? 
• What, if any, methods did you use to offset costs of care and expenses such as 
loans, credit cards, or second mortgages? 
 
Effects of financial distress on treatment and outcomes. 
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• Did the worry about your financial situation affect any of your treatment 
decisions? 
• Did you ever not receive, limit or stop treatment because of the inability to pay for 
it? (E.g. not filling prescriptions or taking fewer medications) Probe: Tell me 
more about that. 
 
Current Quality of Life 
• Looking back on your life before your cancer diagnosis, what has changed about 
your life overall? 
• How do you think it has affected your family/loved ones? 
o How would you describe their quality of life before, during and after 
treatment? 
• What are your current healthcare needs and are they being met or addressed? 
(Probe: include follow-up care, preventive screenings or other chronic conditions) 
  
Ending interview 
• If you could give another person who is diagnosed with cancer advice about 
finances and stress, what would it be? 
• What advice would you give to the healthcare system (hospitals, cancer centers, 
insurance companies, government) to alleviate the financial consequences of a 
cancer diagnosis and treatment? 
• What else do you think it would be important for me to know about financial 
stress and cancer that I did not ask you about today? 
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APPENDIX C: STUDY 1 QUESTIONNAIRE 
 
Introduction 
 This questionnaire is about your experience with cancer specifically your 
experience with financial burden as a result of the cancer treatment, access to care, and 
social support during your illness. All answers are completely confidential. Please do not 
write your name of the questionnaire.  
 
Section I Financial Toxicity Scale (Cost-Prom) 
 
Below is a list of statements related to the financial impact of your illness. Please place 
an X in the box which describes how you feel about that statement. 
 
 Not at 
all 
A little 
bit 
Some-
times 
Quite a 
bit 
Very 
Much 
I feel financially stressed. 0 1 2 3 4 
I am satisfied with my current 
financial situation. 
0 1 2 3 4 
I worry about the financial problems I 
will have in the future as a result of 
my illness or treatment. 
0 1 2 3 4 
I am frustrated that I cannot work or 
contribute as much as I usually do. 
0 1 2 3 4 
My cancer or treatment has reduced 
my satisfaction with my present 
financial situation. 
0 1 2 3 4 
I feel in control of my financial 
situation. 
0 1 2 3 4 
I am able to meet my monthly 
expenses. 
0 1 2 3 4 
I know that I have enough money in 
savings, retirement or assets to cover 
the costs of my treatment. 
0 1 2 3 4 
I am concerned about keeping my job 
and income, including working at 
home.  
0 1 2 3 4 
I feel I have no choice about the 
amount of money I spend on care. 
0 1 2 3 4 
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My out of pocket medical expenses are 
more than I thought they would be. 
0 1 2 3 4 
 
Section II Brief Health Literacy Screening Tool (BRIEF) 
 
Please circle the answer that best represents your response. 
 Always Often Some- 
times 
Rarely Never 
How often do you have someone help you 
read hospital materials? 
1 2 3 4 5 
How often do you have a problem 
understanding the written materials about your 
medical condition? 
1 2 3 4 5 
How often do you have a problem 
understanding what is told to you about your 
medical condition?  
1 2 3 4 5 
 Not at 
all 
A little 
bit 
Some-
what 
Quite a 
bit 
Extre
mely 
How confident are you filling out medical 
forms by yourself?  
1 2 3 4 5 
 
Introduction 
 This questionnaire is about your experience with cancer specifically your 
experience with insurance, being uninsured or receiving Medicaid coverage. It will help us 
to assess the impact of medical insurance on the affordability and ability to receive health 
care services. All answers are completely confidential.  
 
Section III Well-Being (Fact-G Version 4) 
Below is a list of statements that other people have said are important.  Please circle or 
mark one number per line to indicate your response as it applies to the past 7 days.  
 
Physical Well-Being 
 Not at 
all 
A little 
bit 
Somew
hat 
Quite a 
bit 
Very 
much 
I have a lack of energy. 0 1 2 3 4 
I have nausea. 0 1 2 3 4 
Because of my physical condition, I 
have trouble meeting the needs of my 
family. 
0 1 2 3 4 
I have pain. 0 1 2 3 4 
I am bothered by side effects of 
treatment. 
0 1 2 3 4 
I feel ill. 0 1 2 3 4 
I am forced to spend time in bed. 0 1 2 3 4 
 
Social/Family Well-Being 
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 Not at 
all 
A little 
bit 
Somew
hat 
Quite a 
bit 
Very 
much 
I feel close to my friends. 0 1 2 3 4 
I get emotional support from my 
family. 
0 1 2 3 4 
I get support from my friends. 0 1 2 3 4 
I am satisfied with family 
communication about my illness. 
0 1 2 3 4 
I feel close to my partner (or the 
person who is my main support). 
0 1 2 3 4 
Regardless of your current level of sexual activity, please answer the following question. If you prefer not 
to answer it, please mark this box ☐ and go to the next section.  
I am satisfied with my sex life.  0 1 2 3 4 
 
Please circle or mark on number per line to indicate your response as it applies to 
the past 7 days. 
 
Emotional Well-Being 
 Not at 
all 
A little 
bit 
Somew
hat 
Quite a 
bit 
Very 
much 
I feel sad. 0 1 2 3 4 
I am satisfied with how I am coping 
with my illness. 
0 1 2 3 4 
I am losing hope in the fight against 
my illness. 
0 1 2 3 4 
I feel nervous.  0 1 2 3 4 
I worry about dying.  0 1 2 3 4 
I worry that my condition will get 
worse.  
0 1 2 3 4 
 
Functional Well-Being 
 Not at 
all 
A little 
bit 
Somew
hat 
Quite a 
bit 
Very 
much 
I am able to work (include work at 
home). 
0 1 2 3 4 
My work (include work at home) is 
fulfilling. 
0 1 2 3 4 
I am able to enjoy life. 0 1 2 3 4 
I have accepted my illness. 0 1 2 3 4 
I am sleeping well. 0 1 2 3 4 
I am enjoying the things I usually do 
for fun. 
0 1 2 3 4 
I am content with the quality of my 
life right now.  
0 1 2 3 4 
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Section V Healthcare Access 
 
Q1 How was your cancer found?  
1- It was found during a screening test (such as a mammogram,  colonoscopy) 
2- It was found during a routine check-up or physical exam with my doctor. 
3- It was found when I went to my doctor because I was sick and had physical 
symptoms.  
4- It was found after I went to the emergency room because I was sick. 
 
Q2 What type of cancer did you have? _________________ 
 
Q3 Prior to your cancer diagnosis, where did you receive most of your healthcare?  
1- At my doctor’s office 
2- At a clinic 
3- At an immediate or urgent care center 
4- At the emergency room 
5- I never needed healthcare 
 
Q4 Did you get routine screening for cancer such as a mammogram or colonoscopy 
before your cancer diagnosis?  
____ Yes  ____ No 
 
Q5 Did you go to your doctor or a clinic for regular check-ups before your cancer 
diagnosis? 
 ____ Yes  ____ No 
 
Q6 At the time of your first cancer diagnosis did you have insurance? 
  ____ Yes  ____ No 
  
If you had insurance which of the following types of insurance did you have 
(check all that apply)?  
1- Private Insurance through my employer 
2- Private insurance I purchased myself 
3- Veteran’s Administration coverage 
4- Medicare disability insurance 
5- Medicaid 
 
Q7 Did you have medical insurance prior to your cancer diagnosis? 
 ____ Yes  ____ No 
 
If you did not have medical insurance prior to your cancer diagnosis, what 
was the reason (check all that apply)? 
1- My employer did not offer insurance as a benefit 
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2- I could not afford the cost of health insurance 
3- I did not think I needed insurance 
4- I was not eligible for Medicaid when I applied 
5- I wasn’t working and could not afford insurance  
6- I didn’t know how to get insurance I could afford 
 
Q8 Which of the following insurances changes have you experienced since your 
cancer diagnosis?  
1- None, I still have the same insurance 
2- None, I still do not have any insurance 
3- I lost my insurance because I can no longer work 
4- I lost my insurance because I can no longer afford it 
5- I became eligible for Medicaid 
6- I became eligible for Medicare disability 
7- I lost my insurance coverage through my employer and now pay for my own 
 
Q9 If you have Medicaid, when did you get it?   
Month ____ Year____ 
 
Q10 If you have Medicaid, did you (check all that apply)  
1- Have it before you got sick with cancer 
2- Apply for it when you got cancer 
3- Apply for it after you got cancer because you lost your private insurance 
4- Apply for it when a social worker or other person told you about it 
5- Apply for it when you learned that Medicaid rules had changed making you 
eligible 
 
Q11 If you have Medicaid, how did you learn about it (check all that apply)?  
1- I heard on the news that I might be eligible 
2- I saw a sign or was given information at the doctor’s office, clinic or hospital 
3- My doctor told me about it 
4- A social worker or discharge planner at the doctor’s office, clinic or hospital 
told me about it 
5- A friend or family member told me about it 
6- A family member has it and told me about it 
 
Q12 Did you know that Medicaid became available to more people in Kentucky as 
part of the Affordable Care Act (Obama care) in January 2014? 
____ Yes  ___ No 
 
Q13 Did you apply for Medicaid because you heard it was more available? 
 ____ Yes  ____ No 
 
Section VI Demographic Questions 
 
Gender:   ___ Male ___ Female 
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Age:  
 
What is your ethnicity?  
1- Latina/Latino/Hispanic ancestry 
2- Not Hispanic 
 
What is your racial/ethnic group?  
1- Caucasian/White 
2- African-American/Black 
3- Asian 
4- American Indian/Alaskan Native 
5- Native Hawaiian/Other Pacific Islander 
6- Other __________________________ 
 
Have you ever been or are you currently married?   
1- Single, never married 
2- Currently married 
3- Not married, but in a relationship with significant other 
4- Separated or divorced 
5- Widowed 
 
How many children under the age of 18 are living in your home?  _____ 
 
What is the highest level of formal education that you have completed?  
1- Less than high school 
2- Completed high school or GED 
3- Some college (includes technical, vocational, or certificate program and 
Associate’s degree) 
4- Bachelor’s degree 
5- Postgraduate or professional degree (includes Master’s, MD, PhD, and JD) 
 
Do you currently work for pay? ____ Yes  ____ No 
 
What is your current job status?  
1- Employed full-time 
2- Employed part-time 
3- Unemployed 
4- Homemaker 
5- Disabled 
6- Retired 
 
Before your cancer diagnosis, what was your job status?  
1- Employed full-time 
2- Employed part-time 
3- Unemployed 
4- Homemaker 
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5- Disabled 
6- Retired 
 
If you currently work for pay, in the last month: 
     How many hours per week did you work on average for pay? _3___ 
     How many days off did you take because of physical health problems? ____ 
     How many days off did you take because of emotional health problems? ____ 
 
What is your occupation?  
1- Homemaker 
2- Executive of manager 
3- Professional or technical 
4- Clerical, sales or service work 
5- Occupation in agriculture, forestry or fisheries 
6- Occupation in crafts, repair, manufacturing, transportation or operation of 
machinery 
 
How important is your occupation or continuing to work to your well-being? If 
disabled or unemployed, how important was your occupation or continuing to work 
to your well-being?  
1- Not at all important 
2- Not very important 
3- Somewhat important 
4- Moderately important 
5- Very important 
 
What are/were your household (family) gross wages or income last year (before 
taxes)?  
1- Less than $25,000 
2- $25,001-$40,000 
3- $40,001-$60,000 
4- $60,001-$80,000 
5- Over $80,000 
6- I don’t know 
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APPENDIX E: STUDY 1 TEMPLATE & EXAMPLE OF MEMOS 
 
The below templates are informed by Corbin & Strauss (2015) chapters 6 & 10. 
 
Memo 1: Open Data Exploration 
 Purpose – beginning to explore concept.  
 
Memo 2: Develops the Properties and Dimensions Further 
 Purpose – is to sensitize to possible properties/dimensions. 
 
Memo 3: Comparison and Question-Asking Memo. 
 Purpose – it to make more sensitive to data.  
 
Memo 4: Summary Memo 
Purpose – demonstrate the relationships between conditions, actions-interactions, 
and consequences.  
 
Conceptual Heading: What defines this theme? 
 
 
Questions to ask throughout the process:  
1. What seems to be going on here? 
2. What theme keeps emerging over and over when I read these? 
3. What thoughts/ideas come through in the data even though it may not be 
said directly? 
 
Example 
 
Advocated Memo 1 Data Exploration 
 
Provided by spouses.  
• During a cancer experience patients are facing a life threatening disease. Having 
someone to advocate for them allows them to take a step back and let someone 
else have control of part of the situation. This allows the patient to focus on their 
health and well-being.  
 
• 'my wife is a medical professional. She also is a person who is very conscious of 
what costs are and is not afraid to say, "We can't afford to have that type of 
service, even though you might want to have a 2nd or 3rd opinion, which is fine, 
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we can deal with that. Unless, you can have that as a part of our insurance 
situation, I don't see ..." Your spouse can be skeptical of any 2nd or 3rd opinion 
just because they're out of network.” #26 
 
Spouses all for having someone to just give to all over to. They provide support, 
advocacy.  
 
Excerpts in this category revolve around the concept of someone else taking control of 
part of the situation. 
 
PARENT - she got it from calling around and asking, because she had to do the 
same thing for my father who is disabled. So she kind of knew the avenues.  For 
me she went in there. - #10 
Knowing the avenues to take when seeking disability such as in this case or navigating 
the insurance world can provide a lot of assistance. In this case the patient’s mother was 
able to advocate for her to get disability assistance when she could no longer work due to 
her treatment.  
 
Provided by Child  
• Adult Children were also able to provide advocacy support. --60-year-old woman 
with three adult children comments on how one of her children encouraged her to 
have a voice. 
'Yeah. She's real good at helping me advocate and encouraging me to use my 
voice because when you're in the middle of it's a whole different story. #6 
 
Provided by Medical Professionals 
• Med Prof provided emotional support in the form of Advocacy – this stretches the 
expectations of formal support providers to also include emotional supports -
opposed to what is explain in theory. This may be due to the deep level at which 
health care can effect a patient – medical providers cross the divide between 
formal and information – they become personal relationships – friends.   
'I felt like my healthcare system was an advocate. - #22 
“Yes, she has become more of a friend and an advocate b/c she got on the phone and was 
talking to them and they paid attention to her.  I can barely walk—but I can’t use a 
walker or a cane—but she got on the phone and made them pay attention about it like the 
wheelchair back in December.  So that I can get around without being stuck in the 
house.” - #2 
 
Advocate Memo 2 Develops 
Advocate. A life threatening or severe disease, such as cancer, can cause a patient to feel 
vulnerable. They may feel week due to the effects of the illness itself or the physical 
demand treatment has on their bodies. In this emotional support theme, we see that family 
members (spouses, parents, adult children, siblings) and medical professionals (Nurses) 
served as advocates. Having someone to advocate for you allows you to take a step back 
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and let someone else have control of part of the situation. This allows the patient to focus 
on their health and well-being.  
Emotional supports are expected to be performed by Family and Friends. In this 
study several different family member roles engaged in advocating for the needs of the 
patient.  In the below quote from #26, the participant appears to speak with confidence 
about his spouse’s ability to handle the situation and ensure that whichever health 
decision the select will make the most economical sense. 
 
Parents can have past life experiences that prove to be useful as seen in the case of 
a 35-year-old, single female. Knowing the avenues to take when seeking disability such 
as in this case or navigating the insurance world can provide a lot of assistance. In this 
case the patient’s mother was able to advocate for her to get disability assistance when 
she could no longer work due to her treatment.  
Adult Children were also able to provide advocacy support. In the below excerpt a 
60-year-old woman with three adult children comments on how one of her offspring 
encouraged her to have a voice in her medical care and decision-making processes. 
 
From the perspective of social support theory, medical professionals are in the 
formal support provider categories and expected to provide information and instrumental 
supports. In this study they are also observed providing emotional support.  Med Prof 
provided emotional support in the form of Advocacy – this stretches the expectations of 
formal support providers to also include emotional supports -opposed to what is explain 
in theory. This may be due to the deep level at which health care can effect a patient – 
medical providers cross the divide between formal and information – they become 
personal relationships – friends.   
 
During a cancer experience, patients are faced with a life-threatening disease. Having 
someone to advocate for them allows them to take a step back and let someone else have 
control of part of the situation. This allows the patient to focus on their health and well-
being.  
 
Advocacy Memo 3 Questioning Memo 
Provider advocates for the patient’s wellbeing, medical care, and health service 
needs. In providing this assistance, patients are comforted and may feel supported having 
the confidence that someone else can take care of things. Provider supports the patient by 
ensuring their well-being and needs are met. Acts as a voice for the patient. The patient 
has confidence in the provider to make sure what is needed is done.  
 
Advocacy Memo 4 Summary Memo 
 
A life threatening or severe disease, such as cancer, can cause a patient to feel 
vulnerable. They may feel weak due to the effects of the illness itself or the physical 
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demand treatment has on their bodies. In this emotional support theme, we see that family 
members (spouses, parents, adult children, siblings) and medical professionals (Nurses or 
other providers) served as advocates. They take control of a situation and resolve the 
issue so that the patient does not need to worry about it. In this act they are a voice for the 
patient speaking up for their wellbeing, medical care, and needed health service. In 
providing this assistance, patients may feel supported and confident that someone else 
can take care of some thing for them while they focus on their treatment and survival.  
According to theory, emotional support is expected to be performed by family and 
friends. In this study several different family members (spouse, parent, adult child, 
sibling) engaged in advocating for the needs of the patient.  In the below quote from #26, 
the participant appears to speak with confidence about his spouse’s ability to handle the 
situation and ensure that whichever health decision was made would make the most 
economic sense.  
“My wife is a medical professional. She also is a person who is very conscious of 
what costs are and is not afraid to say, ‘We can't afford to have that type of 
service, even though you might want to have a 2nd or 3rd opinion, which is fine, 
we can deal with that. Unless, you can have that as a part of our insurance 
situation, I don't see.’ Your spouse can be skeptical of any 2nd or 3rd opinion just 
because they're out of network.” #26 (66-year-old, male, Prostate & Bladder) 
 
This example is in accordance with the role expectations of a spouse as they are expected 
to be a primary support. Having a spouse available to attend appointments and assist in 
treatment decisions can alleviate some of the responsibility and burden from the patient.  
Other family members can step into this primary supportive role as well. Parents 
may have past life experiences that prove to be useful as seen in the case of a 35-year-old, 
single female.  
“She [mother] got it from calling around and asking, because she had to do the 
same thing for my father who is disabled. So, she kind of knew the avenues.  For 
me she went in there.” #10 (35-year-old, female, Leukemia) 
 
Knowing the avenues to take when seeking medical treatment or navigating the insurance 
world can provide valuable assistance and guidance. In this case the patient’s mother was 
able to advocate for her to get disability assistance when she could no longer work due to 
her treatment. 
Similarly, adult children may be in the position to provide advocacy support as well. In 
the below excerpt a 60-year-old woman with three adult children comments on how one 
of her daughters encouraged her to have a voice in her medical care and decision-making 
processes. 
“She's really good at helping me advocate and encouraging me to use my voice 
because when you're in the middle of it's a whole different story. #6 (60-year-old, 
female, Lung Cancer) 
 
From the perspective of social support theory, Medical Professionals are in the 
formal support provider categories and expected to provide information and instrumental 
supports. In this study they provide emotional support as well.  In the next two excerpts 
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participants comment on their medical professionals getting them the services they 
needed. 
“I felt like my healthcare system was an advocate.” #22 (62-year-old, female, 
Breast Cancer) 
 
“Yes, she has become more of a friend and an advocate b/c she got on the phone 
and was talking to them and they paid attention to her.  I can barely walk—but I 
can’t use a walker or a cane—but she got on the phone and made them pay 
attention about it like the wheelchair back in December.  So that I can get around 
without being stuck in the house.” #2 (65-year-old, female, Breast Cancer) 
 
Having someone to advocate for you allows you to take a step back and let another 
person have control of part of the situation. This allows the patient to focus on their 
health and well-being.  
 
Conceptual Heading – What defines this theme? 
 
Provider supports the patient by ensuring their well-being and needs are met. Acts as a 
voice for the patient. 
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APPENDIX F: SITUATIONAL MAPPING 
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APPENDIX G: STUDY 1 REFLEXIVITY  
In order to further establish trustworthiness, this section will introduce me as the 
researcher providing background information that has prepared me for completing this 
research task.  
This is my sixth year in the PhD program at the University of Louisville, Kent 
School of Social Work.  I am a PhD Candidate and have successfully completed all 
required coursework and the comprehensive examination process. Coursework 
requirements included research design and analysis for both qualitative and quantitative 
studies. The in-depth course on qualitative analysis assisted in the development of the 
focus for this proposed study. Other coursework that has assisted in preparing me for this 
task includes theory and research ethics. 
In addition to my coursework, I have had the opportunity to work on qualitative 
and quantitative studies with several different professors at the university.  I have 
engaged in studies addressing the psychosocial needs of cancer patients as well as 
community needs analysis, teaching practices, and theory development. Working under 
the guidance of well-established professors has provided me with the skillset required to 
tackle this project. 
 Some skills cannot be learned through the classroom or university environment; 
instead, developed over life experiences. I am a non-traditional student obtaining my 
higher degree at an older age. Prior to returning to obtain my Master’s and PhD, I worked 
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in a variety of settings. The majority of my career was focused in mental health and child 
welfare. These positions helped to develop skills of empathy and understanding for the 
effects of oppression, life stressors, and varied life situations.   
Other positions I have held over the years have prepared me as well. I spent 
several years working in a laboratory processing materials for cancer screening. This 
position provided me with insight into the breadth of those affected by cancer and the 
importance of cancer screening awareness.  The final position that I will discuss may be 
most influential on my current studies. For several years I was a financial loan processor 
working with individuals who had poor credit ratings and excessive amounts of debt. In 
this position, I had the opportunity to meet with individuals who struggled financially. 
The experience was humbling and provided me with insight into how difficult it was for 
those individuals to seek financial assistance and to ask for help. 
In addition to my work history experience, I have had three family members who 
have experienced cancer: my grandmother, uncle and step-father. These family members 
have all died from the effects of having lung cancer and I was unaware of their financial 
concerns at the time of their cancer experiences. When speaking with my mother about 
her and my stepfather’s experience, she elaborated on the stress of the associated costs. 
Although they had adequate funds to afford him care, the expense was immense and the 
loss that much greater after he lost his battle. Additionally, although I do not know for 
certain, I suspect my uncle selected to not receive cancer treatment due to cost. He was 
diagnosed at a late stage and the cost/benefit may not have been in his favor. As for my 
grandmother, she would be considered lucky back then as they removed half of her lung 
and with the assistance of oxygen, she survived several years after.  
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All of my educational, career, and life experiences have led to the development of 
who I am as a researcher on this project. As I engaged in the analysis process, I was 
challenged to recognize who I am and how that may affect the interpretation of the 
participant’s experience.  It was my goal to allow the views of the participant to not be 
overshadowed by any preconceptions that I had.  
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APPENDIX H: CONSENT PREAMBLE  
 
Hello 
You are being invited to participate in a research study by answering the 
following survey about understanding the financial demands cancer patients may 
experience during and after treatment, as well as exploring their preferences for support 
and information.  There are no known risks for your participation in this research study.  
The information collected may not benefit you directly.  The information learned in this 
study may be helpful to others. The information you provide will be used to inform 
medical professionals about the information patients want and need regarding the costs of 
cancer treatment and available resources to assist them.   Your completed survey will be 
collected in a protected survey collection system and then stored on a password protected 
and secured computer.  The survey will take approximately 20-30 minutes to complete. 
Individuals from the University of Louisville Kent School of Social Work, the 
Institutional Review Board (IRB), the Human Subjects Protection Program Office 
(HSPPO), and other regulatory agencies may inspect these records. In all other respects, 
however, the data will be held in confidence to the extent permitted by law.  Should the 
data be published, your identity will not be disclosed. 
Taking part in this study is voluntary.  By completing this survey you agree to 
take part in this research study.  You do not have to answer any questions that make you 
uncomfortable. You may choose not to take part at all. If you decide to be in this study 
you may stop taking part at any time.  
If you have any questions, concerns, or complaints about the research study, 
please contact:  Dr. Kayser at [telephone number] 
If you have any questions about your rights as a research subject, you may call the 
Human Subjects Protection Program Office at [telephone number]. You can discuss any 
questions about your rights as a research subject, in private, with a member of the 
Institutional Review Board (IRB). You may also call this number if you have other 
questions about the research, and you cannot reach the research staff, or want to talk to 
someone else. The IRB is an independent committee made up of people from the 
University community, staff of the institutions, as well as people from the community not 
connected with these institutions. The IRB has reviewed this research study. 
If you have concerns or complaints about the research or research staff and you do not 
wish to give your name, you may call [telephone number]. This is a 24-hour hotline 
answered by people who do not work at the University of Louisville. 
This study is supported through a Doctoral Training Grant from the American 
Cancer Society and approved by the University of Louisville IRB: 17.0187. 
Sincerely, 
Karen Kayser, PhD and Lisa Smith, MSSW 
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APPENDIX I: STUDY 2 CALL FOR PARTICIPANTS 
What was your experience with the financial costs of cancer treatment? 
This study, conducted by researchers at the University of Louisville, is about the impact 
of cancer treatment on the financial well-being and quality of life of cancer survivors. 
We are inviting volunteers who have been diagnosed with breast cancer or blood 
(Leukemia, Lymphoma, or Myeloma) cancer within the past five years to participate in 
this study.  
This study is open to men and women 18 years and older. It involves taking a 20-30 
minute online survey and it is completely anonymous.   
By better understanding your experiences we may be able to help others navigate the 
financial terrain of cancer. 
If interested in participating follow this link to the survey. 
https://qmsweb.louisville.edu/blue/a.aspx?l=3325_1_AAAAAAAAaB8  
  
Please let me know if you have any question. 
Lisa Smith 
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APPENDIX J: STUDY 2 QUESTIONNAIRE  
  
Financial Impact of Cancer: Patient Preferences for Information and Support 
 
Introduction 
 This questionnaire is about your experience with cancer and the impact this has had 
on you financially. It attempts to explore your preferences to receiving information about 
you medical costs as well as explore helpful resources and supports you may have relied 
on. It will help us to assess the impact of the costs of cancer care and understand how to 
financially guide future cancer patients. All answers are completely confidential. This 
survey is expected to take about 30 minutes to complete.  
 
Section I Contextual Questions 
 
What type of cancer did you have? 
1- Blood cancer 
a. Leukemia 
b. Lymphoma 
c. Myeloma 
2- Breast cancer 
 
What type of cancer treatment did you receive? (Mark all that apply) 
1- Surgery 
2- Chemotherapy 
3- Radiation 
4- Stem Cell Transplant 
5- Immunotherapy 
6- Other _________________ 
 
What is the current status of your cancer? 
1- Active 
2- Remission 
3- Cured 
 
When were you first diagnosed with cancer? ___yr   (fill-in) 
 
When was your last cancer treatment? ___yr  ___month (fill-in) 
 
When you were diagnosed with cancer,  
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 Nothin
g at all 
A little 
bit 
Some Quite a 
bit 
Very 
Much 
How much did you understand your 
health insurance coverage? 
0 1 2 3 4 
How much did you understand about 
how much your treatment would cost? 
0 1 2 3 4 
How much did you understand how 
much you would have to pay out of 
pocket? 
0 1 2 3 4 
How much financial guidance did you 
received from your cancer clinic?  
0 1 2 3 4 
 
Which statement best describes your experience: 
1. Someone at the cancer center/hospital offered to help me understand my 
insurance, and medical costs. 
2. I asked someone at the cancer center/hospital for help in understanding my 
insurance and medical costs. 
3. I needed help understanding my insurance and medical costs but was not 
sure whom to ask. 
4. I did not need help in understanding my insurance and medical costs. 
5. Other_____ 
 
During your cancer experience: (Mark all that apply) 
 No 
One 
Doctor Financial 
advisor at 
cancer 
center 
Social 
worker 
Nurse Insura
nce 
compa
ny 
 
Who talked to you about your 
treatment costs?  
0 1 2 3 4 5 
Who talked to you about what 
your insurance would cover? 
0 1 2 3 4 5 
Who provided you with 
resources to get financial 
help? 
      
In your opinion, whom should 
talk patients about treatment 
costs, insurance coverage and 
resources?  (mark all that 
apply) 
0 1 2 3 4 5 
 
Was there ever a time during your cancer experience that you felt stressed about your 
financial situation (any time you were concerned about the cost of treatment, 
managing every day expenses, what your insurance might cover, etc.)?  0-No, 1- Yes 
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During your cancer experience: 
 Not at 
all 
A little 
bit 
Some-
times 
Quite a 
bit 
Very 
Muc
h 
Were you ever concerned about how 
you would pay for your medical 
expenses? 
 
0 1 2 3 4 
Were you ever concerned about how 
much your insurance would cover? 
0 1 2 3 4 
Were you ever concerned about how 
you would pay for every day expenses 
(food, rent, utilities, etc)? 
0 1 2 4 5 
 
Patients have reported to experience out-of-pocket expenses related to their cancer 
treatment and follow-up. These include travel, over-the-counter medications, 
supplies, childcare, increases in co-payments and insurance premiums. Over the 
course of your cancer treatment, what was your estimated out-of-pocket expense? 
1) $0 - $5000 
2) $5001 - $10,000 
3) $10,001 - $20,000 
4) $21,001 - $40,000 
5) More than $40,000 
If over $40,000, how much? _________________ 
 
What is your estimated post-treatment expense per year? (I.e. medical costs for 
follow-up visits, screening, medication, etc.). 
1) N/A  
2) $0 - $5000 
3) $5001 - $10,000 
4) Over $10,000 
If over $10,000, how much? ______ 
 
How many times per year do you receive post-treatment services (cancer screening, 
medical appointment, etc.)? _______ 
 
Due to your cancer experience:  
• Did your insurance ever deny a cancer-related medical claim?   
0 – No   1- Yes 
If yes, how many times? ________ 
 
• Did you file an appeal with your insurance provider for not covering cancer-
related medical claims?  0 – No   1- Yes 
If yes, how many times? ________ 
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• Did you contact your medical providers because of an error in their billing 
process?     0 – No   1- Yes 
If yes, how many times? ________ 
 
• Did your receive collection calls due to your medical bills? 0-No, 1- Yes 
 
• Did you file for bankruptcy? 0-No, 1- Yes 
 
 
Due to your cancer experience did you: 
 
 
Not at 
all 
A little 
bit 
Some-
times 
Quite 
a bit 
Very 
Much 
N/A 
Delay receiving treatment 0 1 2 3 4  
Stop receiving treatment 0 1 2 3 4  
Alter medication choices due to 
costs 
0 1 2 3 4  
Cut back on spending for food, 
clothing, entertainment 
0 1 2 3 4  
Modify your mortgage or rent 
payment 
0 1 2 3 4  
Negotiate bill payments 0 1 2 3 4  
Defer student loan payment 0 1 2 3 4  
Sell possessions 0 1 2 3 4  
Use credit cards 0 1 2 3 4  
Use retirement money 0 1 2 3 4  
Use savings 0 1 2 3 4  
Debt consolidation 0 1 2 3 4  
Use vacation time/money 0 1 2 3 4  
Eliminated expenses 0 1 2 3 4  
Gave up career/job 0 1 2 3 4  
Changed career/job 0 1 2 3 4  
Apply for patient grants 0 1 2 3 4  
Use employee sick-time 
assistance 
0 1 2 3 4  
Open a Go Fund Me account 0 1 2 3 4  
 
What helpful information or guidance did you receive regarding your treatment 
costs, payments, insurance, etc.?  (Mark all that apply) 
 [ ] Treatment options and costs.  
[ ] Insurance coverage. 
 [ ] Estimate on how much I would have to pay for treatment.    
[ ] Estimate on out-of-pocket expenses not covered by insurance would be. 
[ ] Eligibility for disability. 
[ ] Eligibility for FMLA. 
[ ] Eligibility for Medicare/Medicaid. 
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[ ] Student loan deferment. 
[ ] Resources to help pay for treatment costs. 
[ ] Resources to help pay for medications. 
[ ] Resources to help pay for every-day living expenses. 
[ ] other ___________________ 
 
 
 
Do you feel the following information would be helpful to receive when diagnosed 
with cancer: 
 Not at 
all 
A little 
bit 
Some-
times 
Quite a 
bit 
Ver
y 
Muc
h 
Treatment options and their costs. 
 
0 1 2 3 4 
What your insurance will cover. 0 1 2 3 4 
Estimated costs you will have to pay. 0 1 2 3 4 
How to file an appeal with your 
insurance company? 
0 1 2 3 4 
Estimated out-of-pocket expenses on 
items that are not covered by 
insurance. 
0 1 2 3 4 
Eligibility for disability 0 1 2 3 4 
Eligibility for the Family and Medical 
leave Act (FMLA). 
0 1 2 3 4 
Eligibility for Medicare/Medicaid 0 1 2 3 4 
Financial resources to help pay for 
medications? 
0 1 2 3 4 
Financial resources to help pay for 
treatment costs? 
0 1 2 3 4 
Financial resources to help pay for 
every-day living expenses (rent, food, 
etc.) 
0 1 2 3 4 
Who to talk to about financial 
questions and concerns. 
0 1 2 3 4 
 
 
What other financial information do you think would be helpful to give to patients 
when they are diagnosed with cancer? _______________________________________ 
 
 
How much do you agree with these statements? 
 Not at 
all 
A little 
bit 
Some-
times 
Quite a 
bit 
Very 
Much 
  250 
Doctors should consider treatment 
costs and insurance coverage before 
making treatment recommendations. 
0 1 2 3 4 
Patients should consider treatment 
costs and insurance coverage before 
making treatment decisions. 
0 1 2 3 4 
During my cancer experience, I had all 
the information I needed to make a 
decision about treatment. 
0 1 2 3 4 
I would seek cancer treatment for no 
matter what the cost. 
0 1 2 3 4 
 
During your cancer experience, did you receive tangible financial support or 
assistance from: 
 Not at 
all 
A little 
bit 
Somew
hat 
Quite a 
bit 
Ver
y 
muc
h 
Parents/Parents-in-law 0 1 2 3 4 
Children 0 1 2 3 4 
Friends 0 1 2 3 4 
Co-workers/Employer  0 1 2 3 4 
Faith-based Community  0 1 2 3 4 
Non-Profit Organizations 0 1 2 3 4 
Medical Center 0 1 2 3 4 
Pharmaceutical Company 0 1 2 3 4 
Other  0 1 2 3 4 
 
Section II Financial Toxicity Scale (Cost-Prom) 
 
Below is a list of statements related to the financial impact of your illness. Please place 
an X in the box that best describes how you feel about that statement. 
 Not at 
all 
A little 
bit 
Some-
times 
Quite a 
bit 
Very 
Much 
I feel financially stressed. 0 1 2 3 4 
I am satisfied with my current 
financial situation. 
0 1 2 3 4 
I worry about the financial problems I 
will have in the future as a result of 
my illness or treatment. 
0 1 2 3 4 
I am frustrated that I cannot work or 
contribute as much as I usually do. 
0 1 2 3 4 
My cancer or treatment has reduced 
my satisfaction with my present 
financial situation. 
0 1 2 3 4 
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I feel in control of my financial 
situation. 
0 1 2 3 4 
I am able to meet my monthly 
expenses. 
0 1 2 3 4 
I know that I have enough money in 
savings, retirement or assets to cover 
the costs of my treatment. 
0 1 2 3 4 
I am concerned about keeping my job 
and income, including working at 
home.  
0 1 2 3 4 
I feel I have no choice about the 
amount of money I spend on care. 
0 1 2 3 4 
My out of pocket medical expenses are 
more than I thought they would be. 
0 1 2 3 4 
 
Section III Perceived Social Support 
 
PROMIS -Emotional Support (Please respond to each item by marking one box per 
row.) 
 Never Rarely Some-
times 
Usually Alw
ays 
I have someone who will listen to me 
when I need to talk. 
1 2 3 4 5 
I have someone to confide in or talk to 
about myself or my problems. 
1 2 3 4 5 
I have someone who makes me feel 
appreciated. 
1 2 3 4 5 
I have someone to talk with when I 
have a bad day. 
1 2 3 4 5 
 
PROMIS - Informational Support (Please respond to each item by marking one box 
per row.) 
 Never Rarely Some-
times 
Usually Alw
ays 
I have someone to give me good 
advice about a crisis if I need it. 
1 2 3 4 5 
I have someone to turn to for 
suggestions about how to deal with a 
problem. 
1 2 3 4 5 
I have someone to give me 
information if I need it. 
1 2 3 4 5 
I get useful advice about important 
things in life. 
1 2 3 4 5 
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PROMIS - Instrumental Support (Please respond to each item by marking one box 
per row.) 
 Never Rarely Some-
times 
Usually Alwa
ys 
Do you have someone to help you if 
you are confined to bed? 
1 2 3 4 5 
Do you have someone to take you to 
the doctor if you need it? 
1 2 3 4 5 
Do you have someone to help with 
your daily chores if you are sick? 
1 2 3 4 5 
Do you have someone to run errands if 
you need it? 
1 2 3 4 5 
Section IV Received Social Support 
 
We are interested in learning about some of the ways that you feel people have helped you 
or tried to make life more pleasant for you over the past four weeks. Please read each item 
carefully and indicate how often these activities happened to you during the past four 
weeks. 
 Not at 
all 
Once or 
twice 
About 
once a 
week 
Several 
times a 
week 
Abou
t 
every 
day 
Gave you some information on how to 
do something. 
1 2 3 4 5 
Helped you understand why you didn’t 
do something well. 
1 2 3 4 5 
Suggested some action you should 
take. 
1 2 3 4 5 
Gave you feedback on how you were 
doing without saying it was good or 
bad. 
1 2 3 4 5 
Made it clear what was expected of 
you. 
     
Told you what he/she did in a situation 
that was similar to yours.  
1 2 3 4 5 
Told you that he/she feels close to you. 1 2 3 4 5 
Let you know that he/she will always 
be around if you need help.  
1 2 3 4 5 
Told you that you are OK just the way 
you are.  
1 2 3 4 5 
Expressed interest and concern in your 
well-being. 
1 2 3 4 5 
Comforted you by showing you some 
physical affection. 
1 2 3 4 5 
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Told you that he/she would keep the 
things you talk about private. 
1 2 3 4 5 
Agreed that what you wanted to do 
was the right thing. 
1 2 3 4 5 
Did some activity together to help you 
get your mind off things.  
1 2 3 4 5 
Gave or loaned you over $25 1 2 3 4 5 
Provided you with a place to stay. 1 2 3 4 5 
Loaned you or gave you something (a 
physical object) that you needed. 
1 2 3 4 5 
Pitched in to help you do something 
that needed to get done.  
1 2 3 4 5 
Went with you to someone who could 
take action. 
1 2 3 4 5 
Section V Financial Social Support 
 
 Never Rarely Some-
times 
Usually Alw
ays 
I have someone to talk to about my 
financial concerns. 
 
1 2 3 4 5 
I know where to get information about 
financial assistance to help with my 
cancer expenses. 
1 2 3 4 5 
I know where to get information about 
financial assistance to meet my 
everyday obligations (rent, food, 
utilities, etc.). 
1 2 3 4 5 
I am able to request financial help when 
needed. 
1 2 3 4 5 
I have friends or family who can help 
me financially if needed. 
1 2 3 4 5 
 
During your cancer experience, did you talk to a family member or friend about your 
financial concerns about treatment costs, lost wages, out-of-pocket expenses, etc.?  0- 
No; 1- Yes 
 
• If No, what prevented you from talking about your financial concerns or stress? 
(open-ended)  _________ 
• If yes, who did you talk to (spouse, child, parent, best friend, pastor, etc.)  
__________ 
 
Section VI Quality of Life (Fact-G Version 4) 
Below is a list of statements that other people have said are important.  Please circle or 
mark one number per line to indicate your response as it applies to the past 7 days.  
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Physical Well-Being 
 Not at 
all 
A little 
bit 
Somew
hat 
Quite a 
bit 
Very 
much 
I have a lack of energy. 0 1 2 3 4 
I have nausea. 0 1 2 3 4 
Because of my physical condition, I 
have trouble meeting the needs of my 
family. 
0 1 2 3 4 
I have pain. 0 1 2 3 4 
I am bothered by side effects of 
treatment. 
0 1 2 3 4 
I feel ill. 0 1 2 3 4 
I am forced to spend time in bed. 0 1 2 3 4 
Please circle or mark on number per line to indicate your response as it applies to 
the past 7 days. 
Social/Family Well-Being 
 Not at 
all 
A little 
bit 
Somew
hat 
Quite a 
bit 
Very 
much 
I feel close to my friends. 0 1 2 3 4 
I get emotional support from my 
family. 
0 1 2 3 4 
I get support from my friends. 0 1 2 3 4 
I am satisfied with family 
communication about my illness. 
0 1 2 3 4 
I feel close to my partner (or the 
person who is my main support). 
0 1 2 3 4 
Regardless of your current level of sexual activity, please answer the following 
question. If you prefer not to answer it, please mark this box ☐ and go to the next 
section.  
I am satisfied with my sex life.  0 1 2 3 4 
 
Emotional Well-Being 
 Not at 
all 
A little 
bit 
Somew
hat 
Quite a 
bit 
Ver
y 
muc
h 
I feel sad. 0 1 2 3 4 
I am satisfied with how I am coping 
with my illness. 
0 1 2 3 4 
I am losing hope in the fight against 
my illness. 
0 1 2 3 4 
I feel nervous.  0 1 2 3 4 
I worry about dying.  0 1 2 3 4 
  255 
I worry that my condition will get 
worse.  
0 1 2 3 4 
 
Functional Well-Being 
 Not at 
all 
A little 
bit 
Somew
hat 
Quite a 
bit 
Ver
y 
muc
h 
I am able to work (include work at 
home). 
0 1 2 3 4 
My work (include work at home) is 
fulfilling. 
0 1 2 3 4 
I am able to enjoy life. 0 1 2 3 4 
I have accepted my illness. 0 1 2 3 4 
I am sleeping well. 0 1 2 3 4 
I am enjoying the things I usually do 
for fun. 
0 1 2 3 4 
I am content with the quality of my 
life right now.  
0 1 2 3 4 
Please circle or mark on number per line to indicate your response as it applies to 
the past 7 days. 
Economic Well-Being  
 Not at 
all 
A little 
bit 
Somew
hat 
Quite a 
bit 
Very 
much 
I believe that being sick will hurt me 
financially. 
0 1 2 3 4 
People like me are able to get the 
healthcare they need. 
0 1 2 3 4 
I am able to make enough money to 
pay for my healthcare. 
0 1 2 3 4 
I have to pay more for my medical 
care than I can afford.  
0 1 2 3 4 
I am able to pay for my medical bills. 0 1 2 3 4 
I can easily get information about 
healthcare. 
0 1 2 3 4 
I can afford medical check-ups even 
when I am not sick. 
0 1 2 3 4 
I have enough money to take care of 
my healthcare needs.  
0 1 2 3 4 
I can get the health insurance we need. 0 1 2 3 4 
My family thinks good healthcare is 
important. 
0 1 2 3 4 
I know how to get the healthcare 
services I need. 
0 1 2 3 4 
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I know people who will help me out 
when I am sick. 
0 1 2 3 4 
People I know best have healthy 
habits. 
0 1 2 3 4 
I understand the healthcare system. 0 1 2 3 4 
The medicine I need is too expensive 
for me. 
0 1 2 3 4 
I am treated the same as other patients 
when I go for medical care. 
0 1 2 3 4 
Healthcare services are easy to get in 
my neighborhood. 
0 1 2 3 4 
 
 
 
Section VII Social Constraints 
 
How often in the PAST MONTH has someone: 
 Not at 
all 
A little 
bit 
Some 
-times 
Qui
te a 
bit 
Very 
often 
Changed the subject when you tried to 
discuss your illness? 
0 1 2 3 4 
How often did it seem that other people 
did not understand your situation? 
0 1 2 3 4 
How often did other people avoid you? 0 1 2 3 4 
How often did other people minimize 
your problems? 
0 1 2 3 4 
How often did other people seem to be 
hiding their feelings? 
0 1 2 3 4 
How often did other people act 
uncomfortable when you talked about 
your illness? 
0 1 2 3 4 
How often have other people trivialized 
your problems? 
0 1 2 3 4 
How often have other people complained 
about their own problems when you 
wanted to share yours? 
0 1 2 3 4 
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How often did other people act cheerful 
around you to hide their true feelings and 
concerns? 
0 1 2 3 4 
How often did other people tell you not 
to worry so much about your health?  
0 1 2 3 4 
How often did other people tell you to try 
not to think about the cancer? 
0 1 2 3 4 
How often did you get the idea that other 
people didn’t want to hear about your 
financial concerns? 
0 1 2 3 4 
How often did you feel as though you 
had to keep your feelings about your 
cancer to yourself because they made 
other people uncomfortable? 
0 1 2 3 4 
How often did other people make you 
feel as though you had to keep your 
feelings about your cancer to yourself, 
because it made others upset? 
0 1 2 3 4 
How often did you feel other people let 
you down by not showing you as much 
love and concern as you would have 
liked?  
0 1 2 3 4 
How often did you feel that you could 
discuss your feelings about your cancer-
related financial concerns with (other 
people/important other) when you wanted 
to? 
0 1 2 3 4 
 
Section VIII Brief Health Literacy Screening Tool (BRIEF) 
 
Please circle the answer that best represents your response. 
 Always Often Some- 
times 
Rarely Nev
er 
How often do you have someone help you 
read hospital materials? 
1 2 3 4 5 
How often do you have a problem 
understanding the written materials about your 
medical condition? 
1 2 3 4 5 
How often do you have a problem 
understanding what is told to you about your 
medical condition?  
1 2 3 4 5 
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 Not at 
all 
A little 
bit 
Some-
what 
Quite a 
bit 
Extr
emel
y 
How confident are you filling out medical 
forms by yourself?  
1 2 3 4 5 
 
 
Do you have any final thoughts or advice you would like share regarding the 
financial impact you have experienced due to your cancer experience?  ___________ 
 
 
 
________________________________________________________________________  
 
 
 
Section IX Demographic Questions 
 
Home zip code: 
 
How old are you? ____ (age in years) 
 
Gender:    
Are you male or female? 
1- Male  
2- Female 
 
Race/Ethnicity 
What is your racial/ethnic group? 
7- African-American/Black 
8- Asian 
9- American Indian/Alaskan Native 
10- Caucasian/White 
11- Hispanic 
12- Native Hawaiian/Other Pacific Islander 
13- Other __________________________ 
 
What is your current marital status?  
6- Single, never married 
7- Married 
8- Not married, but in a relationship with significant other 
9- Separated or divorced 
10- Widowed 
  
How many children under the age of 18 are living in your home?  _____ 
 
What is your current job status? 
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7- Employed full-time 
8- Employed part-time 
9- Unemployed 
10- Homemaker 
11- Disabled 
12- Retired 
 
Before your cancer diagnosis, what was your job status?  
7- Employed full-time 
8- Employed part-time 
9- Unemployed 
10- Homemaker 
11- Disabled 
12- Retired 
 
If your job status changed, did it change because of your cancer? 0 – No 1- Yes 
 
Did you have to leave your job temporarily to receive cancer treatment or recover? 
0 – No   1- Yes 
 
Did you have to leave your job permanently due to your cancer? 0 – No   1- Yes 
 
What was your insurance status at your first cancer diagnosis? (Check all that 
apply) 
1- Employer paid private insurance 
2- Self-paid private insurance 
3- Veteran’s Administration coverage 
4- Medicare disability insurance 
5- Medicaid 
6- No insurance 
Has your insurance status changed since your first cancer diagnosis? 0 – No   1- Yes 
 
If yes, which of the following insurance changes did you experience? 
1- I lost my because I can no longer work 
2- I lost my insurance because I can no longer afford it 
3- I became eligible for Medicaid 
4- I became eligible for Medicare disability 
 
What is your current insurance status? (Mark all that apply) 
1- Employer paid private insurance 
2- Self-paid private insurance 
3- Veteran’s Administration coverage 
4- Medicare disability insurance 
5- Medicaid 
6- No insurance 
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What is the highest level of formal education that you have completed? 
6- Less than high school 
7- Completed high school or GED 
8- Some college or technical school (includes technical, vocational, or certificate 
program and Associate’s degree) 
9- Bachelor’s degree 
10- Postgraduate or professional degree (includes Master’s, MD, PhD, and JD) 
 
What is your occupation? 
7- Homemaker 
8- Executive of manager 
9- Professional or technical 
10- Clerical, sales or service work 
11- Occupation in agriculture, forestry or fisheries 
12- Occupation in crafts, repair, manufacturing, transportation or operation of 
machinery 
What were your household (family) gross wages or income last year (before taxes)? 
7- Less than $25,000 
8- $25,001-$40,000 
9- $40,001-$60,000 
10- $60,001-$80,000 
11- Over $80,000 
12- I don’t know 
 
 
 
 
 
Thank you for your help. 
 
If you would be willing to participate in any follow-up questions or related studies please 
provide your name and email address/method to contact you. 
 
_______________________________________________ 
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APPENDIX K: QUANTITATIVE STRAND TABLE OF VARIABLES 
 
 Study 2 overview of variables, measurements, and level of measure.    
 
Variables Measure Level of 
Measure 
Independent Variable   
Financial Burden of Cancer COST – Comprehensive Score for 
Financial Toxicity  
• 11-item, self-rated Likert scale 
(0 = Not at All to 5 = Very 
Much) 
Interval 
Moderator/Mediator 
Variable 
Social Support – Perceived 
 
 
 
 
Social Support - Received 
 
PROMIS – Emotional, Informational, 
& Instrumental short scales 
• Each scale has 8-items, 5-point 
Likert scale 
 
Inventory of Socially Supportive 
Behaviors (ISSB) 
• 40-item, 5-point Likert scale 
 
Interval 
 
 
 
 
Interval 
Criterion/Dependent 
Variable 
Quality of Life  
• Domains: Physical, 
Functional, Social & 
Emotional 
 
• Doman: 
Socioeconomic 
 
 
 
FACT-G   
• 28 –item Likert scale (0 = Not 
at All to 4= Very Much).  
 
Socioeconomic Well-Being Scale  
• 17-item Likert scale (0 = Not at 
All to 4= Very Much) 
 
 
Interval 
 
 
 
Interval 
Contextual Characteristics 
• Cancer type,  
• Cancer treatment, 
• Disease status, 
• Elapsed time since 
cancer Treatment 
 
See questionnaire for specific 
questions. 
 
Nominal/ 
Ordinal 
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Covariate 
• Social Constraint 
 
Social Constraint Scale 
• 16 item Likert scale. 
 
Interval 
Covariate/Descriptive 
• Age,  
• Gender, 
• Race/Ethnicity, 
• Marital Status, 
• Employment, 
• Education 
• Insurance Status, 
• Income 
 
 
See questionnaire for specific 
questions. 
 
Interval/ 
Nominal/ 
Ordinal 
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APPENDIX L: PREPARING DATASET 
 
Overview of Steps 
1. Downloaded responses – n=131 – one deleted for missing data; deleted 4 for 
various types of cancer other than blood or breast (Colon, Kidney, Lung, Other- 
not specified).  
2. Created SPSS database with blood and breast cancer patients. 
3. Reverse coded variables and calculated scales. 
4. Created Composite variable for Social Support. 
5. Tested for assumptions.  
6. Dummy variables were created for control variables.  
 
Calculate Scales and Handling Missing Values 
 
Cost scale 
Missing values (4) were replaced with a simple mean substitution.  This is the 
method the developers of the scale specified to use for missing data (de Souza). 
Following guidelines, items 2,6,7,8 were reverse scored and all items were totaled using 
SPSS (reverse codes 0-4, 1-3,2-2). In review of the data an outlier was found. Upon 
review of that case it was determined that a response was not entered correctly into SPSS. 
The correct response was determined by reviewing the original excel data file. Possible 
score range is 0-44. The higher the score, the worse the financial toxicity. A standard 
frequency distribution was conducted using SPSS. A mean score of 19.14 (SD = 8.56) 
range 0-44. See tests for assumptions and table for skewness and kurtosis for more 
information.  
PROMIS Social Support scales 
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 Guidelines for scoring the three PROMIS Social Support scales were followed. 
The short form for each domain was used. Two responses were missing and these where 
replaced with the mean score of participants responses as directed by the scale guidelines 
obtained from the Assessment Center (assessmentcenter.net). Raw scores were calculated 
and then translated to the designated T-score for each scale. The T-score allows the 
evaluation against the general U.S. population. A score of 50 (SD – 10) was determined 
by scale developers to be the average of the reference. 
Composite Variable. A social support composite variable was created out of 
Social Support PROMIS scales following the direction of Song, Lin, Ward and Fine 
(2013). The variables created a meaning full grouping and were correlated but not highly 
correlated. A simple average approach was used as the scales are continuous. Z scores 
should be used when the original variables differ in variance with the outcome variable. 
This was not an issue but to verify such a second composite variable was created using Z 
scores and both composite variables were compared showing similar distribution.  
Creating a composite variable can control for Type 1 errors (rejecting the null hypothesis 
– supporting the hypothesis when it should be rejected). Power analysis were conducted 
to justify creating a composite variable opposed to using the Bonferroni correction. 
Power was high for all variables. 
Steps used to create an equal weighted composite in SPSS:  Transform à 
Compute variable à (Add each scales )/3. 
Received Social Support 
The short form for the Inventory of Socially Supportive Behaviors (ISSB) was 
used to measure the amount of social support received. Following study guidelines for 
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scoring, 7 missing values were replaced with a simple mean substitution. Per scale 
tabulation instructions, mean substitution was calculated from all participant responses 
for that item.  To obtain a total score, all items were then summed.  
Social Constraint 
Social Constraint required recoding of question 16. Mean substitution was used 
for 3 missing responses. All items were summed. The higher the score the more social 
constraint. 
Quality of Life 
Functional Assessment of Cancer Therapy scale (FACT-G) and the FACT-G plus 
socio-economic well-being scales were used to determine quality of life. Reversal of 
questions were followed: Physical Well-being subscale all 7 items; Emotional Well-being 
subscale item 1,3,4,5,6; Economic Well-being subscale items 1,4,15. Followed scale 
guidelines for missing data which involved adding up the individual’s responses for that 
subscale and dividing by the number responded to.  
Tests for Assumptions 
Prior to conducting the analyses for the study aims, the data was reviewed to 
determine if it met the assumptions for analysis. Box and Whisker plots were created to 
identify outliers. Outliers were identified; therefore, additional analysis used histograms, 
skewness and kurtosis values, and the interquartile range (IQR). Outliers were all within 
the 1.5 IQR range so these observations stayed in the data pool. 
 Tests for normal distribution were conducted. Shapiro-Wilks raised concern over 
all scales expect the FACT-G. Upon further inspection of (histograms, skewness and 
kurtosis values) all scales appeared to meet expectations for normality except for social 
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constraint. Final decision as based off the robustness of the sample size being large 
enough to advert issues of normality. Further, the PROCESS model used for the Mediator 
analysis uses bootstrap technique at 5000 samples to handle issues of non-normal 
distribution.  
Issue of multicollinearity were examined through Pearson’s Correlations. 
Variables were not too highly correlated. The received support variable in the blood and 
breast cancer dataset was not properly correlated with other variables; more information 
can be found in Chapter 6 and 7. To determine if the data had issues of linearity or 
heteroscedasticity, scatter plots and linear regressions were used. All data appeared to be 
linear and homoscedastic.  
Outliers 
Outliers can lead to Type I and Type II errors (Tabachnick, et al., 2013); 
therefore, careful review of the data was conducted. The presence of outliers was 
assessed a box and whisker plot assessment. The box and whisker plot in SPSS indicate if 
an observation is over 1.5 Inter-quartile Range (IQR) rule. SPSS calculates the upper and 
lower quartiles and then multiplies the difference by 1.5. Any observation beyond this 
calculation would be indicated as an outlier. According to Hoaglin and Iglewicz (1987), 
this IQR rule can be incorrect about 50% of the time and a more appropriate indicator is 
at a multiplication of 2.2. This requires that the researcher review any outliers indicated 
by SPSS. Box and whisker plots were reviewed and assessed for outliers. 
Creating Box and Whisker Plot for Outliers. 
Steps in SPSS: 
1) Select Graphs 
2) Legacy Dialog 
3) Boxplot 
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4) Simple 
5) Define 
6) Select the variable you want to examine into the Variable box. 
7) Select a categorical variable for the x-axis. 
8) Select OK 
Normal Distribution 
Distribution was check by using the Shapiro-Wilks Analysis, Skewness and 
Kurtosis and if the absolute value was less than the value of the standard error multiplied 
by 3. The data size is large enough (n= 126) that the assumption of normality is not a 
concern (reference Lawson email and StatistisHowTo.com) 
Shapiro-Wilks. SPSS Steps: 
1) Analyze  
2) Descriptive Statistics 
3) Explore 
4) Select data into Dependent List 
5) Select Plots  
a. Select Normality plots with tests 
6) Significance indicates not normal distribution.  
In order to check for normality a normal distribution of data a Shapiro-Wilks analysis 
was conducted on all scales. The Quality of Life FACT -G scale was found to be not 
significant (p < 0.118). This indicated that the data was normally distributed. The 
remaining scales were found to be significant: FACT-G with Economic Well-being (p < 
0.02), COST (p <0.001), Social Constraint (p < 0.000), Received Social Support (p < 
0.03), Emotional, Informational and Instrumental Social Support each (p < 0.001), 
Composite Social Support (p < 0.001).This infers that the data for these scales is not 
normally distributed and required further investigation. 
Skewness and Kurtosis. In order to check for normal distribution of data a 
descriptive analysis was conducted to identify skewness and kurtosis. When assessing for 
skewed data, a zero value indicates the distribution tail is equal on both sides. A 
positively skewed data has the tail on the right and negatively skewed has the tail on the 
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left. The further the calculated value is from zero the more likely it indicates a non-
normal distribution. A value between -1 and +1 is typically within normal range. Another 
method to determine normal distribution is to determine interquartile range (i.e., if the 
absolute value is less than the value of the standard error multiplied by 3). For this later 
assessment, two scales raise some concern as their values are slightly above the 
acceptable range (see table for values). For these two scales, bootstrapping analysis will 
need to be implemented. Kurtosis is the assessment of the peak of the distribution. It 
indicates if the peak is too sharp or too flat. Using the same assessment as above, there 
does not appear to be any issues with kurtosis. All scales were further viewed using 
scatter plots and histograms for interpretation of normative data. 
Table Appendix.1: Skewness and Kurtosis Values. 
Variable Skewness Kurtosis 
COST  0.354 0.732 
Emotional Support -0.303 -0.830 
Informational Support -0.232 -0.658 
Instrumental Support -0.159 -0.90 
Composite Support -.265 -.954 
Received Support 0.1.43 -0.835 
Social Constraint 0.755 -0.481 
FACT-G -0.353 -0.376 
FACT-G Plus -0.351 -0.456 
COST Comprehensive Score for Financial Toxicity, FACT-G Functional Assessment of 
Cancer Therapy scale for QoL, FACT-G Plus Socioeconomic Well-being scale. 
 
Linearity  
SPSS steps to create scatter plot using criterion variable (predicted variable). 
1) Graphs à Legacy Dialog à Scatter/Dot à Select Simple à Define 
2) Move dependent variable to Y Axis and independent variable to X Axis 
3) Double click on chart. Select fit line.  
4) Scatter plots looked acceptable. (Received social support looked concerning but 
had a slight linear relationship.) 
Test for Homoscedasticity 
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Homoscedasticity results if you have a consistent relationship across the page. 
Heteroscedasticity exists if the relationship is erratic which is not desired. Scatter plots 
were conducted on all scales with no issues of heteroscedasticity. 
SPSS steps to create plot to examine homoscedasticity.  
1) Analyze 
2) Select Regression 
3) Select Linear 
4) Put scale interested in Dependent and another variable in the Independent  
5) Plots – put ZRESID in Y axis and ZPred in X axis 
6) Continue and OK 
7) Double click on the table and select “fit line” on the plot. Want line to be flat.  
This provides the predictor on the x axis and error on the y axis.  
Multicollinearity 
Multicollinearity occurs when two IVs are highly correlated. Pearson’s 
Correlation was run to check for correlations (desired r < .80). All scales were below r = 
.80 except FACT-G and FACT-G Plus. This is expected as they are partially the same 
scale and will not be run in the same analysis.   
Reliability  
 Scale reliability analysis were conducted to ensure the scale reflects the construct 
it is measuring. 
Steps in SPSS: 
1) Analysis 
2) Scale  
3) Reliability analysis 
4) Select all items of each scale. 
5) Model: Alpha 
6) Select Run 
Dummy Variables 
Multiple regression cannot handle a nominal variable with more than 2 levels. 
Dummy variables were created for variables that theoretically may impact the outcome 
variable. Items were recoded with 0 or 1 with zero = other and 1 = category of interest.  
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APPENDIX M: PEARSON BIVARIATE CORRELATIONS 
 
Pearson’s bivariate correlations were used to determine if relationships between 
interval/ratio level variables exist (Meyers et al., 2013; Field, 2013; Lawson et al., 2014). 
Pearson’s correlation report if items are negatively or positively correlated. Accepted 
affect values are basic Cohen conversions: -1 to -0.51 equals strong negative correlation; 
-0.5 to -0.20 equals moderate negative correlation; -0.19 to -0.01 equals weak negative 
correlation; 0.00 equals no correlation; 0.01 to 0.19 equals weak positive correlation; 0.2 
to 0.50 equals moderate positive correlation; 0.51 to 1 equals a strong positive 
correlation. If assumptions are not met and the data contains outliers or is not normally 
distributed, correlations can be determined using a rank order method: Spearman’s rho or 
Kendall’s tau (Lawson et al. 2014; Fields, 2013).  
Analysis Plan to Determine Co-variables (adapted from Lawson et al., 2014 Chapter 6) 
Study Question: What is the relationship between quality of life and 
interval/ratio variables listed below? 
• Age 
• Social Support 
• Financial Burden 
• Social constraint 
Hypothesis:   Experimental: There is a relationship between quality of 
life and variables. 
 Null:  There is no significant relationship.  
Expected: There will be no relationship between quality of life and the 
identified variables. 
Assumptions: Interval level data, normal distributions 
SPSS steps for analysis:   
Analyze à Scroll down to correlate à Bivariate à Pearson 
(1) Select variables 
(2) OK to run 
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APPENDIX N: ANALYSIS OF VARIANCE 
 
 Analysis of Variance (ANOVA) was used to determine if there are relationships 
between quality of life (DV) and any nominal/ordinal variables in this study. The 
ANOVA will report if any significant differences occur between the groups in the 
analysis; therefore, indicating a variable that may affect the outcome.  
Analysis Plan (adapted from Lawson, et al., 2014 – Chapter 2) 
Study Question: Is there a difference in quality of life between 
[nominal/ordinal variable categories]? 
• Disease Status 
• Gender 
• Race/Ethnicity 
• Marital Status 
• Education 
• Employment 
• Insurance Status 
• Treatment 
Hypothesis:   Experimental: There is a difference in quality of life 
between [nominal/ordinal variable categories]. 
 Null:  There is no significant difference.  
Expected: There will be no significant difference.  
Type of Design: Non-Experimental Ex Post Facto  
Assumptions: Nominal/Ordinal IV, Interval/ratio DV, normal 
distributions 
SPSS Steps for Analysis:  
Analyze à Select General Linear Model à Univariate  
(3) Move Quality of life (DV) into Dependent box 
(4) Move [nominal/ordinal level variable] (IV) into Factor box 
(5) Select options: Descriptive, Estimates of Effect Size, Observed Power 
and Homogeneity of Variance Test  
(6) Run Analysis 
Partial eta-squared effect sizes (Lawson, et al., 2014): 
 0.010 = small effect size 
 0.059 = medium effect size 
 0.138 = large effect size 
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Power 
As the statistical power increase the chances of making a Type II error and 
wrongly rejecting the null hypothesis decreases. More power to decrease risk of Type II 
error.  
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APPENDIX O: MODERATION ANALYSES IN PROCESS 
 Hierarchical stepwise multiple regression analysis will be simulated through the 
Introduction to Mediation, Moderation, and Conditional Process Analysis (PROCESS) 
macro.  
Analysis Plan (adapted from Lawson, et al., 2014 – Chapter 7) 
Level of Measurement: IV interval/ratio level; DV interval/ratio level 
Type of Design: Non-Experimental Ex Post Facto  
Number of Samples: One sample  
Assumptions: Interval/ratio level data, normal distributions, linear 
relationship (scatter plot), homoscedasticity (error and 
model fit), not multicollinearity. Sample size, 
misspecification of variables? 
Possible control variables:  Interval: social constraint, 
Ordinal/Nominal:  cancer treatment, education, 
employment, insurance status, and marital status. 
  
SPSS Steps for PROCESS Moderation Analysis 
1. Select Analysis 
2. Select Regression 
3. Select PROCESS 
4. Put Social Support in Proposed Moderator W box and Financial burden in X 
variable Box  
5. Put Quality of life in the Y Variable box 
6. Select Model #1 (or 3 for Moderated Moderator) 
7. Select Options 
a. Select Mean Center, Visualizing Interactions, Regression Coefficients, 
Heteroscedasticity  
8. Click continue 
9. OK to run 
10. Moderator effect is indicated by significant model fit (overall, for each variable 
and for interaction). 
11. If significant – run again with covariates (dummy variable covariates) 
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12. Move: Cancer Treatment, Education, Employment, Insurance and Marital Status 
(items selected due to outcomes of ANOVA analysis to see if these variables 
played a role). 
13. OK to run 
14. Remove non-significant variables from the equation. 
15. Add Social Constraint to Moderator Z box. 
16. Select Model 3 (Model 3 used because Social Constraint is a continuous 
variables) 
 
Example: SPSS Output for Moderation Analysis 
 
Received Social Support moderates the relations between Financial Toxicity and Quality 
of Life (Fact-G). 
 
*************** PROCESS Procedure for SPSS Version 3.3 ******************* 
 
          Written by Andrew F. Hayes, Ph.D.       www.afhayes.com 
    Documentation available in Hayes (2018). www.guilford.com/p/hayes3 
 
************************************************************************
** 
Model  : 1 
    Y  : QoL 
    X  : COST 
    W  : RecSS 
 
Sample 
Size:  106 
 
************************************************************************
** 
OUTCOME VARIABLE: 
 QoL 
 
Model Summary 
          R       R-sq        MSE     F(HC0)        df1        df2          p 
      .6213      .3861   253.5251    18.1830     3.0000   102.0000      .0000 
 
Model 
                   coeff    se(HC0)          t                  p       LLCI       ULCI 
constant    67.0876     1.5141    44.3072      .0000    64.0842    70.0909 
COST        -1.4101     .2153    -6.5484        .0000    -1.8372     -.9830 
RecSS       .3198      .1041        3.0733        .0027      .1134      .5262 
Int_1         .0335      .0141        2.3773        .0193      .0056      .0615 
 
Product terms key: 
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 Int_1    :        COST     x        RecSS 
 
Covariance matrix of regression parameter estimates: 
           constant       COST      RecSS      Int_1 
constant     2.2926      .0743     -.0319     -.0020 
COST          .0743      .0464     -.0012     -.0017 
RecSS        -.0319     -.0012      .0108      .0003 
Int_1        -.0020     -.0017      .0003      .0002 
 
Test(s) of highest order unconditional interaction(s): 
       R2-chng     F(HC0)        df1        df2          p 
X*W      .0287     5.6515     1.0000   102.0000      .0193 
---------- 
    Focal predict: COST     (X) 
          Mod var: RecSS    (W) 
 
Conditional effects of the focal predictor at values of the moderator(s): 
 
      RecSS     Effect    se(HC0)          t          p       LLCI       ULCI 
   -15.5233    -1.9303      .3825    -5.0470      .0000    -2.6890    -1.1717 
     1.4767    -1.3606      .2046    -6.6506      .0000    -1.7664     -.9548 
    16.3567     -.8619      .2115    -4.0757      .0001    -1.2814     -.4425 
 
Data for visualizing the conditional effect of the focal predictor: 
Paste text below into a SPSS syntax window and execute to produce plot. 
 
DATA LIST FREE/ 
   COST       RecSS      QoL        . 
BEGIN DATA. 
    -8.1406   -15.5233    77.8370 
     1.7394   -15.5233    58.7652 
     5.7394   -15.5233    51.0438 
    -8.1406     1.4767    78.6360 
     1.7394     1.4767    65.1931 
     5.7394     1.4767    59.7507 
    -8.1406    16.3567    79.3353 
     1.7394    16.3567    70.8195 
     5.7394    16.3567    67.3718 
END DATA. 
GRAPH/SCATTERPLOT= 
 COST     WITH     QoL      BY       RecSS    . 
 
*********************** ANALYSIS NOTES AND ERRORS ******************
****** 
 
Level of confidence for all confidence intervals in output: 
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  95.0000 
 
W values in conditional tables are the 16th, 50th, and 84th percentiles. 
 
NOTE: A heteroscedasticity consistent standard error and covariance matrix estimator wa
s used. 
 
NOTE: The following variables were mean centered prior to analysis: 
          RecSS    COST 
 
------ END MATRIX ----- 
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APPENDIX P: MEDIATION ANALYSIS IN PROCESS 
 The PROCRESS macro for SPSS was used to simulate the linear regression 
analyses to determine mediation.  
Analysis Plan (adapted from Lawson, et al., 2014)   
Level of Measurement: Interval/ratio (DV), Interval/ratio (IV) 
Type of Design: Non-Experimental - Ex Post Facto  
Number of Samples: One sample  
Assumptions: Normal distributions, linear relationship 
 
SPSS Steps for Analysis Hypotheses 2.1 – 2.4 
(1) Open Data Set 
(2) Analyze 
(3) Regression 
(4) PROCESS v3.3 by Hayes (2017) 
(5) Move variables in to respective boxes 
a. DV into X Variable box 
b. IV into Y variable box 
c. Mediator Variable into Mediator(s) M box. 
d. (Moderated Mediator model 14 add to box Moderator W 
box – for social constraint) 
(6) Select appropriate Model (4 or 14) 
(7) Click on Options 
a. Select Show covariance, generate code for visualizing, 
show total effect (model 4 only), effect size, standardized 
coefficients, Heteroscedasticity (Huber-White). 
(8) Continue 
(9) OK to run 
 
Example: SPSS Output for Moderation Analysis 
 
Perceived Social Support mediates the relations with Financial Toxicity and Quality of 
Life (Fact-G). 
 
*************** PROCESS Procedure for SPSS Version 3.3 ******************* 
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          Written by Andrew F. Hayes, Ph.D.       www.afhayes.com 
    Documentation available in Hayes (2018). www.guilford.com/p/hayes3 
 
************************************************************************
** 
Model  : 4 
    Y  : QofL 
    X  : COST 
    M  : CompSS 
 
Sample 
Size:  126 
 
************************************************************************
** 
OUTCOME VARIABLE: 
 CompSS 
 
Model Summary 
          R       R-sq        MSE     F(HC0)        df1        df2          p 
      .4596      .2112    54.6455    34.1629     1.0000   124.0000      .0000 
 
Model 
              coeff    se(HC0)          t          p       LLCI       ULCI 
constant    60.0540     1.3842    43.3844      .0000    57.3142    62.7938 
COST         -.4384      .0750    -5.8449      .0000     -.5868     -.2899 
 
Standardized coefficients 
          coeff 
COST     -.4596 
 
Covariance matrix of regression parameter estimates: 
           constant       COST 
constant     1.9161     -.0927 
COST         -.0927      .0056 
 
************************************************************************
** 
OUTCOME VARIABLE: 
 QofL 
 
Model Summary 
          R       R-sq        MSE     F(HC0)        df1        df2          p 
      .6794      .4616   213.3253    48.3349     2.0000   123.0000      .0000 
 
Model 
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              coeff    se(HC0)          t          p       LLCI       ULCI 
constant    38.6393    11.0004     3.5125      .0006    16.8645    60.4140 
COST         -.9472      .1664    -5.6930      .0000    -1.2766     -.6179 
CompSS        .9004      .1783     5.0498      .0000      .5475     1.2534 
 
Standardized coefficients 
            coeff 
COST       -.4169 
CompSS      .3780 
 
Covariance matrix of regression parameter estimates: 
           constant       COST     CompSS 
constant   121.0099    -1.1063    -1.8931 
COST        -1.1063      .0277      .0119 
CompSS      -1.8931      .0119      .0318 
 
************************** TOTAL EFFECT MODEL ***********************
***** 
OUTCOME VARIABLE: 
 QofL 
 
Model Summary 
          R       R-sq        MSE     F(HC0)        df1        df2          p 
      .5907      .3489   255.9078    72.2851     1.0000   124.0000      .0000 
 
Model 
              coeff    se(HC0)          t          p       LLCI       ULCI 
constant    92.7123     2.9718    31.1970      .0000    86.8302    98.5944 
COST        -1.3419      .1578    -8.5021      .0000    -1.6543    -1.0295 
 
Standardized coefficients 
          coeff 
COST     -.5907 
 
Covariance matrix of regression parameter estimates: 
           constant       COST 
constant     8.8318     -.4169 
COST         -.4169      .0249 
 
************** TOTAL, DIRECT, AND INDIRECT EFFECTS OF X ON Y *******
******* 
 
Total effect of X on Y 
     Effect    se(HC0)          t          p       LLCI       ULCI       c_ps       c_cs 
    -1.3419      .1578    -8.5021      .0000    -1.6543    -1.0295     -.0680     -.5907 
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Direct effect of X on Y 
     Effect    se(HC0)          t          p       LLCI       ULCI      c'_ps      c'_cs 
     -.9472      .1664    -5.6930      .0000    -1.2766     -.6179     -.0480     -.4169 
 
Indirect effect(s) of X on Y: 
           Effect     BootSE   BootLLCI   BootULCI 
CompSS     -.3947      .1147     -.6580     -.2112 
 
Partially standardized indirect effect(s) of X on Y: 
           Effect     BootSE   BootLLCI   BootULCI 
CompSS     -.0200      .0054     -.0322     -.0109 
 
Completely standardized indirect effect(s) of X on Y: 
           Effect     BootSE   BootLLCI   BootULCI 
CompSS     -.1737      .0434     -.2680     -.0972 
 
*********************** ANALYSIS NOTES AND ERRORS ******************
****** 
 
Level of confidence for all confidence intervals in output: 
  95.0000 
 
Number of bootstrap samples for percentile bootstrap confidence intervals: 
  1000 
 
NOTE: A heteroscedasticity consistent standard error and covariance matrix estimator wa
s used. 
 
------ END MATRIX ----- 
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APPENDIX Q: NON-SIGNIFICANT ANALYSIS TABLES 
 
Hypothesis 1.1: Received social support did not moderate the relationship between 
COST and QoL (FACT-G) in the dataset with both Blood and Breast cancers. 
Table Q.1 Hypothesis 1.1 Non-significant Interaction Variable for Hypothesis 1.1. 
Variable b SE  95% CL p F (df) R2 D R2 
Predictor Variables    0.001 25.23 (3, 122) 0.38  
   Constant 67.07 1.37 [64.35, 69.79] 0.001    
   Financial Toxicity 
(centered) -1.37 0.18 [-1.72, -1.02] 0.001 
   
   Received Support 
(centered) 0.21 0.10 [0.02, 0.40] 0.3 
   
Interaction        
   Financial Toxicity 
x Received Support 0.01 0.01 [-0.01, 0.04] 0.24 1.38 (1, 122) 0.01 
 
Hypothesis 1.2: Perceived social support did not moderate the relationship between 
financial toxicity and QoL (FACT-G). 
Table Q.2:  Moderator Analysis of Perceived Social Support (Composite*)  and  FT on 
QofL. 
R2 = 0.47, F (3, 122) = 40.56, p = 0.001   
Variable b SE  t p 95% CL 
Constant 66.33 1.4 47.33 0.001 [63.55, 69.10] 
COST (centered) -0.93 0.17 -5.55 0.001 [-1.25, -0.60] 
Composite Support (centered) 0.94 0.17 5.36 0.001 [0.59, 1.28] 
COST x Composite Support -0.02 0.02 -0.99 0.32 [-0.07, 0.02] 
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Table Q.3: Emotional Perceived Support and Financial Burden Linear Model 
Predicting QoL. 
R2 = 0.46, F (3, 122) = 35.87, p = 0.001   
Variable b SE  t p 95% CL 
Constant 67.17 1.36 49.25 0.001 [64.47, 69.87] 
COST (centered) -1.04 0.16 -6.68 0.001 [-1.35, -0.73] 
Emotional Support (centered) 0.82 0.17 4.84 0.001 [0.48, 1.15] 
COST x Emotional Support 0.004 0.02 0.22 0.82 [-0.03, 0.04] 
 
 
Table Q.4: Informational Perceived Support and Financial Burden Linear Model 
Prediction QoL. 
R2 = 0.43, F (3, 122) = 32.01, p = 0.001   
Variable b SE  t p 95% CL 
Constant 66.89 1.42 47.25 0.001 [64.09, 69.69] 
COST (centered) -1.03 0.17 -6.12 0.001 [-1.36, -0.70] 
Informational Support (centered) 0.63 0.16 4.08 0.001 [0.33, 0.94] 
COST x Informational Support 0.004 0.02 -0.26 0.8 [-0.38, 0.03] 
 
 
Table Q.5: Instrumental Perceived Support and Financial Burden Linear Model 
Prediction QoL. 
R2 = 0.44, F (3, 122) = 41.17, p = 0.001   
Variable b SE  t p 95% CL 
Constant 65.92 1.44 45.78 0.001 [63.07, 68.77] 
COST (centered) -1.09 0.16 -6.78 0.001 [-1.42, -0.77] 
Instrumental Support (centered) 0.59 0.15 3.97 0.001 [0.30, 0.88] 
COST x Instrumental Support -0.33 0.02 -1.88 0.06 [-0.069, 0.00] 
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Hypothesis 1.3: Received social support will moderate the relationship between 
financial burden and QoL (FACT-G Plus).  
Table Q.6 Received Social Support and Financial Burden Linear Model of QoL 
with economic well-being. 
Variable b SE t p 95% CL 
Constant 111.42 1.89 58.99 0.001 [107.68, 115.16] 
COST (centered) -2.54 0.25 -9.93 0.001 [-3.05, -2.04] 
Received Support 
(centered) 0.37 0.12 3.06 0.03 [0.13, 0.62] 
COST x 
Received Support 0.03 0.02 1.63 0.11 [-0.05, 0.06] 
 
Hypothesis 1.4: Perceived social support will moderate the relationship between 
financial burden and QoL (FACT-G Plus).  
Table Q.7: Composite Perceived Support and Financial Burden Linear Model for QoL 
with Socio-economic Well-being. 
R2 = 0.59, F (3, 122) = 61.61, p = 0.001   
Variable b SE  t p 95% CL 
Constant 110.43 1.91 57.88 0.001 [106.66, 114.21] 
COST (centered) -1.87 0.24 -7.68 0.001 [-2.35, -1.38] 
Composite Support 
(centered) 1.41 0.25 5.71 0.001 [0.92, 1.89] 
COST x Composite 
Support -0.03 0.03 -1.02 0.31 [-0.04, 0.04] 
 
Table Q.8: Emotional Perceived Support and Financial Burden Linear Model for QoL 
with Socio-economic Well-being. 
R2 = 0.58, F (3, 122) = 57.99, p = 0.001   
Variable b SE  t p 95% CL 
Constant 111.59 1.91 58.35 0.001 [107.81, 115.38] 
COST (centered) -2.05 0.24 -8.52 0.001 [-2.53, -1.57] 
Emotional Support 
(centered) 1.2 0.24 4.9 0.001 [0.71, 1.68] 
COST x Emotional 
Support 0.01 0.03 0.3 0.77 [-0.04, 0.06] 
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Table Q.9: Informational Perceived Support and Financial Burden Linear Model for 
QoL with Socio-economic Well-being. 
R2 = 0.57, F (3, 122) = 51.27, p = 0.001   
Variable b SE  t p 95% CL 
Constant 111.46 1.96 56.92 0.001 [107.59, 115.34] 
COST (centered) -2.01 0.25 -8.06 0.001 [-2.50, -1.52] 
Informational Support 
(centered) 0.98 0.22 4.51 0.001 [0.55, 1.42] 
COST x Informational 
Support 0 0.02 0.11 0.91 [-0.38, 0.04] 
 
 
Table 7.20: Instrumental Perceived Support and Financial Burden Linear Model for 
QoL with Socio-economic Well-being. 
R2 = 0.56, F (3, 122) = 64.07, p = 0.001   
Variable b SE  t p 95% CL 
Constant 109.62 1.96 55.87 0.001 [105.73, 113.50] 
COST (centered) -2.12 0.23 -9.33 0.001 [-2.57, -1.67] 
Instrumental Support 
(centered) 0.88 0.2 4.38 0.001 [0.48, 1.27] 
COST x Instrumental 
Support -0.05 0.02 -2.11 0.04 [-0.101, 0.003] 
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